株探米国株
英語
エドガーで原本を確認する
0001867443 false 0001867443 2023-06-15 2023-06-15 0001867443 CNGLU:UnitsEachConsistingOfOneShareOfClassCommonStockParValue0.000001PerShareAndOneRedeemableWarrantOfOneShareOfCommonStockMember 2023-06-15 2023-06-15 0001867443 CNGLU:ClassCommonStockIncludedAsPartOfUnitsMember 2023-06-15 2023-06-15 0001867443 CNGLU:RedeemableWarrantsIncludedAsPartOfUnitsMember 2023-06-15 2023-06-15 0001867443 CNGLU:RepresentativesSharesOfClassCommonStockMember 2023-06-15 2023-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 15, 2023

 

Canna-Global Acquisition Corp

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-41102   86-3692449
(Commission File Number)   (IRS Employer Identification No.)

 

4640 Admiralty Way, Suite 500

Marina Del Rey, California 90292

(Address of principal executive offices, including zip Code)

 

310-496-5700

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

  Name of Each Exchange on Which Registered
Units, each consisting of one share of Class A common stock, par value $0.000001 per share and one redeemable warrant of one share of Common Stock   CNGLU   The Nasdaq Stock Market LLC
Class A common stock included as part of the units   CNGL   The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units   CNGLW   The Nasdaq Stock Market LLC
Representative’s shares of Class A common stock   CNGL   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement

 

Bid Implementation and Business Combination Agreement

 

The following summary and description of the Agreement does not purport to be complete, describes the material provisions of the Agreement (as defined below), and is qualified in its entirety by reference to the full text of the Agreement filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated by reference. Unless otherwise defined herein, the capitalized terms used in this Current Report on Form 8-K are defined in the Agreement.

 

General Terms and Effects; Closing

 

On June 15, 2023, Canna-Global Acquisition Corp, a Delaware corporation (“Canna-Global”), entered into a definitive Bid Implementation and Business Combination Agreement (the “Agreement”) with New Quantum Holdings Pty Ltd. (“New Quantum” or the “Company”), along with J. Gerald Combs, solely in his capacity as the representative from and after the Effective Time (as defined below) for the stockholders of Canna-Global, and Hyun Jong Chung, solely in his capacity as the representative from and after the Effective Time for New Quantum in accordance with the terms and conditions of the Agreement (collectively, the “Parties”). The transactions contemplated in the Agreement are in connection with Canna-Global’s initial business combination and are hereinafter referred to as the “Business Combination” and the underlying transactions contemplated therein as the “Transactions.”

 

New Quantum is an Australian fintech B2B company that provides, along with its subsidiaries, global unified fintech as a service (FaaS), delivering a fully integrated digital platform for wealth managers, family offices, governments, asset managers, fintech businesses, and financial advisors. New Quantum’s operating system for financial services firms, combined with the financial infrastructure of the newly acquired Morrison Securities from the ASX-listed, Sequoia Financial Group (ASX:SEQ) in June 2023, represents a vertically integrated business model to financial services firms.

 

The Agreement provides that, among other things, and upon the terms and subject to the conditions thereof, at closing of the Business Combination (the “Closing”), Canna Global will acquire all of the ordinary shares of New Quantum and New Quantum will become a wholly-owned subsidiary of Canna-Global, and Canna-Global’s Class A Common Stock will be listed on the Nasdaq Global Market under the ticker symbol “NQ.”

 

As part of the Transactions, Canna-Global will amend and restate its Second Amended and Restated Certificate of Incorporation (the “Charter”) to, among other matters: (a) change its name to “New Quantum Corporation” or such other name as mutually agreed to by the Parties; (b) reduce Canna-Global’s board of directors (the “Board”) to five individuals divided into three classes; and (c) remove and change certain provisions in the Charter related to Canna-Global’s status as a blank check company. Additionally, each then-outstanding share of Class B Common Stock of Canna-Global will be converted into one share of Class A Common Stock.

 

 
 

 

The Business Combination is expected to close in the second half of 2023, following the receipt of the required approval by Canna-Global’s stockholders and the fulfillment of each Party’s closing conditions.

 

Exchange Consideration

 

In accordance with the terms and subject to the conditions of the Agreement, and contingent upon the Closing, as consideration for the Business Combination, New Quantum shareholders collectively shall be entitled to receive from Canna-Global, in full payment for their ordinary shares in New Quantum, Canna-Global shall issue and deliver to the New Quantum shareholders that number of Canna-Global Class A Common Stock (the “Consideration Shares”) determined as follows: Eight Hundred Million U.S. Dollars ($800,000,000), plus (or minus if negative) (ii) (A) the Net Working Capital (as defined in the Agreement) less (B) the Company Net Working Capital Amount (as defined in the Agreement) minus (iii) the Closing Net Debt (as defined in the Agreement), minus (iv) the amount of any unpaid Transaction Expenses (as defined in the Agreement), and plus (v) the SPAC Closing Net Debt (as defined in the Agreement), and plus (vi) the Escrow Amount (as defined in the Agreement), with the aggregate of items (i) to (vi) being divided by $10.00 being the value of each share of Canna-Global Class A Common Stock (as equitably adjusted for share splits, share dividends, combinations, recapitalizations and the like after the Closing).

 

Each New Quantum shareholder shall receive that number of Consideration Shares based on the number of the ordinary shares of New Quantum owned by such New Quantum shareholder, divided by the total number of the ordinary shares of the New Quantum owned by all New Quantum shareholders (such percentage being each such New Quantum shareholder’s “Pro Rata Share”) as set forth opposite the name of each New Quantum shareholder on Annex I of the Agreement. For the avoidance of doubt, no cash consideration is payable by Canna-Global (the “Exchange”). Following the Exchange, the New Quantum shareholders will become shareholders of Canna-Global and New Quantum will continue as a wholly-owned subsidiary of Canna-Global. Each New Quantum shareholder, upon receiving the Canna-Global Class A Common Stock, will cease to have any other rights in and to the ordinary shares of New Quantum.

 

Representations and Warranties

 

The Agreement contains customary representations and warranties made by each of Canna-Global and New Quantum as of the date of the Agreement or other specified dates, in each case relating to, among other things, organization and qualification, governing documents, capitalization, authority, no conflicts and absence of litigation. Many of the representations and warranties are qualified by materiality or Material Adverse Effect. As used in the Agreement, “Material Adverse Effect” means, with respect to any specified person or entity, any fact, event, occurrence, change or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (i) the business, assets, liabilities, results of operations or condition (financial or otherwise) of such person or entity and its subsidiaries, taken as a whole, or (ii) the ability of such person or entity or any of its subsidiaries on a timely basis to consummate the transactions contemplated by the Agreement or the ancillary documents to which it is a party or bound or to perform its obligations thereunder, in each case, subject to certain customary exceptions. The Agreement also contains thresholds for claims arise from a breach of representations and warranties of New Quantum, subject to certain limitations. For a single claim, the threshold is USD$250,000, and for the aggregate of all claims, the threshold is USD$3,000,000.

 

No Survival

 

The representations and warranties of the Parties contained in the Agreement terminate as of, and do not survive, the Closing, and there are no indemnification rights for another Party’s breach. The covenants and agreements of the parties contained in the Agreement do not survive the Closing, except those covenants and agreements to be performed after the Closing, which covenants and agreements will survive until fully performed in accordance with their terms.

 

Covenants of the Parties

 

Each party agreed in the Agreement to use its commercially reasonable efforts to effect the Closing and to comply as promptly as practicable with all requirements of governmental authorities applicable to the transactions contemplated by the Agreement. The Agreement also contains, subject to certain exceptions, certain customary covenants by each of the parties during the period from the date of the Agreement and continuing until the earlier of the termination of the Agreement in accordance with its terms or the Closing (the “Interim Period”), including (i) the provision of access to their properties, books and personnel; (ii) the operation of their respective businesses in the ordinary course of business; (iii) the provision of certain specified financial statements by New Quantum to Canna-Global; (iv) Canna-Global’s public filings; (v) no insider trading; (vi) notifications of certain breaches, consent requirements or other matters; (vii) efforts to consummate the Business Combination; (viii) tax matters; (ix) further assurances; (x) public announcements; and (xi) confidentiality. Canna-Global will use commercially reasonable efforts to obtain financing that is reasonably acceptable to New Quantum (a “Transaction Financing”) in order to cause the Minimum Cash Requirement to be satisfied and New Quantum and its representatives will reasonably cooperate with Canna-Global in connection with such efforts. The Agreement also contains certain customary post-Closing covenants regarding indemnification of directors and officers and the purchase of tail directors’ and officers’ liability insurance and use of Trust Account proceeds. In addition, New Quantum agreed to obtain its required shareholder approvals in the manner required under its organizational documents and applicable law for, among other things, the adoption and approval of the Agreement and each of the ancillary documents to which New Quantum is or is required to be a party or bound, and the consummation of the Business Combination.

 

 
 

 

Registration Statement on Form S-4

 

The parties made customary covenants regarding the Registration Statement, in connection with the registration under the Securities Act of 1933, as amended (the “Securities Act”) of the shares of Canna-Global Class A Common Stock to be issued under the Agreement as the Consideration Shares. The Registration Statement also will contain the Canna-Global proxy statement to solicit proxies from Canna-Global’s stockholders to approve, among other things, unless otherwise agreed to between Canna-Global and New Quantum (i) the Agreement and the Transactions, including the issuance of Canna-Global’s securities in connection with the Business Combination; (ii) the adoption and approval of the amended and restated Canna-Global Charter, among other matters, (a) provide that the name of Canna-Global shall be changed to “New Quantum Corporation” or such other name as mutually agreed to by Canna-Global and New Quantum before Closing of the Agreement, (b) provide for size and structure of the board of directors of Canna-Global in accordance with the Agreement, and (c) remove and revise certain provisions in the certificate of incorporation related to Canna-Global’s status as a blank check company; (iii) the adoption and approval of a new equity incentive plan (the “Incentive Plan”); and (iv) the appointment of the members of the board of directors of Canna-Global in accordance with the Agreement.

 

Conditions to Each Party’s Obligations to Close

 

Pursuant to the Agreement, the obligations of the Parties to consummate the Business Combination are subject to the satisfaction or waiver of certain customary closing conditions of the respective Parties, including, without limitation (i) the representations and warranties of the respective Parties being true and correct subject to the materiality standards contained in the Agreement; (ii) material compliance by the Parties of their respective pre-closing covenants and agreements, subject to the standards contained in the Agreement; (iii) the approval by Canna-Global’s stockholders of the Business Combination; (iv) no governmental authority shall have enacted any law or order which has the effect of prohibiting the consummation of the Business Combination; (v) a Registration Statement on Form S-4 containing a prospectus and proxy statement (as amended or supplemented, the “Prospectus and Proxy Statement”) shall have been declared effective by the Securities and Exchange Commission (the “SEC”) and shall remain effective as of the Closing, and no stop order or similar order shall be in effect with respect to the Prospectus and Proxy Statement; and (vi) the members of the post-Closing board of directors of the combined company shall have been elected or appointed as of the Closing in accordance with the requirements set forth in the Agreement.

 

Termination

 

The Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing. If the Agreement is terminated, all further obligations of the parties related to public announcements, confidentiality, document retention, fees and expenses, trust account waiver, termination and general provisions under the Agreement will terminate and will be of no further force and effect, and no party to the Agreement will have any further liability to any other party thereto except for liability for certain fraud claims or for willful breach of the Agreement prior to the termination.

 

The Agreement may be terminated at any time prior to the Closing by either Canna-Global or New Quantum if the Closing has not occurred on or prior to December 2, 2023 (the “Business Combination Deadline”) unless Canna-Global, at its election, receives shareholder approval for a Charter amendment to extend the term it has to consummate a business combination (“Extension Option”), for Canna-Global to consummate a business combination pursuant to the Charter amendment. A party is not entitled to terminate the Agreement if the failure of the Closing to occur by such date was caused by or the result of a breach of the Agreement by such Party.

 

The Agreement may also be terminated under certain other customary and limited circumstances prior the Closing, including, among other reasons by mutual written consent of Canna-Global and New Quantum; by New Quantum for Canna-Global’s material uncured breach of the Agreement, if the breach would result in the failure of the related Closing condition; by Canna-Global for the material uncured breach of the Agreement by New Quantum, if the breach would result in the failure of the related Closing condition; by Canna-Global if there has been a Material Adverse Effect with respect to New Quantum since the date of the Agreement, which is uncured; by either Canna-Global or New Quantum if Canna-Global holds an extraordinary general meeting of its shareholders to approve the Agreement and the Business Combination and such approval is not obtained, among other reasons set forth in the Agreement.

 

 
 

 

Governing Law

 

The Agreement and all claims related to the Business Combination shall be governed by the laws of the State of Delaware.

 

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement’s full text filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated by reference. The Agreement has been filed to provide investors with information regarding its terms and is not intended to provide any factual or other information about Canna-Global, New Quantum or any other Party to the Agreement. In particular, the assertions embodied in the representations and warranties contained in the Agreement were made as of the execution date of the Agreement only and are qualified by information in confidential disclosure schedules provided by the parties in connection with the signing of the Agreement. Moreover, certain representations and warranties in the Agreement may have been used for the purpose of allocating risk between the parties rather than establishing matters of fact and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors and reports and documents filed with the SEC. Accordingly, you should not rely on the representations and warranties in the Agreement as characterizations of the actual statements of fact about the parties. In addition, the representations, warranties, covenants and agreements and other terms of the Agreement may be subject to subsequent waiver or modification. Moreover, information concerning the subject matter of the representations and warranties and other terms may change after the date of the Agreement, which subsequent information may or may not be fully reflected in Canna-Global’s public disclosures. Shareholders of Canna-Global and other interested parties are urged to read the Agreement in its entirety.

 

Sponsor Support Agreement

 

At or prior to the Effective Time (as defined in the Agreement), Canna-Global, New Quantum, and Canna-Global LLC, a Delaware limited liability company (the “Sponsor”), will enter into a sponsor support agreement (the “Sponsor Support Agreement”) pursuant to which the Sponsor will agree to, among other things, (i) appear at the Canna-Global shareholders’ meeting for purposes of constituting a quorum, and (ii) vote to adopt and approve the Agreement and the other documents and transactions contemplated under the Agreement, including the Business Combination. The foregoing description of the Sponsor Support Agreement is subject to and qualified in its entirety by reference to the full text of the form of the Sponsor Support Agreement, a copy of which is included as Exhibit 2.1 hereto, and the terms of which are incorporated by reference.

 

Lock-Up Agreement

 

At or prior to the Effective Time, the Significant Company Holders (as defined in the Agreement), the Key Sponsor (each as defined in the Agreement) of New Quantum, and each one percent (1%) or greater shareholders of New Quantum (the “One-Percent Shareholders”) will be asked to sign the Lock-Up Agreement, pursuant to which each of the Significant Company Holders, the Key Sponsor of New Quantum and the One-Percent Shareholders agree that their shares of Canna-Global Class A Common Stock will be locked up during the period commencing from the Closing and ending (i) 12 months from the Closing, at which time 75% of the shares will be released from lock-up; and (ii) 18 months from the Closing, at which time the remaining 25% will be released from lock-up (the “Restricted Securities”). The foregoing description of the Lock-Up Agreement is subject to and qualified in its entirety by reference to the full text of the Lock-Up Agreement, a copy of which is included as Exhibit 2.2 hereto, and the terms of which are incorporated by reference.

 

Non-Competition and Non-Solicitation Agreement

 

Simultaneously with the execution and delivery of the Agreement, each Key Executive of New Quantum (as defined in the Agreement) will execute a Non-Competition and Non-Solicitation Agreement (collectively, the “Non-Competition Agreements”) in favor of Canna-Global. The foregoing description of the Non-Competition Agreements is subject to and qualified in its entirety by reference to the full text of the Non-Competition Agreements, a form of which is included as Exhibit 2.3 hereto, and the terms of which are incorporated by reference.

 

 
 

 

PIPE Investment

 

In connection with entry into the Agreement, Canna-Global may use commercially reasonable efforts as practicable, after the date of the Agreement and at or prior to the End Date, to enter into and consummate subscription agreements with investors relating to a private equity investment in Canna-Global to purchase shares of Canna-Global in connection with a private placement, and/or enter into backstop arrangements with potential investors, in either case on terms mutually agreeable to New Quantum and Canna-Global, acting reasonably (a “PIPE Investment”). Likewise, New Quantum may enter into one or private equity investments before the Closing, as provided in the Agreement. The foregoing description of the PIPE Investment does not purport to be complete and is qualified in its entirety by the terms and conditions of the subscription agreements related to the PIPE Investment entered into from time-to-time.

 

Registration Rights Agreement

 

At or prior to the Effective Time, the Sponsor, certain New Quantum shareholders and their respective affiliates, will enter into a registration rights agreement (the “Registration Rights Agreement”), pursuant to which, among other things, Canna Global will be obligated to file a registration statement after Closing to register the resale of certain securities of New Quantum held by the Sponsor, certain New Quantum shareholders and their respective affiliates. The Registration Rights Agreement will also provide the respective parties with “piggy-back” registration rights, subject to certain requirements and customary conditions. The foregoing description of the Registration Rights Agreement is subject to and qualified in its entirety by reference to the full text of the form of Registration Rights Agreement, a copy of which is included as Exhibit 2.4 hereto, and the terms of which are incorporated by reference.

 

Bidder’s Statement

 

As promptly as practicable after the effective date of the Agreement, Canna-Global will lodge a Bidder’s Statement with the Australian Securities and Investments Commission (“ASIC”) in respect of its Takeover Bid for New Quantum in accordance with Chapter 6 of the Australian Act and the terms of the Agreement. The foregoing description of the Bidder’s Statement does not purport to be complete.

 

Joinder Agreement

 

At or prior to Effective Time, Canna-Global, J. Gerald Combs, solely in his capacity as the representative for the stockholders of Canna-Global, New Quantum, Hyun Jong Chung, solely in his capacity as the representative of New Quantum, will execute a joinder agreement to the Agreement (the “Joinder Agreement”) with Significant Company Holders of New Quantum. The foregoing description of the Joinder Agreement is subject to and qualified in its entirety by reference to the full text of the Joinder Agreement, a form of which is included as Exhibit 2.6 hereto, and the terms of which are incorporated by reference.

 

Prospectus and Proxy Statement

 

As promptly as practicable after the effective date of the Agreement, Canna-Global will file with the SEC the Prospectus and Proxy Statement and certain related documents in connection with a meeting of Canna-Global’s shareholders to consider approval and adoption of (i) the Agreement and the Business Combination; (ii) any other proposals as either the SEC or the Nasdaq Global Market (or the respective staff members thereof) may indicate are necessary in comments to the Prospectus and Proxy Statement or in correspondence related thereto; (iii) any other proposals as reasonably agreed by Canna-Global and New Quantum to be necessary or appropriate in connection with the Business Combination; and (4) the adjournment of the special meeting, if necessary, to permit further solicitation of proxies because there are not sufficient votes to approve and adopt one or more of the foregoing.

 

Item 7.01 Regulation FD Disclosure

 

Press Release

 

On June 15, 2023, Canna-Global issued two press releases announcing the execution of the Agreement. The press releases are attached as Exhibit 99.1 and Exhibit 99.2 respectively. The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is being furnished and will not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”).

 

 
 

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “outlook” or words of similar meaning. These forward-looking statements include, but are not limited to, statements regarding New Quantum’s industry and market sizes, future opportunities for Canna-Global and New Quantum, Canna-Global’s and New Quantum’s estimated future results and the Business Combination, including the implied enterprise value, the Business Combination and ownership structure and the likelihood and ability of the parties to successfully consummate the Business Combination. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

 

The Press Release contains statements that constitute “forward-looking statements,” including with respect to the Business Combination, within the meaning of the federal securities laws. Forward-looking statements may include, but are not limited to, statements with respect to New Quantum’s products, the likelihood of regulatory approval of such products and their proposed uses; New Quantum’s growth prospects and its potential target markets, as well as the size of those markets; New Quantum’s projected financial and operational performance; new product and service offerings New Quantum may introduce in the future; the potential Business Combination, including the implied enterprise value, the expected post-closing ownership structure and the likelihood and ability of the parties to successfully consummate the Business Combination; the anticipated effect of the announcement or pendency of the Business Combination on Canna-Global or New Quantum’s business relationships, performance, and business generally; and other statements regarding Canna-Global’s and New Quantum’s expectations, hopes, beliefs, intentions or strategies regarding the future.

 

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Prospectus and Proxy Statement, other documents filed by Canna-Global from time to time with SEC, and any risk factors made available to you in connection with Canna-Global, New Quantum and the Business Combination. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of Canna-Global and New Quantum), and other assumptions, that may cause the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. No assurance can be given that the Business Combination discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Canna-Global. Copies of these documents are or will be available on the SEC’s website, www.sec.gov. Canna-Global undertakes no obligation to update these statements for revisions or changes after the date of this Current Report on Form 8-K, except as required by law.

 

In addition to factors previously disclosed in Canna-Global reports filed with the SEC and those identified elsewhere in this Current Report on Form 8-K, the following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: (i) the risk that the Business Combination may not be completed in a timely manner or at all, which may adversely affect the price of Canna-Global securities; (ii) the risk that the Business Combination may not be completed by the Business Combination Deadline and the potential failure to obtain the Extension Option, if sought; (iii) the failure to satisfy the conditions to the consummation of the Business Combination, including the adoption of the Agreement by the shareholders of Canna-Global, the satisfaction of the minimum cash amount following redemptions by Canna-Global public shareholders, (iv) the receipt of certain governmental and regulatory approvals; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the Agreement; (vi) the potential effect of the announcement or pendency of the Business Combination on New Quantum’s business relationships, performance and business generally; (vii) risks that the Business Combination disrupts current plans and operations of New Quantum; (viii) the outcome of any legal proceedings that may be instituted against New Quantum or Canna-Global related to the Agreement or the Business Combination; (ix) the risk that Canna-Global will be unable to maintain the listing of Canna-Global’s securities on the Nasdaq Global Market; (x) the risk that the price of Canna-Global’s securities, including following the Closing, may be volatile due to a variety of factors, including changes in the competitive and regulated industries in which New Quantum operates, variations in performance across competitors, changes in laws and regulations affecting New Quantum’s business and changes in the capital structure; (xi) the inability to implement business plans, forecasts, and other expectations after the completion of the Business Combination and identify and realize additional opportunities; (xii) the risk of downturns and the possibility of rapid change in the highly competitive industry in which New Quantum operates, (xiii) the risk of changes in applicable law, rules, regulations, regulatory guidance, or social conditions in the countries in which New Quantum’s customers and suppliers operate in that could adversely impact New Quantum’s operations or the market generally for special purpose acquisition companies; (xiv) the risk of supply chain and supply route challenges, including COVID-19, could result in delays or increased costs for New Quantum and partners deploying their technologies; (xv) the risk that New Quantum may not achieve or sustain profitability; (xvi) the risk that New Quantum will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; (xvii) the risk that New Quantum experiences difficulties in managing its growth and expanding operations; (xviii) changes in overall economic conditions that impact spending on New Quantum’s products; and (xix) deterioration in conditions of the money management industry or in broader economic conditions.

 

 
 

 

Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. All information set forth herein speaks only as of the date hereof in the case of information about Canna-Global and New Quantum or the date of such information in the case of information from persons other than Canna-Global or New Quantum, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this Current Report on Form 8-K. Forecasts and estimates regarding New Quantum’s industry and end markets are based on sources we believe to be reliable, however there can be no assurance these forecasts and estimates will prove accurate in whole or in part. Annualized, pro forma, projected, and estimated numbers are used for illustrative purpose only, are not forecasts and may not reflect actual results.

 

Additional Information and Where to Find It

 

In connection with the Business Combination, Canna-Global intends to file relevant materials with the SEC, including the Prospectus and Proxy Statement and other documents regarding the Business Combination. CANNA-GLOBAL’S SHAREHOLDERS AND OTHER INTERESTED PERSONS ARE ADVISED TO READ THIS CURRENT REPORT ON FORM 8-K AND, WHEN AVAILABLE, THE PROSPECTUS AND PROXY STATEMENT AND DOCUMENTS INCORPORATED BY REFERENCE THEREIN FILED IN CONNECTION WITH THE BUSINESS COMBINATION, AS THESE MATERIALS WILL CONTAIN IMPORTANT INFORMATION ABOUT NEW QUANTUM, CANNA-GLOBAL, AND THE BUSINESS COMBINATION. Promptly after the Prospectus and Proxy Statement is declared effective by the SEC, Canna-Global will mail the definitive Prospectus and Proxy Statement and a proxy card to each shareholder of Canna-Global entitled to vote at the meeting relating to the approval of the Business Combination and other proposals set forth in the Prospectus and Proxy Statement. Before making any voting or investment decision, investors, and shareholders of Canna-Global are urged to carefully read the entire Prospectus and Proxy Statement, when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the Business Combination. Documents filed by Canna-Global with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov (Commission File No: 001-41102) or by directing a request to Canna-Global Acquisition Corp, 4640 Admiralty Way, Suite 500, Marina Del Rey, California, 90292.

 

Participants in the Solicitation

 

Canna-Global, Canna-Global LLC (Canna-Global’s sponsor) and New Quantum and their respective directors and officers and other members of management and employees may be deemed participants in the solicitation of proxies in connection with the proposed Business Combination. Canna-Global stockholders and other interested persons may obtain, without charge, more detailed information regarding directors and officers of Canna-Global in the final prospectus of Canna-Global filed with the SEC on November 29, 2021, the Registration Statement and other relevant materials filed with the SEC in connection with the proposed Business Combination when they become available. These documents can be obtained free of charge from the sources indicated above.

 

 
 

 

No Offer or Solicitation

 

This Current Report on Form 8-K shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the Business Combination. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, and there shall be no sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
1.1*  

Bid Implementation and Business Combination Agreement, dated as of June 15, 2023, by and among Canna-Global Acquisition Corp and New Quantum Holdings Pty Ltd., an Australian company with Australian Company Number (ACN) 628 253 743, along with J. Gerald Combs, solely in his capacity as the representative for the stockholders of Canna-Global and Hyun Jong Chung, solely in his capacity as the representative for New Quantum.

     
2.1   Sponsor Support Agreement, dated as of June 15, 2023, by and among Canna-Global, New Quantum, and Canna-Global LLC, a Delaware limited liability company.
     
2.2  

Form of Lock-Up Agreement by and among each of the Significant Company Holders, the Key Sponsor and the One-Percent Shareholders.

     
2.3   Form of Non-Competition and Non-Solicitation Agreement
     
2.4   Form of Registration Rights Agreement by and among Canna-Global, Canna-Global LLC and certain directors of Canna-Global
     
2.5  

Form of Letter of Transmittal for Securities of New Quantum Holdings Pty Ltd. surrendered for payment pursuant to the Bid Implementation and Business Combination Agreement by and among Canna-Global Acquisition Corp, J. Gerald Combs, Hyun Jong Chung, and New Quantum Holdings Pty Ltd.

     
2.6  

Joinder Agreement to Bid Implementation and Business Combination Agreement

     

99.1

  Press Release dated June 15, 2023
     
99.2   Press Release dated June 15, 2023
     
104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101). Canna-Global agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon request.

 

* Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act, Canna-Global has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CANNA-GLOBAL ACQUISITION CORP
   
Date: June 16, 2023 By: /s/ J. Gerald Combs
    J. Gerald Combs
    Chief Executive Officer

 

 

 

EX-1.1 2 ex1-1.htm

 

Exhibit 1.1 

 

CONFIDENTIAL

 

 

 

BID IMPLEMENTATION AND BUSINESS COMBINATION AGREEMENT

 

by and among

 

CANNA-GLOBAL ACQUISITION CORP.,

 

as Purchaser,

 

J. GERALD COMBS,
in the capacity as the Purchaser Representative,

 

 

NEW QUANTUM HOLDINGS PTY LTD.,

 

as the Company,

 

HYUN JONG CHUNG,
in his capacity as the Company Representative,

 

 

 

Dated as of June 15, 2023

 

 

 

 

 

ARTICLE I TAKEOVER BID 2
   
  1.1 General Obligations. 2
  1.2 Access to People and Information. 3
  1.3 Implementation Obligations of Company. 3
  1.4 Post-Closing Board. 3
       
ARTICLE II THE TAKEOVER OFFER 4
   
  2.1 Takeover Offer by Purchaser. 4
  2.2 Conditions of the Takeover Offer. 4
  2.3 Status of the Conditions. 4
  2.4 Takeover Offer Period. 4
  2.5 Variation. 5
       
ARTICLE III DOCUMENTATION AND RECOMMENDATION OF COMPANY DIRECTORS 5
   
  3.1 Purchaser’s obligations to prepare documentation. 5
  3.2 Company’s Obligations to Prepare Documentation. 5
  3.3 Provision of Information. 5
  3.4 Recommendation of Company Directors. 5
  3.5 Review of Bidder’s Statement and Target’s Statement. 6
  3.6 Timetable. 6
  3.7 Consent to Early Dispatch of Bidder’s Statement. 6
  3.8 No Solicitation. 6
       
ARTICLE IV CONSIDERATION 8
   
  4.1 Takeover Offer Consideration. 8
  4.2 Preference Shares Consideration. 9
       
ARTICLE V REPRESENTATIONS AND WARRANTIES OF PURCHASER 9
   
  5.1 Organization and Standing. 9
  5.2 Authorization; Binding Agreement. 9
  5.3 Governmental Approvals. 10
  5.4 Non-Contravention. 10
  5.5 Capitalization. 10
  5.6 SEC Filings and Purchaser Financials. 11
  5.7 Absence of Certain Changes. 12
  5.8 Compliance with Laws. 12
  5.9 Actions; Orders; Permits. 12
  5.10 Taxes and Returns. 12
  5.11 Employees and Employee Benefit Plans. 12
  5.12 Properties. 13
  5.13 Material Contracts. 13
  5.14 Transactions with Affiliates. 13
  5.15 Investment Company Act. 13
  5.16 Finders and Brokers. 13
  5.17 Ownership of Takeover Offer Consideration. 13
  5.18 Certain Business Practices. 13
  5.19 Insurance. 14
  5.20 Purchaser Trust Account. 14
  5.21 Independent Investigation. 14
       
ARTICLE VI REPRESENTATIONS AND WARRANTIES OF THE COMPANY 15
   
  6.1 Organization and Standing. 15
  6.2 Authorization; Binding Agreement. 15
  6.3 Capitalization. 16
  6.4 Subsidiaries. 16

 

i

 

  6.5 Governmental Approvals. 17
  6.6 Non-Contravention. 17
  6.7 Financial Statements. 17
  6.8 Absence of Certain Changes. 19
  6.9 Compliance with Laws. 19
  6.10 Company Permits. 19
  6.11 Litigation. 19
  6.12 Material Contracts. 19
  6.13 Intellectual Property. 21
  6.14 Taxes and Returns. 23
  6.15 Real Property. 24
  6.16 Personal Property. 24
  6.17 Title to and Sufficiency of Assets. 25
  6.18 Employee Matters. 25
  6.19 Benefit Plans. 26
  6.20 Environmental Matters. 27
  6.21 Transactions with Affiliates. 27
  6.22 Insurance. 27
  6.23 Books and Records. 28
  6.24 Top Customers and Suppliers. 28
  6.25 Certain Business Practices. 28
  6.26 Compliance with Privacy Laws, Privacy Policies and Certain Contracts. 28
  6.27 Investment Company Act. 29
  6.28 Finders and Brokers. 29
  6.29 Independent Investigation. 30
  6.30 Information Supplied. 30
  6.31 Disclosure. 30
  6.32 Notice of Claims. 30
  6.33 Company to Consider Claims. 30
  6.34 Small Claims. 31
  6.35 Time Limits for Claims. 31
  6.36 General Limits on Types of Claims. 31
  6.37 Purchaser Must Pursue Third Party. 32
  6.38 Benefits Received. 32
  6.39 Mitigation. 32
  6.40 Other Actions. 32
  6.41 Materiality Adverse Effect. 32
       
ARTICLE VII COVENANTS 32
   
  7.1 Access and Information. 32
  7.2 Conduct of Business of the Company. 33
  7.3 Conduct of Business of Purchaser. 35
  7.4 Annual and Interim Financial Statements. 37
  7.5 Purchaser Public Filings. 37
  7.6 No Trading. 37
  7.7 Notification of Certain Matters. 38
  7.8 Efforts. 38
  7.9 Tax Matters. 39
  7.10 Further Assurances. 40
  7.11 The Registration Statement. 40
  7.12 Public Announcements. 42
  7.13 Confidential Information. 42
  7.14 Documents and Information. 43
  7.15 Post-Closing Board of Directors and Executive Officers. 43
  7.16 Indemnification of Directors and Officers; Tail Insurance. 44
  7.17 Use of Trust Account Proceeds. 44

 

ii

 

  7.18 PIPE Investment. 44
  7.19 New Equity Incentive Plan. 45
  7.20 Purchaser Completion Obligation. 45
  7.21 Company Closing Obligations. 46
       
ARTICLE VIII NON-SURVIVAL OF REPRESENTATIONS, WARRANTIES AND COVENANTS 47
   
ARTICLE IX CLOSING CONDITIONS 48
   
  9.1 Conditions to Each Party’s Obligations. 48
  9.2 Frustration of Conditions. 48
       
ARTICLE X TERMINATION AND EXPENSES 49
   
  10.1 Termination. 49
  10.2 Effect of Termination. 49
  10.3 Fees and Expenses. 50
  10.4 Reserved. 50
  10.5 Limitation of Liability for Acquisition Parties. 50
  10.6 Limitation of Liability of Company Representative and Purchaser Representative. 50
       
ARTICLE XI WAIVERS AND RELEASES 50
   
  11.1 Waiver of Claims Against Trust. 50
  11.2 Release and Covenant Not to Sue. 51
       
ARTICLE XII MISCELLANEOUS 52
   
  12.1 Notices. 52
  12.2 Binding Effect; Assignment. 53
  12.3 Third Parties. 53
  12.4 Arbitration. 53
  12.5 Governing Law; Jurisdiction. 54
  12.6 WAIVER OF JURY TRIAL. 54
  12.7 Specific Performance. 54
  12.8 Severability. 54
  12.9 Amendment. 54
  12.10 Waiver. 55
  12.11 Entire Agreement. 55
  12.12 Interpretation. 55
  12.13 Counterparts. 56
  12.14 Purchaser Representative. 56
  12.15 Company Representative. 57
  12.16 Legal Representation. 58
       
ARTICLE XIII DEFINITIONS 60
   
  13.1 Certain Definitions. 60

 

iii

 

INDEX OF ANNEXES

 

Annex Description
Annex I List of Company Shareholders
Annex II List of Preference Shareholders
Annex III List of Lock-up Shareholders

 

INDEX OF EXHIBITS

 

Exhibit Description
Exhibit A Form of Sponsor Support Agreement
Exhibit B Form of Lock-Up Agreement
Exhibit C Form of Non-Competition and Non-Solicitation Agreement
Exhibit D Form of New Equity Incentive Plan
Exhibit E Form of Registration Rights Agreement
Exhibit F Extension Escrow Agreement
Exhibit G Letter of Transmittal
Exhibit H Joinder Agreement

 

iv

 

BID IMPLEMENTATION AND BUSINESS COMBINATION AGREEMENT

 

This Bid Implementation and Business Combination Agreement (this “Agreement”) is made and entered into as of June 15, 2023 by and among (i) Canna-Global Acquisition Corp, a company incorporated in Delaware (together with its successors, “Purchaser”), (ii) J. Gerald Combs, solely in his capacity as the representative from and after the Effective Time (as defined below) for the stockholders of Purchaser in accordance with the terms and conditions of this Agreement (the “Purchaser Representative”), (iii) New Quantum Holdings Pty Ltd., an Australian company with Australian Company Number (ACN) 628 253 743 (the “Company”), and (iv) Hyun Jong Chung, solely in his capacity as the representative from and after the Effective Time (as defined below) for the Company in accordance with the terms and conditions of this Agreement (the “Company Representative”). Purchaser, the Purchaser Representative, the Company and the Company Representative are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties.”

 

RECITALS

 

A. The Company, directly and indirectly through its subsidiaries, is a provider of a core and digital wealth management platform that offers Software-as-a-Service (“SaaS”) products to manage investment portfolios efficiently for the financial services industry;

 

B. Purchaser is a blank check company incorporated as a Delaware corporation for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;

 

C. Upon the terms and subject to the conditions set forth in this Agreement, Purchaser proposes to acquire all of the issued and outstanding ordinary class shares of the Company (the “Company Shares”) by way of a Takeover Bid and to effect a business combination whereby upon the terms and subject to the conditions of this Agreement, in accordance with Section 251(h) of the Delaware General Corporations Law (the “DGCL”), as soon as practicable following the registration of the Company Shares in Purchaser’s name under the Companies Act (the “Effective Time”) and pursuant to or in connection with the Takeover Bid, each Company Share issued and outstanding immediately prior to the Effective Time shall be transferred to Acquirer in exchange for the right of each holder of the Company Shares (each, a “Company Shareholder”) to receive, such number of newly issued Purchaser Shares as determined in accordance with this Agreement;

 

D. Ownership of the Company Shares will also give Purchaser indirect ownership of the Company’s subsidiaries, including New Quantum Pty Ltd., ACN 632 007 571, VueNow Pty Ltd., ACN 637 057 106, NQ Dealer Pty Ltd., ACN 636 578 544, and Licorish Pty Ltd., ACN 653 970 720. Furthermore, Company has agreed to acquire 80% of the ordinary shares on issue in Morrison Securities Pty Limited, ACN 001 430 342 (“Morrison”) pursuant to a share purchase agreement dated on or around June 5, 2023 (“Morrison Transaction”), Purchaser shall also have indirect ownership of 80% of Morrison (collectively, the “Company Subsidiaries”);

 

E. The boards of directors of the Company and Purchaser have each (i) determined that the Takeover Bid is fair, advisable and in the best interests of their respective companies and stockholders, (ii) approved this Agreement and the transactions contemplated hereby, including the Takeover Bid, upon the terms and subject to the conditions set forth herein (the “Transactions”), and (iii) determined to recommend to their respective stockholders the approval and adoption of this Agreement and the Transactions contemplated hereby, including the Takeover Bid (subject only to the qualification that no Superior Proposal emerges);

 

F. At or prior to the Effective Time, and as a condition and an inducement to Purchaser and the Company entering into this Agreement, specified stockholders of Purchaser are entering into and delivering a Sponsor Support Agreement, substantially in the form attached hereto as Exhibit A (each, a “Sponsor Support Agreement”), pursuant to which each such Purchaser stockholder has agreed (x) not to transfer or redeem any shares of Purchaser Common Stock held by such Purchaser stockholder in accordance with the Insider Letter, (y) to vote in favor of this Agreement and the Transactions at Purchaser Special Meeting in accordance with the Insider Letter and (z) waive any adjustment to the conversion ratio set forth in Purchaser Certificate of Incorporation or any other anti-dilution or similar protection with respect to such Purchaser’s Class B Common Stock (whether resulting from the Transactions contemplated hereby, by the Ancillary Documents or by any other transaction consummated in connection with the Transactions contemplated hereby); and

 

1

 

G. At or prior to the Effective Time, the Company Shareholders holding at least 1% of the Company Shares at Closing (the “Lock-up Shareholders”) have entered into a Lock-Up Agreement with Purchaser, the form of which is attached as Exhibit B hereto (each, a “Lock-Up Agreement”) and (b) simultaneously with the execution and delivery of this Agreement, Significant Company Holders, Key Executives and Key Employees have entered into a Non-Competition and Non-Solicitation Agreement in favor of Purchaser and the Company, the form of which is attached as Exhibit C hereto (each, a “Non-Competition Agreement”), each of which agreements described in clauses (a) and (b) above will become effective as of the Closing. For illustrative purposes, the Company Shareholders holding at least 1% of the Company Shares at the date of this Agreement are listed under Annex III, but note that the Company must provide the Purchaser a revised list at least 5 days prior to the Closing;

 

H. At or prior to the Effective Time, Purchaser, the Sponsor, the Significant Company Holders and their respective Affiliates, shall enter into a Registration Rights Agreement, substantially in the form attached hereto as Exhibit E (each, a “Registration Rights Agreement”), which shall be effective as of Closing;

 

I. At or prior to the Effective Time , the Company has deposited USD$319,846.95 the first installment of the escrow amount (the “Escrow Amount”) with the Escrow Agent (as defined below) pursuant to an Extension Escrow Agreement, the form of which is attached as Exhibit F hereto (the “Extension Escrow Agreement”); At or prior to the Effective Time, Purchaser shall send, or shall cause the Exchange Agent to send, to each Company Stockholder, a letter of transmittal for use in such exchange, in the form attached hereto as Exhibit G (a “Letter of Transmittal”) (which shall specify that the delivery of Company Shares in respect of the Takeover Offer Consideration shall be effected, and risk of loss and title shall pass, only upon proper delivery of a properly completed and duly executed Letter of Transmittal and required documents specified in the Letter of Transmittal (the “Transmittal Documents”)), to the Exchange Agent for use in such exchange;

 

J. At or prior to the Effective Time, Significant Company Holders shall enter into a Joinder Agreement substantially in the form attached hereto as Exhibit H (each, a “Joinder Agreement”), agreeing in writing to be bound by any and all of the terms and conditions of this Agreement, which shall be effective as of the Effective Time;

 

K. At the Effective Time, each Company Convertible Note that is at such time outstanding shall, by virtue of the Business Combination pursuant to the terms of each Company Convertible Note, and without any action on the part of Purchaser, the Company, the holder of such Company Convertible Note or any other Person, be assumed by Purchaser;

 

L. On and from the date of this Agreement, the parties agree to use their reasonable endeavours for a period of six (6) months to procure that the Preference Shareholders agree to sell their Redeemable Preference Shares in the Company to the Purchaser by way of private treaty sale on substantially the same terms outlined in this Agreement; and

 

M. Certain capitalized terms used herein are defined in ‎Article XIII hereof.

 

NOW, THEREFORE, in consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and the representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Parties hereto agree as follows:

 

ARTICLE I TAKEOVER BID

 

1.1 General Obligations. The Company and Purchaser must each:

 

(a) use all reasonable endeavors and commit necessary resources (including management and the resources of external advisers); and

 

2

 

(b) procure that its Representatives work in good faith and in a timely and co-operative fashion with the other party and its Representatives (including by attending meetings and by providing such records and information as the other party reasonably requires), to implement the Takeover Bid in accordance with the terms and conditions set out in this Agreement.

 

1.2 Access to People and Information.

 

(a) Between the date of this Agreement and the earlier of the end of the Takeover Offer Period and the date this Agreement is terminated, the Company and Purchaser (each, an “Acquisition Party”) must, to the extent reasonably required to implement the Takeover Bid:

 

(i) as soon as reasonably practicable provide the other Acquisition Party and its Representatives with any documents, records, and other information reasonably requested by them; and

 

(ii) provide the other Acquisition Party and its Officers and Advisers with reasonable access within normal business hours to the other Acquisition Party’s Officers and Advisers which the Party reasonably requires for the purposes of (A) further understanding the other Party’s financial position (including its working capital position), trading performance and management control systems, (B) implementing the Takeover Bid, (C) preparing for carrying on the business of Company and Purchaser following implementation of the Takeover Bid and (D) any other purpose which is agreed in writing between the parties.

 

(b) The obligations in Section ‎1.2 ‎(a), do not apply to the extent that:

 

(i) in respect of Company, the access or information is connected to the Company Board’s deliberations in relation to the transactions contemplated by this Agreement, or confidential information connected to a Competing Proposal which the Company is prohibited from disclosing; and

 

(ii) in respect of Purchaser, the access or information is connected to the Purchaser Board’s deliberations in relation to the transactions contemplated by this Agreement.

 

(c) Each Acquisition Party must:

 

(i) keep all information obtained by it under this Section ‎1.2 confidential (except to the extent that disclosure of that information is required to be made by law, including in the Bidder’s Statement or Target’s Statement);

 

(ii) provide the other Party with reasonable notice of any request for information or access; and

 

(iii) comply with the reasonable requirements of the other Party in relation to any access granted.

 

1.3 Implementation Obligations of Company. Company must provide all necessary information about the Company’s Register of Shareholders to Purchaser that Purchaser reasonably requires in order to assist Purchaser to solicit acceptances under the Takeover Bid.

 

1.4 Post-Closing Board.

 

(a) Subject to the terms of Purchaser’s Organizational Documents, Purchaser shall take all such action within its power as may be necessary or appropriate such that as soon as practicable after Purchaser has a Relevant Interest in more than 90% of the Company Shares and the Takeover Offer has become unconditional or is declared by Purchaser to be free of all Conditions, the board of directors of Purchaser shall consist of five (5) members including (i) one member of the board of Purchaser continuing in office from prior to the Effective Time who will be selected by Purchaser, which, if requested by the Company, shall be an independent director within the meaning of Nasdaq Rule 5605(a)(2), and (ii) four directors designated by the Company, with at least two being independent directors within the meaning of Nasdaq Rule 5605(a)(2) (the “Post-Closing Directors”. If the Company does not require the Purchaser nominated member of the board to be an independent director, then the Company will ensure that it has appointed at least three independent directors within the meaning of Nasdaq Rule 5605(a)(2));

 

3

 

(b) With respect to the Post-Closing Directors, Purchaser must procure:

 

(i) Purchaser shareholder approval;

 

(ii) the receipt by Purchaser of a consent to act as a director of Purchaser from the Post-Closing Directors; and

 

(iii) the finalization of the terms of the Post-Closing Directors’ appointment as an executive director of Purchaser, which shall be substantially similar to those of the other members of Purchaser’s Board of Directors.

 

(c) Section 1.4(a) and (b)‎ are subject always to:

 

(i) a proper board being constituted at all times; and

 

(ii) Purchaser procuring that its appointee to the Company Board does not participate in decisions of Company in relation to the Takeover Bid until after the End Date and a quorum remains for that purpose.

 

ARTICLE II THE TAKEOVER OFFER

 

2.1 Takeover Offer by Purchaser. Purchaser must, by no later than the Takeover Offer Date, and in any event as soon as reasonably practicable, make the Takeover Offer to all Company Shareholders in respect of all of their Company Shares on the terms of this Agreement or terms no less favorable to Company Shareholders than the terms of this Agreement and otherwise in accordance with all applicable provisions of the Australian Act.

 

2.2 Conditions of the Takeover Offer.

 

(a) The Takeover Offer and any contract which results from its acceptance will be subject to the Conditions.

 

(b) Purchaser may waive the satisfaction of any Condition in its sole discretion, other than the Conditions in Sections 9.1(b),9.1(f), 9.1(g) and 9.1(j), which may only be waived with consent of the Company.

 

2.3 Status of the Conditions.

 

(a) Subject to Section ‎2.3 ‎(b), Purchaser must notify the Company whether all the Conditions have been satisfied or waived by the Record Date.

 

(b) Subject to any statutory or fiduciary duty under the Australian Act or any other Law, each Party must use all reasonable endeavors to satisfy the Conditions as soon as practicable after the date of this Agreement. Each Party must not do or cause (or omit to do) anything which will, or is likely to, result in any of the Conditions being breached, or not being able to be, satisfied. If any event occurs or becomes apparent which would cause any of the Conditions to be breached or prevent them from being able to be satisfied, each Party must notify other Parties in writing of the event or circumstance as soon as reasonably practicable after they become aware of the event or circumstance, and the Parties must negotiate in good faith to seek to rectify that position. Each Party must, as far as reasonably practicable, consult with other Parties within a reasonable time in advance of any action which is likely to cause a breach of the Conditions or prevent them from being able to be satisfied.

 

2.4 Takeover Offer Period. The Parties intend that the Takeover Offer Period will be one month from the Takeover Offer Date but acknowledge and agree that the Takeover Offer Period may be extended by Purchaser at its discretion or automatically, in accordance with the Australian Act.

 

4

 

2.5 Variation.

 

(a) Purchaser may vary the Takeover Offer only in accordance with the Australian Act.

 

(b) Subject to the Australian Act, Purchaser may declare the Takeover Offer to be free from any Condition or extend the Takeover Offer Period at any time.

 

ARTICLE III DOCUMENTATION AND RECOMMENDATION OF COMPANY DIRECTORS

 

3.1 Purchaser’s obligations to prepare documentation.

 

(a) Purchaser will prepare:

 

(i) the Bidder’s Statement; and

 

(ii) an acceptance form for the Takeover Offer,

 

in each case consistent with Sections ‎4.1 and ‎2.2 and in accordance with the Australian Act. Company will provide Purchaser with reasonable assistance to prepare the Bidder’s Statement.

 

(b) Purchaser agrees to do and to procure its Officers to do such things as are reasonably necessary to prepare the Bidder’s Statement, its lodgment with ASIC and dispatch to Company Shareholders in accordance with the Timetable, subject to Company granting any necessary consents and ASIC granting any necessary modifications.

 

3.2 Company’s Obligations to Prepare Documentation.

 

(a) Company will prepare the Target’s Statement in response to the Takeover Offer in accordance with the Australian Act.

 

(b) Company agrees to do and to procure its Officers to do such things as are reasonably necessary to prepare the Target’s Statement, its lodgment with ASIC and dispatch to Company Shareholders in accordance with the Timetable, subject to Purchaser granting any necessary consents and ASIC granting any necessary modifications.

 

3.3 Provision of Information. Each Acquisition Party agrees that it will provide to the other Acquisition Party such information (including Confidential Information on the terms set out in this Agreement) as is reasonably required by the other party in order to enable the other party to fulfil its obligations under this Agreement, including, but not limited to, the preparation of the Bidder’s Statement and Target’s Statement.

 

3.4 Recommendation of Company Directors. Company represents and warrants that:

 

(a) the Company Board will recommend that all Company Shareholders accept the Takeover Offer, subject to there being no Superior Proposal;

 

(b) it has been informed by each of the directors of Company that they intend to accept the Takeover Offer immediately upon the Takeover Offer becoming open for acceptance in respect of all Company Shares owned or controlled by that director, subject to there being no Superior Proposal; and

 

5

 

(c) it has been informed by each of the directors of Company that they will not withdraw, revise, revoke or qualify, or make any public statement inconsistent with, the recommendation in Section 3.4‎(a) unless a Superior Proposal emerged.

 

3.5 Review of Bidder’s Statement and Target’s Statement.

 

(a) Purchaser agrees that it will provide Company with a reasonable opportunity to review the final draft of its Bidder’s Statement and any supplementary Bidder’s statements and Company agrees that it will provide Purchaser with a reasonable opportunity to review the final draft of its Target’s Statement and any supplementary Target’s statements; and

 

(b) each Party agrees to consider in good faith, and consult in relation to, all reasonable and timely comments received from the other and its Advisers and make such changes to its statement as are reasonably required by the other.

 

3.6 Timetable. Each Party agrees to use its reasonable endeavors to comply with the Timetable.

 

3.7 Consent to Early Dispatch of Bidder’s Statement. Company agrees (by authority of its directors) that the Takeover Offer and accompanying documents to be sent by Purchaser under the Takeover Bid under item 6 of section 633(1) of the Australian Act may (subject to agreement with Company) be sent earlier than the date for sending under item 6 of section 633(1) of the Australian Act as contemplated in the Timetable.

 

3.8 No Solicitation.

 

(a) Takeover Proposal. The Company shall not, and shall direct and cause its Subsidiaries and the Company’s and its Subsidiaries’ directors, officers, employees, investment bankers, attorneys, accountants, consultants, or other agents or advisors (with respect to any Person, the foregoing Persons are referred to herein as such Person’s “Representatives”) not to, directly or indirectly, solicit, initiate, or knowingly take any action to facilitate or encourage the submission of any Takeover Proposal or the making of any proposal that could reasonably be expected to lead to any Takeover Proposal, or, subject to Section 3.8(b): (i) conduct or engage in any discussions or negotiations with, disclose any non-public information relating to the Company or any of its Subsidiaries to, afford access to the business, properties, assets, books, or records of the Company or any of its Subsidiaries to, or knowingly assist, participate in, facilitate, or encourage any effort by, any third party (or its potential sources of financing) that is seeking to make, or has made, any Takeover Proposal; (ii) except where the Company Board makes a good faith determination, after consultation with its financial advisors and outside legal counsel, that the failure to do so would cause the Company Board to be in breach of its fiduciary duties, amend or grant any waiver or release under any standstill or similar agreement with respect to any class of equity securities of the Company or any of its Subsidiaries; or (iii) enter into any agreement in principle, letter of intent, term sheet, acquisition agreement, merger agreement, option agreement, joint venture agreement, partnership agreement, or other Contract relating to any Takeover Proposal (each, a “Company Acquisition Agreement”). Except as expressly permitted by this Section 3.8, the Company Board shall not effect a Company Adverse Recommendation Change. The Company shall, and shall cause its Subsidiaries and the Company’s and its Subsidiaries’ Representatives to cease immediately and cause to be terminated any and all existing activities, discussions, or negotiations, if any, with any third party conducted prior to the date hereof with respect to any Takeover Proposal and shall use its reasonable best efforts to cause any such third party (or its agents or advisors) in possession of non-public information in respect of the Company or any of its Subsidiaries that was furnished by or on behalf of the Company and its Subsidiaries to return or destroy (and confirm destruction of) all such information. Without limiting the foregoing, it is understood that any violation of or the taking of actions inconsistent with the restrictions set forth in this Section 3.8 by any Representative of the Company or its Subsidiaries, whether or not such Representative is purporting to act on behalf of the Company or any of its Subsidiaries, shall be deemed to be a breach of this Section 3.8 by the Company.

 

(b) Superior Proposal. Notwithstanding Section 3.8(a), prior to Purchaser obtaining the Requisite Company Vote (if applicable), the Company Board, directly or indirectly through any Representative, may, subject to Section 3.8(c): (i) participate in negotiations or discussions with any third party that has made (and not withdrawn) a bona fide, unsolicited Takeover Proposal in writing that the Company Board believes in good faith, after consultation with its financial advisors and outside legal counsel, constitutes a Superior Proposal; (ii) thereafter furnish to such third party non-public information relating to the Company or any of its Subsidiaries pursuant to an executed confidentiality agreement that constitutes an Acceptable Confidentiality Agreement (a copy of which confidentiality agreement shall be promptly (in all events within 24 hours) provided for informational purposes only to Purchaser); (iii) following receipt of and on account of a Superior Proposal, make a Company Adverse Recommendation Change; and/or (iv) take any action that any court of competent jurisdiction orders the Company to take (which order remains unstayed), but in each case referred to in the foregoing clauses (i) through (iv), only if the Company Board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to take such action would cause the Company Board to be in breach of its fiduciary duties under applicable Law. Nothing contained herein shall prevent the Company Board from disclosing to the Company’s stockholders a position contemplated by Rule 14d-9 and Rule 14e-2(a) promulgated under the Exchange Act with regard to a Takeover Proposal, if the Company determines, after consultation with its financial advisors and outside legal counsel, that failure to disclose such position would cause the Company Board to be in breach of its fiduciary duties under applicable Law.

 

6

 

(c) Notification to Purchaser. The Company Board shall not take any of the actions referred to in clauses (i) through (iv) of Section 3.8(b) unless the Company shall have delivered to Purchaser a prior written notice advising Purchaser that it intends to take such action. The Company shall notify Purchaser promptly (but in no event later than 24 hours) after it obtains Knowledge of the receipt by the Company (or any of its Representatives) of any Takeover Proposal, any inquiry that could reasonably be expected to lead to a Takeover Proposal, any request for non-public information relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, books, or records of the Company or any of its Subsidiaries by any third party. In such notice, the Company shall identify the third party making, and details of the material terms and conditions of, any such Takeover Proposal, indication or request, including any proposed financing. The Company shall keep Purchaser fully informed, on a current basis, of the status and material terms of any such Takeover Proposal, indication or request, including any material amendments or proposed amendments as to price, proposed financing, and other material terms thereof. The Company shall provide Purchaser with at least forty-eight (48) hours prior notice of any meeting of the Company Board (or such lesser notice as is provided to the members of the Company Board) at which the Company Board is reasonably expected to consider any Takeover Proposal. The Company shall promptly provide Parent with a list of any non-public information concerning the Company’s and any of its Subsidiary’s business, present or future performance, financial condition, or results of operations, provided to any third party, and, to the extent such information has not been previously provided to Purchaser, copies of such information.

 

(d) Company Adverse Recommendation Change or Company Acquisition Agreement. Except as expressly permitted by this Section 3.8, the Company Board shall not effect a Company Adverse Recommendation Change or enter into (or permit any Subsidiary to enter into) a Company Acquisition Agreement. Notwithstanding the foregoing, at any time prior to obtaining the Requisite Company Vote (if applicable), the Company Board may effect a Company Adverse Recommendation Change or enter into (or permit any Subsidiary to enter into) a Company Acquisition Agreement that did not result from a breach of this Section 3.8, if:

 

(i) the Company promptly notifies Purchaser, in writing, at least five (5) Business Days (the “Superior Proposal Notice Period”) before making a Company Adverse Recommendation Change or entering into (or causing a Subsidiary to enter into) a Company Acquisition Agreement, of its intention to take such action with respect to a Superior Proposal, which notice shall state expressly that the Company has received a Takeover Proposal that the Company Board intends to declare a Superior Proposal and that the Company Board intends to effect a Company Adverse Recommendation Change and/or the Company intends to enter into a Company Acquisition Agreement;

 

(ii) the Company specifies the identity of the party making the Superior Proposal and the material terms and conditions thereof in such notice and includes an unredacted copy of the Takeover Proposal and attaches to such notice the most current version of any proposed agreement (which version shall be updated on a prompt basis) for such Superior Proposal and any related documents, including financing documents, to the extent provided by the relevant party in connection with the Superior Proposal;

 

(iii) the Company and its Representatives during the Superior Proposal Notice Period, negotiate with Purchaser in good faith to make such adjustments in the terms and conditions of this Agreement so that such Takeover Proposal ceases to constitute a Superior Proposal, if Purchaser, in its discretion, proposes to make such adjustments (it being agreed that in the event that, after commencement of the Superior Proposal Notice Period, there is any material revision to the terms of a Superior Proposal, including, any revision in price or financing, the Superior Proposal Notice Period shall be extended, if applicable, to ensure that at least three (3) Business Days remain in the Superior Proposal Notice Period subsequent to the time the Company notifies Purchaser of any such material revision (it being understood that there may be multiple extensions)); and

 

7

 

(iv) the Company Board determines in good faith, after consulting with its financial advisors and outside legal counsel, that such Takeover Proposal continues to constitute a Superior Proposal (after taking into account any adjustments made by Purchaser during the Superior Proposal Notice Period in the terms and conditions of this Agreement) and that the failure to take such action would cause the Company Board to be in breach of its fiduciary duties under applicable Law.

 

ARTICLE IV CONSIDERATION

 

4.1 Takeover Offer Consideration.

 

Subject to and upon the terms and conditions of this Agreement, in full payment for the Company Shares, Purchaser shall issue and deliver to the Company Shareholders that number of Purchaser Class A Common Stock determined as follows: (i) Eight Hundred Million U.S. Dollars ($800,000,000), plus (or minus if negative) (ii) (A) the Net Working Capital less (B) the Company Net Working Capital Amount minus (iii) the Closing Net Debt, minus (iv) the amount of any unpaid Transaction Expenses, and plus (v) the SPAC Closing Net Debt, and plus (vi) the Escrow Amount (but only the amounts that have been actually paid and to the extent that this has not already been counted in the calculation of the SPAC Closing Net Debt), with the aggregate of items (i) to (vi) being divided by $10.00 being the value of each share of Purchaser Class A Common Stock (as equitably adjusted for share splits, share dividends, combinations, recapitalizations and the like after the Closing) (the “Consideration Shares”). Each Company Shareholder shall receive that number of Consideration Shares based on the number of Company Ordinary Shares owned by such Company Shareholder, divided by the total number of Company Shares owned by all Company Shareholders (such percentage being each such Company Shareholder’s “Pro Rata Share”) as set forth opposite the name of each Company Shareholder on Annex I. For the avoidance of doubt, no cash consideration is payable by Purchaser for Exchange Consideration.

 

“Calculation Date” means the earlier of October 31, 2023, and seven (7) days prior to Closing.

 

“Closing Net Debt” means as of the Calculation Date, the aggregate amount of all financial indebtedness (whether or not due and payable at that time and including accrued but unpaid interest and other charges and costs relating to that financial indebtedness) of the Company less the aggregate of all cash and cash equivalents of the Company.

 

“Company Net Working Capital Amount” means “Two Million US Dollars (USD$2,000,000)”.

 

“Net Working Capital” means as of the Calculation Date, (i) all current assets of the Target Companies (except the Company’s interest in the asset of Morrison), on a consolidated basis, minus (ii) all current liabilities (excluding the liabilities of Morrison, Closing Net Debt and unpaid Transaction Expenses), on a consolidated basis and as determined in accordance with the Accounting Principles; provided, that, for purposes of this definition, whether or not the following is consistent with the Accounting Principles, “Current Assets” will exclude, without duplication, any cash or cash equivalents and any receivable from a Company Shareholder.

 

“SPAC Closing Net Debt” means as of the Calculation Date, the aggregate amount of all financial Indebtedness and Liabilities (whether or not due and payable at that time and including accrued but unpaid interest, expenses, and other charges and costs relating to that financial Indebtedness and Liabilities relating to transactions contemplated hereby) of the Purchaser less the aggregate of all cash and cash equivalents of the Purchaser.

 

8

 

4.2 Preference Shares Consideration.

 

Subject to and upon the terms and conditions of this Agreement, on and from the date of this Agreement, the parties agree to use their reasonable endeavours for a period of six (6) months to procure that the holders of the Redeemable Preference Shares (the “Preference Shareholders”) agree to sell their Redeemable Preference Shares in the Company to the Purchaser by way of private treaty sale for total consideration of Class A Common Stock equal in value to US$5,000,000 (“Preference Share Consideration”).

 

Subject to entry into a formalised agreement by private treaty, each Preference Shareholder will receive that proportion of Preference Share Consideration as set forth opposite the name of each Preference Shareholder on Annex II (as adjusted to account for any redemption of the Redeemable Preference Shares). For the avoidance of doubt, no cash consideration is proposed to be paid by Purchaser to the Preference Shareholders for the Redeemable Preference Shares.

 

ARTICLE V REPRESENTATIONS AND WARRANTIES OF PURCHASER

 

Except as set forth in (i) the disclosure schedules delivered by Purchaser to the Company on the date hereof (the “Purchaser Disclosure Schedules”), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, or (ii) the SEC Reports that are available on the SEC’s website through EDGAR, Purchaser represents and warrants to the Company as of the date of this Agreement and as of the End Date, as follows:

 

5.1 Organization and Standing. Purchaser is a corporation duly incorporated, validly existing and in good standing under the Laws of Delaware. Purchaser has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Purchaser is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing can be cured without material cost or expense. Purchaser has heretofore made available to the Company accurate and complete copies of its Organizational Documents, as currently in effect. Purchaser is not in violation of any provision of its Organizational Documents in any material respect.

 

5.2 Authorization; Binding Agreement. Purchaser has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is a party, to perform Purchaser’s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, subject to obtaining the Required Purchaser Stockholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby and thereby (a) have been duly and validly authorized by the board of directors of Purchaser, and (b) other than the Required Purchaser Stockholder Approval, no other corporate proceedings, other than as set forth elsewhere in the Agreement, on the part of Purchaser are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which Purchaser is a party shall be when delivered, duly and validly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general application affecting the enforcement of creditors’ rights generally or by any applicable statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the “Enforceability Exceptions”). Purchaser’s board of directors, by resolutions duly adopted at a meeting duly called and held (i) determined that this Agreement and the Business Combination and the other transactions contemplated hereby are advisable, fair to, and in the best interests of, Purchaser and its stockholders, (ii) approved this Agreement and the Business Combination and the other transactions contemplated by this Agreement in accordance with the DGCL, (iii) directed that this Agreement be submitted to Purchaser’s stockholders for adoption and (iv) resolved to recommend that Purchaser’s stockholders adopt this Agreement.

 

9

 

5.3 Governmental Approvals. Except as otherwise described in Schedule ‎5.3, no Consent of or with any Governmental Authority, on the part of Purchaser is required to be obtained or made in connection with the execution, delivery or performance by Purchaser of this Agreement and each Ancillary Document to which it is a party or the consummation by Purchaser of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings as contemplated by this Agreement, (c) any filings required with Nasdaq or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/ or any state “blue sky” securities Laws, and the rules and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not reasonably be expected to have a Material Adverse Effect on Purchaser.

 

5.4 Non-Contravention. Except as otherwise described in Schedule ‎5.4, the execution and delivery by Purchaser of this Agreement and each Ancillary Document to which it is a party, the consummation by Purchaser of the transactions contemplated hereby and thereby, and compliance by Purchaser with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of Purchaser’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section ‎5.3 hereof, and the waiting periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to Purchaser, or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by Purchaser under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of Purchaser under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any Purchaser Material Contract, except for any deviations from any of the foregoing clauses (a), (b) or (c) that would not reasonably be expected to have a Material Adverse Effect on Purchaser.

 

5.5 Capitalization.

 

(a) Purchaser is authorized to issue 220,000,000 shares of common stock, including 200,000,000 shares of Purchaser Class A Common Stock and 20,000,000 shares of Purchaser Class B Common Stock, par value $0.000001 per share; and is authorized to issue 2,000,000 Purchaser Preferred Shares. The issued and outstanding Purchaser Securities as of the date of this Agreement are set forth on Schedule ‎5.5 ‎(a). There are no issued or outstanding Purchaser Preferred Shares. All outstanding shares of Purchaser Common Stock are duly authorized, validly issued, fully paid and non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the DGCL, Purchaser’s Organizational Documents or any Contract to which Purchaser is a party. None of the outstanding Purchaser Securities has been issued in violation of any applicable securities Laws.

 

(b) Except as set forth in Schedule ‎5.5 ‎(a) or Schedule ‎5.5 ‎‎(b) there are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares of Purchaser or (B) obligating Purchaser to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating Purchaser to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other than the Redemption or as expressly set forth in this Agreement, there are no outstanding obligations of Purchaser to repurchase, redeem or otherwise acquire any shares of Purchaser or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Schedule ‎5.5 ‎‎(b), there are no stockholders agreements, voting trusts or other agreements or understandings to which Purchaser is a party with respect to the voting of any shares of Purchaser.

 

(c) All Indebtedness of Purchaser as of the date of this Agreement is disclosed on Schedule ‎5.5 ‎‎(c). No Indebtedness of Purchaser contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by Purchaser or (iii) the ability of Purchaser to grant any Lien on its properties or assets.

 

10

 

(d) Since the date of formation of Purchaser, and except as contemplated by this Agreement, Purchaser has not declared or paid any distribution or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and Purchaser’s board of directors has not authorized any of the foregoing.

 

5.6 SEC Filings and Purchaser Financials.

 

(a) Purchaser, since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required to be filed or furnished by Purchaser with the SEC under the Securities Act and/or the Exchange Act, together with any amendments, restatements or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent to the date of this Agreement. Except to the extent available on the SEC’s web site through EDGAR, Purchaser has delivered to the Company copies in the form filed with the SEC of all of the following: (i) Purchaser’s annual reports on Form 10-K for each fiscal year of Purchaser beginning with the first year Purchaser was required to file such a form, (ii) Purchaser’s quarterly reports on Form 10-Q for each fiscal quarter that Purchaser filed such reports to disclose its quarterly financial results in each of the fiscal years of Purchaser referred to in clause (i) above, (iii) all other forms, reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by Purchaser with the SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements, prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR, are, collectively, the “SEC Reports”) and (iv) all certifications and statements required by (A) Rules 13a-14 or 15d-14 under the Exchange Act, and (B) 18 U.S.C. §1350 (Section 906 of SOX) with respect to any report referred to in clause (i) above (collectively, the “Public Certifications”). The SEC Reports (x) were prepared in all material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC with respect to any SEC Reports. None of the SEC Reports filed on or prior to the date of this Agreement is subject to ongoing SEC review or investigation as of the date of this Agreement. The Public Certifications are each true as of their respective dates of filing. As used in this Section ‎5.6, the term “file” shall be broadly construed to include any manner permitted by SEC rules and regulations in which a document or information is furnished, supplied or otherwise made available to the SEC. As of the date of this Agreement, (A) Purchaser Public Units, Purchaser Common Stock and Purchaser Public Warrants are listed on Nasdaq, (B) Purchaser has not received any written deficiency notice from Nasdaq relating to the continued listing requirements of such Purchaser Securities, (C) there are no Actions pending or, to the Knowledge of Purchaser, threatened against Purchaser by the Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting of such Purchaser Securities on Nasdaq and (D) such Purchaser Securities are in compliance with all of the applicable corporate governance rules of Nasdaq.

 

(b) The financial statements and notes of Purchaser contained or incorporated by reference in the SEC Reports (the “Purchaser Financials”), fairly present in all material respects the financial position and the results of operations, changes in stockholders’ equity, and cash flows of Purchaser at the respective dates of and for the periods referred to in such financial statements, all in accordance with (i) GAAP methodologies applied on a consistent basis throughout the periods involved and (ii) Regulation S-X or Regulation S-K, as applicable (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).

 

(c) Except as and to the extent reflected or reserved against in Purchaser Financials, Purchaser has not incurred any Liabilities or obligations of the type required to be reflected on a balance sheet in accordance with GAAP that are not adequately reflected or reserved on or provided for in Purchaser Financials, other than Liabilities of the type required to be reflected on a balance sheet in accordance with GAAP that have been incurred since Purchaser’s formation in the ordinary course of business. All debts and Liabilities, fixed or contingent, which should be included under U.S. GAAP on a balance sheet, are included in all material respects in Purchaser Financials as of the date of such Purchaser Financials.

 

11

 

5.7 Absence of Certain Changes. As of the date of this Agreement, except as set forth in Schedule ‎5.7, Purchaser has, (a) since its formation, conducted no business other than its formation, the public offering of its securities (and the related private offerings), public reporting and its search for an initial Business Combination as described in the IPO Prospectus (including the investigation of the Target Companies and the negotiation and execution of this Agreement) and related activities and (b) since April 12, 2021, not been subject to a Material Adverse Effect on Purchaser.

 

5.8 Compliance with Laws. Purchaser is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business except for such noncompliance which would not reasonably be expected to have a Material Adverse Effect on Purchaser, and Purchaser has not received written notice alleging any violation of applicable Law in any material respect by Purchaser. To the best of its Knowledge, Purchaser is not under investigation with respect to any violation or alleged violation of, any law, or judgment, order or decree entered by any court, arbitrator or Governmental Authority, domestic or foreign, and Purchaser has not previously received any subpoenas from any Governmental Authority.

 

5.9 Actions; Orders; Permits. There is no pending or, to the Knowledge of Purchaser, threatened material Action to which Purchaser is subject which would reasonably be expected to have a Material Adverse Effect on Purchaser. There is no material Action that Purchaser has pending against any other Person. Purchaser is not subject to any material Orders of any Governmental Authority, nor are any such Orders pending. Purchaser holds all material Permits necessary to lawfully conduct its business as presently conducted, and to own, lease and operate its assets and properties, all of which are in full force and effect, except where the failure to hold such Consent or for such Consent to be in full force and effect would not reasonably be expected to have a Material Adverse Effect on Purchaser.

 

5.10 Taxes and Returns.

 

(a) Purchaser has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which Tax Returns are accurate and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in Purchaser Financials have been established in accordance with GAAP. Purchaser has complied with all applicable Laws relating to Taxes. Schedule ‎5.10 ‎(a) sets forth each jurisdiction where Purchaser files or is required to file a Tax Return. There are no audits, examinations, investigations or other proceedings pending against Purchaser in respect of any Tax, and Purchaser has not been notified in writing of any proposed Tax claims or assessments against Purchaser (other than, in each case, claims or assessments for which adequate reserves in Purchaser Financials have been established in accordance with GAAP or are immaterial in amount). There are no Liens with respect to any Taxes upon any of Purchaser’s assets, other than Permitted Liens. Purchaser has no outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests by Purchaser for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

 

(b) Since the date of its formation, Purchaser has not (i) changed any Tax accounting methods, policies or procedures except as required by a change in Law, (ii) made, revoked, or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund or (iv) entered into any closing agreement affecting or otherwise settled or compromised any material Tax liability or refund.

 

5.11 Employees and Employee Benefit Plans. Purchaser does not (a) have any paid employees or (b) maintain, sponsor, contribute to or otherwise have any Liability under, any Benefit Plans.

 

5.12 Properties. Purchaser does not own, license or otherwise have any right, title or interest in any material Intellectual Property. Purchaser does not own or lease any material real property or material Personal Property.

 

12

 

5.13 Material Contracts.

 

(a) Except as set forth on Schedule ‎5.13 ‎(a), other than this Agreement and the Ancillary Documents, there are no Contracts to which Purchaser is a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes a Liability greater than $50,000, (ii) may not be cancelled by Purchaser on less than sixty (60) days’ prior notice without payment of a material penalty or termination fee or (iii) prohibits, prevents, restricts or impairs in any material respect any business practice of Purchaser as its business is currently conducted, any acquisition of material property by Purchaser, or restricts in any material respect the ability of Purchaser to engage in business as currently conducted by it or compete with any other Person (each, a “Purchaser Material Contract”). All Purchaser Material Contracts have been made available to the Company other than those that are exhibits to the SEC Reports.

 

(b) With respect to each Purchaser Material Contract: (i) Purchaser Material Contract was entered into at arms’ length and in the ordinary course of business; (ii) Purchaser Material Contract is legal, valid, binding and enforceable in all material respects against Purchaser and, to the Knowledge of Purchaser, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (iii) Purchaser is not in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default in any material respect by Purchaser, or permit termination or acceleration by the other party, under such Purchaser Material Contract; and (iv) to the Knowledge of Purchaser, no other party to any Purchaser Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination or acceleration by Purchaser under any Purchaser Material Contract.

 

5.14 Transactions with Affiliates. Schedule ‎5.14 sets forth a true, correct and complete list of the Contracts and arrangements that are in existence as of the date of this Agreement under which there are any existing or future Liabilities or obligations between Purchaser and any (a) present or former director, officer or employee or Affiliate of Purchaser, or any immediate family member of any of the foregoing, or (b) record or beneficial owner of more than five percent (5%) of Purchaser’s outstanding capital stock as of the date hereof.

 

5.15 Investment Company Act. Purchaser is not an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each case within the meaning of the Investment Company Act of 1940, as amended.

 

5.16 Finders and Brokers. Except as set forth on Schedule ‎5.16, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from Purchaser, or to Purchaser’s Knowledge from the Target Companies, or from any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of Purchaser.

 

5.17 Ownership of Takeover Offer Consideration. All shares of Purchaser Class A Common Stock to be issued and delivered to the Company Shareholders as Takeover Offer Consideration in accordance with ‎Article IV shall be, upon issuance and delivery of such Purchaser Common Stock, fully paid and non-assessable, free and clear of all Liens, other than restrictions arising from applicable securities Laws, any applicable Lock-Up Agreement, and any Liens incurred by any Company Shareholder, and the issuance and sale of such Purchaser Common Stock pursuant hereto will not be subject to or give rise to any preemptive rights or rights of first refusal.

 

5.18 Certain Business Practices.

 

(a) Neither Purchaser, nor any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act of 1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv) since the formation of Purchaser, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder Purchaser or assist it in connection with any actual or proposed transaction.

 

13

 

(b) The operations of Purchaser are and have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, and no Action involving Purchaser with respect to any of the foregoing is pending or, to the Knowledge of Purchaser, threatened.

 

(c) None of Purchaser or any of its directors or officers, or, to the Knowledge of Purchaser, any other Representative acting on behalf of Purchaser is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”), and Purchaser has not, in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions administered by OFAC.

 

5.19 Insurance. Schedule ‎5.19 lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by Purchaser relating to Purchaser or its business, properties, assets, directors, officers and employees, copies of which have been provided to the Company. All premiums due and payable under all such insurance policies have been timely paid and Purchaser is otherwise in material compliance with the terms of such insurance policies. All such insurance policies are in full force and effect, and to the Knowledge of Purchaser, there is no threatened termination of, or material premium increase with respect to, any of such insurance policies. There have been no insurance claims made by Purchaser. Purchaser has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to have a Material Adverse Effect on Purchaser.

 

5.20 Purchaser Trust Account. As of May 22, 2023, the Trust Account has a balance of no less than $25,295,453. Such monies are invested solely in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act or money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, and held in trust by Continental Stock Transfer & Trust Company pursuant to the Trust Agreement. The Trust Agreement is valid and in full force and effect and enforceable in accordance with its terms (subject to the Enforceability Exceptions) and has not been amended or modified. There are no separate agreements, side letters or other agreements that would cause the description of the Trust Agreement in the SEC Reports to be inaccurate in any material respect and/or that would entitle any Person (other than the underwriters of the IPO, Public Stockholders who shall have elected to redeem their Purchaser Common Stock pursuant to Purchaser Certificate of Incorporation (or in connection with an extension of Purchaser’s deadline to consummate a Business Combination) or Governmental Authorities for Taxes) to any portion of the proceeds in the Trust Account. Prior to the End Date, none of the funds held in the Trust Account may be released except as described in the Trust Agreement.

 

5.21 Independent Investigation. Purchaser has conducted its own independent investigation, review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of the Target Companies, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Target Companies for such purpose. Purchaser acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company set forth in this Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate delivered to Purchaser pursuant hereto, and the information provided by or on behalf of the Company for the Registration Statement; and (b) none of the Company nor its respective Representatives have made any representation or warranty as to the Target Companies, or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to Purchaser pursuant hereto, or with respect to the information provided by or on behalf of the Company for the Registration Statement.

 

14

 

ARTICLE VI REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except as set forth in (i) the disclosure schedules delivered by the Company to Purchaser on the date hereof (the “Company Disclosure Schedules”) (ii) the public records (including any records maintained by any Governmental Authority (including an Australian Government Authority) that are available for inspection by the public including (A) ASIC’s records; (B) any records in respect of land or real property in any state and territory in Australia; (C) the personal property securities register established under the Personal Property Securities Act 2009 (Cth); (D) and IP Australia), (for patents, registered designs and trade marks); (E) WhoIs (for domain names); and (F) any courts of Australia; (iii) all documents contained in the Data Room as at the Cut-Off Time; (iv) the contents of this Agreement and the Ancillary Documents (including, without limitation, all exhibits, schedules, annexures, attachments and appendices to this Agreement) and (v) all written answers given by the Company to the Purchaser, including any emails and the due diligence request list from Rimon, P.C., the Company hereby represents and warrants to Purchaser, as of the date hereof and as of the End Date, as follows:

 

6.1 Organization and Standing. The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of Australia, and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each other Target Company is a corporation or other entity duly formed, validly existing and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each Target Company is duly qualified or licensed and in good standing in the jurisdiction in which it is incorporated or registered and in each other jurisdiction where it does business or operates to the extent that the character of the property owned, or leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary. Schedule ‎6.1 lists all jurisdictions in which any Target Company is qualified to conduct business and all names other than its legal name under which any Target Company does business. The Company has provided to Purchaser accurate and complete copies of its Organizational Documents and the Organizational Documents of each Target Company, each as amended to date and as currently in effect. No Target Company is in violation of any provision of its Organizational Documents.

 

6.2 Authorization; Binding Agreement. The Company has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform the Company’s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, subject to obtaining any approvals required by the Company pursuant to its Organizational Documents and Australian Act. The execution and delivery of this Agreement and each Ancillary Document to which the Company is or is required to be a party and the consummation of the transactions contemplated hereby and thereby, (a) have been duly and validly authorized by the board of directors of the Company in accordance with the Company’s Organizational Documents, the Australian Act, any other applicable Law, or any Contract to which the Company or any of its shareholder is a party or by which it or its securities are bound and (b) no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby, except approval by the Company’s board of directors, shareholders and other approvals required by the Australian Act and any other applicable Law. This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party shall be when delivered, duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. The Company’s board of directors, by resolutions duly adopted at a meeting duly called and held or by action by unanimous written consent in accordance with the Company’s Organizational Documents (i) determined that this Agreement and the Business Combination and the other transactions contemplated hereby are advisable, fair to, and in the best interests of, the Company and its stockholders, (ii) approved this Agreement and the Business Combination and the other transactions contemplated by this Agreement in accordance with the Australian Act, (iii) directed that this Agreement be submitted to the Company Shareholders for adoption and (iv) resolved to recommend that the Company Shareholders adopt this Agreement.

 

6.3 Capitalization.

 

(a) The Company has (a) 7,498,928 ordinary shares and (b) 4,023,000 Redeemable Preference Shares issued and outstanding. Prior to giving effect to the transactions contemplated by this Agreement, all of the issued and outstanding Company Share and other equity interests of the Company are set forth on Schedule ‎6.3 ‎(a), along with the beneficial and record owners thereof, all of which shares and other equity interests are owned free and clear of any Liens other than those imposed under the Company Organizational Documents and applicable Law. All of the issued and outstanding shares and other equity interests of the Company have been duly authorized, are fully paid and non-assessable and not in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the Australian Act, any other applicable Law, the Company Organizational Documents or any Contract to which the Company is a party or by which the Company or its securities are bound. The Company holds no shares or other equity interests of the Company in its treasury directly or indirectly. None of the outstanding shares or other equity interests of the Company were issued in violation of any applicable securities Laws. The Company’s Redeemable Preference Shares constitute 5% or less of the value of the Company’s issued and outstanding equity interests on a fully diluted basis.

 

15

 

(b) Schedule ‎6.3 ‎‎(b) sets forth the beneficial and record owners of all outstanding Company Convertible Securities (including in each case the grant date, number and type of shares issuable thereunder, the exercise price, the expiration date and any vesting schedule) prior to the Business Combination. Other than as set forth on Schedule ‎6.3 ‎‎(b), there are no Company Convertible Securities, or preemptive rights or rights of first refusal or first offer, nor are there any Contracts, commitments, arrangements or restrictions to which the Company or, to the Knowledge of the Company, any of its stockholders is a party or bound relating to any equity securities of the Company, whether or not outstanding. There are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company. Except as set forth on Schedule ‎6.3 ‎‎(b), there are no voting trusts, proxies, shareholder agreements or any other agreements or understandings with respect to the voting of the Company’s equity interests. Except as set forth in the Company’s Organizational Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any equity interests or securities of the Company, nor has the Company granted any registration rights to any Person with respect to the Company’s equity securities. All of the Company’s issued and outstanding securities have been granted, offered, sold and issued in compliance with all applicable securities Laws. Except as set forth on Schedule ‎6.3 ‎‎(b), as a result of the consummation of the transactions contemplated by this Agreement, no equity interests of the Company are issuable, and no rights in connection with any interests, warrants, rights, options or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).

 

(c) Except as disclosed in the Company Financials, since March 31, 2023 the Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.

 

(d) Except as set forth in Schedule 6.3(a) or Schedule 6.3(d) there are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares of the Company or (B) obligating the Company to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating the Company to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other than as expressly set forth in this Agreement, there are no outstanding obligations of the Company to repurchase, redeem or otherwise acquire any shares of the Company or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Schedule 6.3(d), there are no shareholders agreements, voting trusts or other agreements or understandings to which the Company is a party with respect to the voting of any shares of the Company.

 

6.4 Subsidiaries. Schedule ‎‎ ‎6.4 sets forth the name of each Subsidiary of the Company, and with respect to each Subsidiary (a) its jurisdiction of organization, (b) its authorized shares or other equity interests (if applicable), (c) the number of issued and outstanding shares or other equity interests, and (d) the record holders and beneficial owners thereof. All of the outstanding equity securities of each Subsidiary of the Company are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable securities Laws, and owned by one or more of the Company or its Subsidiaries free and clear of all Liens (other than those, if any, imposed by such Subsidiary’s Organizational Documents or applicable securities Laws). There are no Contracts to which the Company or any of its Affiliates is a party or bound with respect to the voting (including voting trusts or proxies) of the equity interests of any Subsidiary of the Company other than the Organizational Documents of any such Subsidiary. Schedule 6.4 sets forth all options, warrants, rights, agreements, subscriptions, convertible securities or commitments to which any Subsidiary of the Company is a party or which are binding upon any Subsidiary of the Company providing for the issuance or redemption of any equity interests of any Subsidiary of the Company. Except as set forth on Schedule ‎6.4, there are no outstanding equity appreciation, phantom equity, profit participation or similar rights granted by any Subsidiary of the Company. No Subsidiary of the Company has any limitation, whether by Contract, Order or applicable Law, on its ability to make any distributions or dividends to its equity holders or repay any debt owed to another Target Company. Except for the equity interests of the Subsidiaries listed on Schedule ‎6.4, (i) the Company does not own or have any rights to acquire, directly or indirectly, any equity interests of, or otherwise Control, any Person, (ii) none of the Company or its Subsidiaries is a participant in any joint venture, partnership or similar arrangement, (iii) there are no outstanding contractual obligations of the Company or its Subsidiaries to provide funds to, or make any investment (in the form of a loan, capital contribution or otherwise) in, any other Person.

 

16

 

6.5 Governmental Approvals. Except as otherwise described in Schedule ‎6.5, no Consent of or with any Governmental Authority on the part of any Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this Agreement or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other than (a) such filings as are expressly contemplated by this Agreement or (b) pursuant to Antitrust Laws.

 

6.6 Non-Contravention. Except as otherwise described in Schedule ‎6.6, the execution and delivery by the Company (or any other Target Company, as applicable) of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party or otherwise bound, and the consummation by any Target Company of the transactions contemplated hereby and thereby and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of the Company’s or any Target Company’s Organizational Documents, (b) subject to obtaining the Consents required from Governmental Authorities referred to in Section ‎6.5 hereof, the waiting periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to any Target Company or any of its material properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by any Target Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of any Target Company under (other than Permitted Liens), (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except in the cases of clauses (b) and (c), as has not been and would not reasonably be expected to be material to any Target Company or its ability to consummate the transactions contemplated by this Agreement or the Ancillary Documents or to perform the Company’s or any such Target Company’s obligations hereunder or thereunder.

 

6.7 Financial Statements.

 

(a) As used herein, the term “Company Financials” means the (i) audited consolidated financial statements of the Target Companies (including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Target Companies as of December 31, 2021 and December 31, 2022, and the related consolidated audited income statements, changes in stockholder equity and statements of cash flows for the fiscal years then ended, each audited by a PCAOB qualified auditor in accordance with GAAP and PCAOB standards (the “Audited Company Financials”), and (ii) the Company prepared unaudited financial statements, consisting of the consolidated balance sheet of the Target Companies as of March 31, 2023 (the “Interim Balance Sheet Date”) and the related consolidated income statement, changes in shareholder equity and statement of cash flows for the three months then ended. True and correct copies of the Company Financials have been provided to Purchaser. The Company Financials (i) accurately reflect the books and records of the Target Companies as of the times and for the periods referred to therein, (ii) were prepared in accordance with IFRS, consistently applied throughout and among the periods involved (except that the unaudited statements exclude the footnote disclosures and other presentation items required for IFRS and exclude year-end adjustments which will not be material in amount), (iii) comply in all material respects with all applicable accounting requirements under the Securities Act and the rules and regulations of the SEC thereunder, and (iv) fairly present in all material respects the consolidated financial position of the Target Companies, as of the respective dates thereof and the consolidated results of the operations and cash flows of the Target Companies for the periods indicated. No Target Company has ever been subject to the reporting requirements of Sections 13(a) and 15(d) of the Exchange Act.

 

17

 

(b) Each Target Company maintains accurate books and records reflecting its assets and Liabilities and maintains proper and adequate internal accounting controls that provide reasonable assurance that (i) such Target Company does not maintain any off-the-book accounts and that such Target Company’s assets are used only in accordance with such Target Company’s management directives, (ii) transactions are executed with management’s authorization, (iii) transactions are recorded as necessary to permit preparation of the financial statements of such Target Company and to maintain accountability for such Target Company’s assets, (iv) access to such Target Company’s assets is permitted only in accordance with management’s authorization, (v) the reporting of such Target Company’s assets is compared with existing assets at regular intervals and verified for actual amounts, and (vi) accounts, notes and other receivables and inventory are recorded accurately, and proper and adequate procedures are implemented to effect the collection of accounts, notes and other receivables on a current and timely basis. All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course consistent with past practice and in accordance with applicable Laws. No Target Company has been subject to or involved in any material fraud that involves management or other employees who have a significant role in the internal controls over financial reporting of any Target Company. In the past five (5) years, no Target Company or its Representatives has received any written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of any Target Company or its internal accounting controls, including any material written complaint, allegation, assertion or claim that any Target Company has engaged in questionable accounting or auditing practices.

 

(c) The Target Companies do not have any Indebtedness other than the Indebtedness set forth on Schedule ‎6.7 ‎(c), which schedule sets for the amounts (including principal and any accrued but unpaid interest or other obligations) with respect to such Indebtedness. Except as disclosed on Schedule ‎6.7 ‎(c), no Indebtedness of any Target Company contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by any Target Company, or (iii) the ability of the Target Companies to grant any Lien on their respective properties or assets.

 

(d) Except as set forth on Schedule ‎6.7 ‎(d), no Target Company is subject to any Liabilities or obligations (whether or not required to be reflected on a balance sheet prepared in accordance with IFRS), except for those that are either (i) adequately reflected or reserved on or provided for in the consolidated balance sheet of the Company and its Subsidiaries as of the Interim Balance Sheet Date contained in the Company Financials or (ii) not material and that were incurred after the Interim Balance Sheet Date in the ordinary course of business consistent with past practice (other than Liabilities for breach of any Contract or violation of any Law), or (iii) obligations for further performance under any Contract to which a Target Company is a party.

 

(e) All financial projections with respect to the Target Companies that were delivered by or on behalf of the Company to Purchaser or its Representatives were prepared in good faith using assumptions that the Company believes to be reasonable.

 

(f) All accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Target Companies (the “Accounts Receivable”) arose from sales actually made or services actually performed in the ordinary course of business and represent valid obligations to a Target Company arising from its business. None of the Accounts Receivable are subject to any right of recourse, defense, deduction, return of goods, counterclaim, offset, or set off on the part of the obligor in excess of any amounts reserved therefore on the Company Financials. All of the Accounts Receivable are, to the Knowledge of the Company, fully collectible according to their terms in amounts not less than the aggregate amounts thereof carried on the books of the Target Companies (net of reserves) within ninety (90) days.

 

6.8 Absence of Certain Changes. Except as set forth on Schedule ‎6.8, since the Interim Balance Sheet Date, the Company and each Target Company has (a) conducted its business only in the ordinary course of business consistent with past practice, (b) not been subject to a Material Adverse Effect and (c) has not taken any action or committed or agreed to take any action that would be prohibited by Section 6.2(b) (without giving effect to Schedule 6.2) if such action were taken on or after the date hereof without the consent of Purchaser.

 

18

 

6.9 Compliance with Laws. Since December 31, 2020, no Target Company is or has been in material conflict or material non-compliance with, or in material default or violation of, nor has any Target Company received, during the past five (5) years, any written or, to the Knowledge of the Company, oral notice of any material conflict or non-compliance with, or material default or violation of, any applicable Laws by which it or any of its properties, assets, employees, business, products or operations are or were bound or affected. For purposes of this Section ‎6.9, “material” shall mean material to the Company and its Subsidiaries taken as a whole.

 

6.10 Company Permits. The Company and each Target Company holds all Permits necessary to lawfully conduct in all material respects its business as presently conducted; and to own, lease and operate its assets and properties; and to market and sell its products (collectively, the “Company Permits”). The Company has made available to Purchaser true, correct and complete copies of all material Company Permits, all of which Company Permits are listed on Schedule ‎6.10. All of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company Permits is pending or, to the Company’s Knowledge, threatened. No Target Company is in violation in any material respect of the terms of any Company Permit, and no Target Company has received any written or, to the Knowledge of the Company, oral notice of any Actions relating to the revocation or modification of any Company Permit.

 

6.11 Litigation. Except as described on Schedule ‎6.11, there is no (a) Action of any nature currently pending or, to the Company’s Knowledge, threatened, and no such Action has been brought in the past five (5) years; or (b) Order now pending or outstanding or that was rendered by a Governmental Authority in the past five (5) years, in either case of (a) or (b) by or against any Target Company, its current or former directors, officers or equity holders (provided, that any litigation involving the directors, officers or equity holders of a Target Company must be related to the Target Company’s business, equity securities or assets), its business, equity securities or assets. The items listed on Schedule ‎6.11, if finally determined adversely to the Target Companies, will not have, either individually or in the aggregate, a Material Adverse Effect upon any Target Company. In the past five (5) years, none of the current or former officers, senior management or directors of any Target Company have been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud.

 

6.12 Material Contracts.

 

(a) Schedule ‎6.12 ‎(a) sets forth a true, correct and complete list of, and the Company has made available to Purchaser (including written summaries of oral Contracts), true, correct and complete copies of, each Contract to which any Target Company is a party or by which any Target Company, or any of its properties or assets are bound or affected (each Contract required to be set forth on Schedule ‎6.12 ‎(a), a “Company Material Contract”) that:

 

(b) contains covenants that materially limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase or acquire an interest in any other Person;

 

(c) involves any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating to the formation, creation, operation, management or control of any partnership or joint venture;

 

(d) involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices;

 

19

 

(e) evidences Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of any Target Company having an outstanding principal amount in excess of $500,000;

 

(f) involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess of $1,000,000 (other than in the ordinary course of business consistent with past practice) or shares or other equity interests of any Target Company or another Person;

 

(g) relates to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity or its business or material assets or the sale of any Target Company, its business or material assets;

 

(h) by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Target Companies under such Contract or Contracts of at least of $250,000 per year or of $1,000,000 in the aggregate;

 

(i) is with any Top Customer or Top Supplier;

 

(j) obligates the Target Companies to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess of $500,000;

 

(k) is between any Target Company and any directors, officers or employees of a Target Company (other than at-will employment arrangements with employees entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and indemnification agreements, or any Related Person;

 

(l) obligates the Target Companies to make any capital commitment or expenditure in excess of $250,000 (including pursuant to any joint venture);

 

(m) relates to a material settlement entered into within three (3) years prior to the date of this Agreement or under which any Target Company has outstanding obligations (other than customary confidentiality obligations) in excess of $250,000;

 

(n) provides another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney;

 

(o) relates to the development, ownership, licensing or use of any Intellectual Property by, to or from any Target Company, other than (A) Off-the-Shelf Software, (B) employee or consultant invention assignment agreements entered into on a Target Company’s standard form of such agreement, (C) confidentiality agreements entered into in the ordinary course of business, (D) non-exclusive licenses from customers or distributors to any Target Company entered into in the ordinary course of business or (E) feedback and ordinary course trade name or logo rights that are not material to any Target Company;

 

(p) that will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to be filed by the Company as an exhibit for a Form S-1 pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities Act as if the Company was the registrant; or

 

(q) is otherwise material to the Company and its Subsidiaries taken as a whole and not described in clauses (i) through ‎(xv) above.

 

(r) Except as disclosed in Schedule ‎6.12 ‎‎(b), with respect to each Company Material Contract: (i) such Company Material Contract is valid and binding and enforceable in all respects against the Target Company party thereto and, to the Knowledge of the Company, each other party thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (ii) the consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company Material Contract; (iii) no Target Company is in breach or default in any material respect, and, to the Knowledge of the Company, no event has occurred that with the passage of time or giving of notice or both would constitute a material breach or default by any Target Company, or permit termination or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company, no other party to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination or acceleration by any Target Company, under such Company Material Contract; (v) no Target Company has received written or, to the Company’s Knowledge, oral notice of an intention by any party to any such Company Material Contract that provides for a continuing obligation by any party thereto to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect any Target Company in any material respect; and (vi) no Target Company has waived any material rights under any such Company Material Contract.

 

20

 

6.13 Intellectual Property.

 

(a) Schedule ‎6.13 ‎(a)(i) sets forth: (i) all Patents, Trademarks and service mark registrations and applications, Copyright registration and applications, and Internet Assets and applications owned or licensed by a Target Company or otherwise used or held for use by a Target Company in which a Target Company is the owner, applicant or assignee (“Company Registered IP”), specifying as to each item, as applicable: (A) the nature of the item, including the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an application for issuance or registration has been filed and (D) the issuance, registration or application numbers and dates; and (ii) all material unregistered Intellectual Property owned or purported to be owned by a Target Company. Schedule ‎6.13 (ii) sets forth all Intellectual Property licenses, sublicenses and other agreements or permissions (“Company IP Licenses”) (other than “shrink wrap,” “click wrap,” and “off the shelf” software agreements and other agreements for Software commercially available on reasonable terms to the public generally with license, maintenance, support and other fees of less than $20,000 per year (collectively, “Off-the-Shelf Software”), which are not required to be listed, although such licenses are “Company IP Licenses” as that term is used herein), under which a Target Company is a licensee or otherwise is authorized to use or practice any Intellectual Property, and describes (A) the applicable Intellectual Property licensed, sublicensed or used and (B) any royalties, license fees or other compensation due from a Target Company, if any. Each Target Company owns, free and clear of all Liens (other than Permitted Liens), has valid and enforceable rights in, and has the unrestricted right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for use by such Target Company, and previously used or licensed by such Target Company, except for the Intellectual Property that is the subject of the Company IP Licenses. No item of Company Registered IP that consists of a pending Patent application fails to identify all pertinent inventors, and for each Patent and Patent application in the Company Registered IP, the Target Companies have obtained valid assignments of inventions from each inventor. Except as set forth on Schedule ‎6.13 ‎(a)(iii), all Company Registered IP is owned exclusively by the applicable Target Company without obligation to pay royalties, licensing fees or other fees, or otherwise account to any third party with respect to such Company Registered IP, and such Target Company has recorded assignments of all Company Registered IP.

 

(b) Each Target Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable to such Target Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary to operate the Target Companies as presently conducted. Each Target Company has performed all obligations imposed on it in the Company IP Licenses, has made all payments required to date, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder. The continued use by the Target Companies of the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is currently being used is not restricted by any applicable license of any Target Company. All registrations for Copyrights, Patents, Trademarks and Internet Assets that are owned by or exclusively licensed to any Target Company are valid, in force and in good standing with all required fees and maintenance fees having been paid with no Actions pending, and all applications to register any Copyrights, Patents and Trademarks are pending and in good standing, all without challenge of any kind. No Target Company is party to any Contract that requires a Target Company to assign to any Person all of its rights in any Intellectual Property developed by a Target Company under such Contract.

 

(c) Schedule ‎6.13 ‎(c) sets forth all licenses, sublicenses and other agreements or permissions under which a Target Company is the licensor (each, an “Outbound IP License”), and for each such Outbound IP License, describes (i) the applicable Intellectual Property licensed, (ii) the licensee under such Outbound IP License, and (iii) any royalties, license fees or other compensation due to a Target Company, if any. Each Target Company has performed all obligations imposed on it in the Outbound IP Licenses, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder.

 

21

 

(d) No Action is pending or, to the Company’s Knowledge, threatened against a Target Company that challenges the validity, enforceability, ownership, or right to use, sell, license or sublicense, or that otherwise relates to, any Intellectual Property currently owned, licensed, used or held for use by the Target Companies, nor, to the Knowledge of the Company, is there any reasonable basis for any such Action. No Target Company has received any written or, to the Knowledge of the Company, oral notice or claim asserting or suggesting that any infringement, misappropriation, violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or has or may have occurred, as a consequence of the business activities of any Target Company, nor to the Knowledge of the Company is there a reasonable basis therefor. There are no Orders to which any Target Company is a party or its otherwise bound that (i) restrict the rights of a Target Company to use, transfer, license or enforce any Intellectual Property owned by a Target Company, (ii) restrict the conduct of the business of a Target Company in order to accommodate a third Person’s Intellectual Property, or (iii) other than the Outbound IP Licenses, grant any third Person any right with respect to any Intellectual Property owned by a Target Company. No Target Company is currently infringing, or has, in the past, infringed, misappropriated or violated any Intellectual Property of any other Person in any material respect in connection with the ownership, use or license of any Intellectual Property owned or purported to be owned by a Target Company or, to the Knowledge of the Company, otherwise in connection with the conduct of the respective businesses of the Target Companies. To the Company’s Knowledge, no third party is currently, or in the past five (5) years has been, infringing upon, misappropriating or otherwise violating any Intellectual Property owned, licensed by, licensed to, or otherwise used or held for use by any Target Company (“Company IP”) in any material respect.

 

(e) All officers, directors, employees and independent contractors (to the extent any such independent contractor had access to Intellectual Property of a Target Company) of a Target Company (and each of their respective Affiliates) have assigned to the Target Companies all Intellectual Property arising from the services performed for a Target Company by such Persons and all such assignments of Company Registered IP have been recorded. No current or former officers, employees or independent contractors of a Target Company have claimed any ownership interest in any Intellectual Property owned by a Target Company. To the Knowledge of the Company, there has been no violation of a Target Company’s policies or practices related to protection of Company IP or any confidentiality or nondisclosure Contract relating to the Intellectual Property owned by a Target Company. The Company has made available to Purchaser true and complete copies of all written Contracts referenced in subsections under which employees and independent contractors assigned their Intellectual Property to a Target Company. To the Company’s Knowledge, none of the employees of any Target Company is obligated under any Contract, or subject to any Order, that would materially interfere with the use of such employee’s best efforts to promote the interests of the Target Companies, or that would materially conflict with the business of any Target Company as presently conducted or contemplated to be conducted. Each Target Company has taken reasonable security measures in order to protect the secrecy, confidentiality and value of the material Company IP.

 

(f) To the Knowledge of the Company, no Person has obtained unauthorized access to third party information and data (including personally identifiable information or information that can be used to identify a natural person (“personal information”)) in the possession of a Target Company, nor has there been any other material compromise of the security, confidentiality or integrity of such information or data, and no written or, to the Knowledge of the Company, oral complaint relating to an improper use or disclosure of, or a breach in the security of, any such information or data has been received by a Target Company. Each Target Company has complied in all material respects with all applicable Laws and Contract requirements relating to privacy, personal information protection, and the collection, processing and use of personal information and its own privacy policies and guidelines, if any, each with respect to the Target Companies’ collection, processing and use of personal information. To the Knowledge of the Company, the operation of the business of the Target Companies has not and does not violate any right to privacy or publicity of any third person or constitute unfair competition or trade practices under applicable Law.

 

22

 

(g) The consummation of any of the transactions contemplated by this Agreement will not result in the material breach, material modification, cancellation, termination, suspension of, or acceleration of any payments with respect to, or release of source code because of (i) any Contract providing for the license or other use of Intellectual Property owned by a Target Company, or (ii) any Company IP License. Following the End Date, the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Target Companies’ rights under such Contracts or Company IP Licenses to the same extent that the Target Companies would have been able to exercise had the transactions contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing fees, royalties or payments which the Target Companies would otherwise be required to pay in the absence of such transactions.

 

6.14 Taxes and Returns.

 

(a) Each Target Company has or will have timely filed, or caused to be timely filed, all federal, state, local and foreign Tax Returns required to be filed by it (taking into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in the Company Financials have been established. Each Target Company has complied with all applicable Laws relating to Tax.

 

(b) There is no Action currently pending or, to the Knowledge of the Company, threatened Action against a Target Company by a Governmental Authority in a jurisdiction where the Target Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.

 

(c) No Target Company is being audited by any Tax authority or has been notified in writing or, to the Knowledge of the Company, orally by any Tax authority that any such audit is contemplated or pending. There are no claims, assessments, audits, examinations, investigations or other Actions pending against a Target Company in respect of any Tax, and no Target Company has been notified in writing of any proposed Tax claims or assessments against it (other than, in each case, claims or assessments for which adequate reserves in the Company Financials have been established).

 

(d) There are no Liens with respect to any Taxes upon any Target Company’s assets, other than Permitted Liens.

 

(e) Each Target Company has collected or withheld all Taxes currently required to be collected or withheld by it, and all such Taxes have been paid to the appropriate Governmental Authorities or set aside in appropriate accounts for future payment when due.

 

(f) No Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any amount of Taxes. There are no outstanding requests by a Target Company for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

 

(g) No Target Company has made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed an agreement with, any taxing authority that would reasonably be expected to have a material impact on its Taxes following the End Date.

 

(h) No Target Company has engaged in any “listed transaction,” as defined in U.S. Treasury Regulation section 1.6011-4(b)(2).

 

(i) No Target Company has any Liability for the Taxes of another Person (other than another Target Company) that are not adequately reflected in the Company Financials (i) under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract or indemnity (excluding commercial agreements entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes). No Target Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding commercial agreements, arrangements or practices entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement or other agreement relating to Taxes with any Governmental Authority) that will be binding on any Target Company with respect to any period following the End Date.

 

23

 

(j) No Target Company has requested or is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.

 

(k) No Target Company: (i) has constituted either a “distributing corporation” or a “controlled corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of securities (to any Person or entity that is not a member of the consolidated group of which the Company is the common parent corporation) qualifying for, or intended to qualify for, Tax-free treatment under Section 355 of the Code (A) within the two-year period ending on the date hereof or (B) in a distribution which could otherwise constitute part of a “plan” or “series of related transactions” (within the meaning of Section 355(e) of the Code) in conjunction with the transactions contemplated by this Agreement; or (ii) is or has ever been (A) a U.S. real property holding corporation within the meaning of Section 897(c)(2) of the Code, or (B) a member of any consolidated, combined, unitary or affiliated group of corporations for any Tax purposes other than a group of which the Company is or was the common parent corporation.

 

6.15 Real Property. Schedule ‎6.15 contains a complete and accurate list of all premises currently leased or subleased or otherwise used or occupied by a Target Company for the operation of the business of a Target Company (“Leased Real Property”), and of all current leases, lease guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or waivers thereto (collectively, the “Company Real Property Leases”), as well as the current annual rent and term under each Company Real Property Lease. The Company has provided to Purchaser a true and complete copy of each of the Company Real Property Leases, and in the case of any oral Company Real Property Lease, a written summary of the material terms of such Company Real Property Lease. The Company Real Property Leases are valid, binding and enforceable in accordance with their terms and are in full force and effect, subject to Enforceability Exceptions. To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party under any of the Company Real Property Leases, and no Target Company has received notice of any such condition. Except as set forth on Schedule 6.15, no Target Company owns or has ever owned any real property or any interest in real property (other than the leasehold interests in the Company Real Property Leases) (the “Owned Real Property”).

 

6.16 Personal Property. Each item of Personal Property which is currently owned, used or leased by a Target Company with a book value or fair market value of greater than Fifty Thousand Dollars ($50,000) is set forth on Schedule ‎6.16, along with, to the extent applicable, a list of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all amendments, terminations and modifications thereof or waivers thereto (“Company Personal Property Leases”). Except as set forth in Schedule ‎6.16, all such items of Personal Property are in good operating condition and repair (reasonable wear and tear excepted consistent with the age of such items) and are suitable for their intended use in the business of the Target Companies. The operation of each Target Company’s business as it is now conducted or presently proposed to be conducted is not in any material respect dependent upon the right to use the Personal Property of Persons other than a Target Company, except for such Personal Property that is owned, leased or licensed by or otherwise contracted to a Target Company or any personal property used by any Target Company personnel in the performance of their duties for a Target Company from their residence in order to comply with applicable Covid-19 restrictions (“Covid-19 Restrictions”). The Company has provided to Purchaser a true and complete copy of each of the Company Personal Property Leases, and in the case of any oral Company Personal Property Lease, a written summary of the material terms of such Company Personal Property Lease. The Company Personal Property Leases are valid, binding and enforceable in accordance with their terms and are in full force and effect. To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party under any of the Company Personal Property Leases, and no Target Company has received notice of any such condition.

 

6.17 Title to and Sufficiency of Assets. Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use, all of its assets, free and clear of all Liens other than (a) Permitted Liens, (b) the rights of lessors under leasehold interests, (c) Liens specifically identified on the consolidated balance sheet of the Target Companies as of the Interim Balance Sheet Date and (d) Liens set forth on Schedule ‎6.17. The assets (including Intellectual Property rights and contractual rights) of the Target Companies constitute all of the assets, rights and properties that are used in the operation of the businesses of the Target Companies as it is now conducted or that are used or held by the Target Companies for use in the operation of the businesses of the Target Companies, and taken together, are adequate and sufficient for the operation of the businesses of the Target Companies as currently conducted.

 

24

 

6.18 Employee Matters.

 

(a) Except as set forth in Schedule ‎6.18 ‎(a), no Target Company is a party to any collective bargaining agreement or other Contract covering any group of employees, labor organization or other representative of any of the employees of any Target Company, and the Company has no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not occurred or, to the Knowledge of the Company, been threatened any strike, slow-down, picketing, work-stoppage, or other similar labor activity with respect to any such employees. Schedule ‎6.18 ‎(a) sets forth all unresolved labor controversies (including unresolved grievances and age or other discrimination claims other than any workers’ compensation or unemployment claims), if any, that are pending or, to the Knowledge of the Company, threatened between any Target Company and Persons employed by or providing services as independent contractors to a Target Company. No current officer or employee of a Target Company has provided any Target Company written or, to the Knowledge of the Company, oral notice of his or her plan to terminate his or her employment with any Target Company.

 

(b) Except as set forth in Schedule ‎6.18 ‎(b), each Target Company (i) is and has been in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment, health and safety and wages and hours, and other Laws relating to discrimination, disability, labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration, workers compensation, working conditions, employee scheduling, occupational safety and health, family and medical leave, and employee terminations, and has not received written or, to the Knowledge of the Company, oral notice that there is any pending Action involving unfair labor practices against a Target Company, (ii) is not liable for any material past due arrears of wages or any material penalty for failure to comply with any of the foregoing, and (iii) is not liable for any material payment to any Governmental Authority with respect to unemployment compensation benefits, social security or other benefits or obligations for employees, independent contractors or consultants (other than routine payments to be made in the ordinary course of business and consistent with past practice). Except as set forth in Schedule ‎6.18 ‎(b), there are no Actions pending or threatened against a Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority, relating to any such Law or regulation, or alleging breach of any express or implied contract of employment, wrongful termination of employment, or alleging any other discriminatory, wrongful or tortious conduct in connection with the employment relationship.

 

(c) Schedule ‎6.18 ‎(c) hereto sets forth a complete and accurate list as of the date hereof of all employees of the Target Companies showing for each as of such date (i) the employee’s name, job title or description, employer, location, salary level (including any bonus, commission, deferred compensation or other remuneration payable (other than any such arrangements under which payments are at the discretion of the Target Companies)); (ii) any bonus, commission or other remuneration other than salary paid during the fiscal year ending December 31, 2022; and (iii) any wages, salary, bonus, commission or other compensation due and owing to each employee during or for the calendar year ending December 31, 2022. Except as set forth on Schedule ‎6.18 ‎(c), (A) no employee is a party to a written employment Contract with a Target Company that is not terminable “at will,” and (B) the Target Companies have paid in full to all their employees all wages, salaries, commission, bonuses and other compensation due to their employees, including overtime compensation, and no Target Company has any obligation or Liability (whether or not contingent) with respect to severance payments to any such employees under the terms of any written or, to the Company’s Knowledge, oral agreement, or commitment or any applicable Law, custom, trade or practice. Except as set forth in Schedule ‎6.18 ‎(c), each Target Company employee has entered into the Company’s standard form of employee non-disclosure, inventions and restrictive covenants agreement with a Target Company (whether pursuant to a separate agreement or incorporated as part of such employee’s overall employment agreement), a copy of which has been made available to Purchaser by the Company.

 

25

 

(d) Schedule ‎6.18 ‎(d) contains a list of all independent contractors (including consultants) currently engaged by any Target Company, along with the position, the entity engaging such Person, date of retention and rate of remuneration. Except as set forth on Schedule ‎6.18 ‎(d), all of such independent contractors are a party to a written Contract with a Target Company. Except as set forth on Schedule ‎6.18 ‎(d), each such independent contractor has entered into customary covenants regarding confidentiality, non-competition, and assignment of inventions and copyrights in such Person’s agreement with a Target Company, a copy of which has been provided to Purchaser by the Company. For the purposes of applicable Law, including the Code, all independent contractors who are currently, or within the last six (6) years have been, engaged by a Target Company are bona fide independent contractors and not employees of a Target Company. Each independent contractor is terminable on fewer than thirty (30) days’ notice, without any obligation of any Target Company to pay severance or a termination fee.

 

6.19 Benefit Plans.

 

(a) Set forth on Schedule ‎6.19 ‎(a) is a true and complete list of each Foreign Plan of a Target Company (each, a “Company Benefit Plan”). Except as set forth on Schedule ‎6.19 ‎(a), no Target Company has ever maintained or contributed to (or had an obligation to contribute to) and Benefit Plan, whether or not subject to the provisions of ERISA, which is not a Foreign Plan.

 

(b) With respect to each Company Benefit Plan which covers any current or former officer, director, consultant or employee (or beneficiary thereof) of a Target Company, the Company has provided to Purchaser accurate and complete copies, if applicable, of: (i) all Company Benefit Plan documents and agreements and related trust agreements or annuity Contracts (including any amendments, modifications or supplements thereto); (ii) all summary plan descriptions and summary of material modifications thereto; (iii) the three (3) most recent Forms 5500, if applicable, and annual report, including all schedules thereto; (iv) the most recent annual and periodic accounting of plan assets; (v) the three (3) most recent nondiscrimination testing reports; (vi) the most recent determination letter received from the IRS, if any; (vii) the most recent actuarial valuation; and (viii) all material communications with any Governmental Authority within the last three (3) years.

 

(c) With respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in all material respects in accordance with its terms, and the requirements of all applicable Laws, and has for the past three (3) years been maintained, where required, in good standing with applicable regulatory authorities and Governmental Authorities; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending, or to the Company’s Knowledge, threatened (other than routine claims for benefits arising in the ordinary course of administration); (iv) all contributions, premiums and other payments (including any special contribution, interest or penalty) required to be made with respect to a Company Benefit have been timely made; (v) all benefits accrued under any unfunded Company Benefit Plan has been paid, accrued, or otherwise adequately reserved in accordance with IFRS and are reflected on the Company Financials; and (vi) no Company Benefit Plan provides for retroactive increases in contributions, premiums or other payments in relation thereto. To the Company’s Knowledge, no Target Company has incurred any obligation in connection with the termination of, or withdrawal from, any Company Benefit Plan.

 

(d) To the extent applicable, the present value of the accrued benefit liabilities (whether or not vested) under each Company Benefit Plan, determined as of the end of the Company’s most recently ended fiscal year on the basis of reasonable actuarial assumptions, each of which is reasonable, did not exceed the current value of the assets of such Company Benefit Plan allocable to such benefit liabilities.

 

(e) The consummation of the transactions contemplated by this Agreement and the Ancillary Documents will not: (i) entitle any individual to severance pay, unemployment compensation or other benefits or compensation under any Company Benefit Plan or under any applicable Law; or (ii) accelerate the time of payment or vesting, or increase the amount of any compensation due, or in respect of, any director, employee or independent contractor of a Target Company.

 

(f) Except to the extent required by applicable Law, no Target Company provides health or welfare benefits to any former or retired employee or is obligated to provide such benefits to any active employee following such employee’s retirement or other termination of employment or service.

 

26

 

(g) All Company Benefit Plans can be terminated at any time prior to the End Date without resulting in any Liability to Purchaser or their respective Affiliates for any additional contributions, penalties, premiums, fees, fines, excise taxes or any other charges or liabilities.

 

6.20 Environmental Matters.

 

Except as set forth in Schedule ‎6.20:

 

(a) Each Target Company, except for matters which have been fully resolved, is and has been in compliance in all material respects with all applicable Environmental Laws in force from time to time, and none of the Target Company is subject to any current Environmental Liabilities relating to any material non-compliance with Environmental Laws (such materiality assessed with respect to a Company Material Adverse Effect).

 

(b) There has been no material release of any Hazardous Materials by the Target Company at, in, on or under any Real Property or Leased Real Property, or in connection with the Target Company’s operations off-site of the Owned Real Property or Leased Real Property.

 

6.21 Transactions with Affiliates. Except as set forth on Schedule 6.21, no Target Company nor any of its Affiliates, nor any officer, director, manager, employee, trustee or beneficiary of a Target Company or any of its Affiliates, nor any immediate family member of any of the foregoing (whether directly or indirectly through an Affiliate of such Person) (each of the foregoing, a “Related Person”) is presently, or in the past two (2) years, has been, a party to any transaction with a Target Company, including any Contract or other arrangement (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b) providing for the rental of real property or Personal Property from or (c) otherwise requiring payments to (other than for services or expenses as directors, officers or employees of the Target Company in the ordinary course of business consistent with past practice) any Related Person or any Person in which any Related Person has an interest as an owner, officer, manager, director, trustee or partner or in which any Related Person has any direct or indirect interest (other than the ownership of securities representing no more than five percent (5%) of the outstanding voting power or economic interest of a publicly traded company). Except as set forth on Schedule 6.21, no Target Company has outstanding any Contract or other arrangement or commitment with any Related Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual Property) which is used in the business of any Target Company, other than personal property used by service providers to the Target Companies while working from home under Covid-19 Restrictions. The assets of the Target Companies do not include any material receivable or other obligation from a Related Person, and the liabilities of the Target Companies do not include any material payable or other obligation or commitment to any Related Person. No Related Person that is not a Target Company owns any asset used by any Target Company in operating its business.

 

6.22 Insurance.

 

(a) Schedule ‎6.22 ‎(a) lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) held by a Target Company relating to a Target Company or its business, properties, assets, directors, officers and employees, copies of which have been provided to Purchaser. All premiums due and payable under all such insurance policies have been timely paid and the Target Companies are otherwise in material compliance with the terms of such insurance policies. Each such insurance policy (i) is legal, valid, binding, enforceable and in full force and effect and (ii) will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the End Date. No Target Company has any self-insurance or co-insurance programs. In the past five (5) years, no Target Company has received any notice from, or on behalf of, any insurance carrier relating to or involving any adverse change or any change other than in the ordinary course of business, in the conditions of insurance, any refusal to issue an insurance policy or non-renewal of a policy.

 

(b) Schedule ‎6.22 ‎‎(b) identifies each individual insurance claim in excess of $50,000 made by a Target Company in the past five (5) years. Each Target Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to be material to the Target Companies. To the Knowledge of the Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without notice or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. In the three (3) years preceding the date hereof, no Target Company has made any claim against an insurance policy as to which the insurer is denying coverage.

 

27

 

6.23 Books and Records. All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course of business consistent with past practice and in accordance with applicable Laws.

 

6.24 Top Customers and Suppliers. Schedule 6.24 lists, by dollar volume received or paid, as applicable, for each of (a) the twelve (12) months ended on December 31, 2022 and (b) the period from January 1, 2023 through the Interim Balance Sheet Date, the ten (10) largest customers of the Target Companies (the “Top Customers”) and the ten largest suppliers of goods or services to the Target Companies (the “Top Suppliers”), along with the amounts of such dollar volumes. The relationships of each Target Company with such suppliers and customers are good commercial working relationships and (i) no Top Supplier or Top Customer within the last twelve (12) months has cancelled or otherwise terminated, or, to the Company’s Knowledge, intends to cancel or otherwise terminate, any material relationships of such Person with a Target Company, (ii) no Top Supplier or Top Customer has during the last twelve (12) months decreased materially or, to the Company’s Knowledge, threatened to stop, decrease or limit materially, or intends to modify materially its material relationships with a Target Company or stop, decrease or limit materially its products or services to any Target Company or its usage or purchase of the products or services of any Target Company, (iii) to the Company’s Knowledge, no Top Supplier or Top Customer intends to refuse to pay any amount due to any Target Company or seek to exercise any remedy against any Target Company, and (iv) no Target Company has within the past two (2) years been engaged in any material dispute with any Top Supplier or Top Customer.

 

6.25 Certain Business Practices.

 

(a) No Target Company, nor to the Knowledge of the Company any of their respective Representatives acting on their behalf within the past five years has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the applicable anti-corruption or bribery Laws or (iii) made any other unlawful payment in violation of applicable bribery Laws. No Target Company, nor to the Knowledge of the Company any of their respective Representatives acting on their behalf has within the past five years directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder any Target Company or assist any Target Company in connection with any actual or proposed transaction.

 

(b) The operations of Target Company are and have been conducted at all times in compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, and no Action involving a Target Company with respect to any of the foregoing is pending or, to the Knowledge of the Company, threatened.

 

(c) No Target Company or any of their respective directors or officers, or, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions administered by OFAC, and no Target Company has in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions administered by OFAC.

 

6.26 Compliance with Privacy Laws, Privacy Policies and Certain Contracts.

 

(a) Except as set forth on Schedule 6.26(a):

 

(i) Neither the Company, nor, the Knowledge of the Company, its officers, directors, managers, employees, agents, subcontractors and vendors to whom Company has given access to Personal Data or other protected information, are and have been at all times, in compliance in all material respects with all applicable Privacy Laws;(ii) Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, the Company has not experienced any loss, damage or unauthorized access, use, disclosure or modification, or breach of security of Personal Data or other protected information maintained by or on behalf of the Company (including, to the Knowledge of the Company, by any agent, subcontractor or vendor of the Company);(iii) Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, (i) no Person, including any Governmental Authority, has made any written claim or commenced any Proceeding with respect to any violation of any Privacy Law by the Company (ii) the Company has not been given written notice of any criminal, civil or administrative violation of any Privacy Law, in any case including any claim or action with respect to any loss, damage or unauthorized access, use, disclosure, modification, or breach of security, of Personal Data or other protected information maintained by or on behalf of the Company (including by any agent, subcontractor or vendor of the Company), and (iii) no data subject has ever made any data subject access requests to the Company.

 

28

 

(b) To the Knowledge of the Company, all activities conducted by the Company with respect to any Personal Data or other protected information are permitted under the Contracts relating to Personal Data or other protected information.

 

(c) To the Knowledge of the Company, each Contract between the Company and a customer of the Company contains all the terms and conditions that the Company is required to include therein under the Company’s Contracts with its vendors and suppliers.

 

(d) The Company has obtained all necessary consents for the collection, use, and disclosure of personal information. Specifically, where applicable, to the Knowledge of the Company all Personal Data transfers have met the data transfer restrictions and requirements for transfer of Personal Data to jurisdictions outside the country of any data subject, including employees, as evidenced by either specific and well documented data subject consent or standard contractual clauses, if applicable. The Company has taken all measures required by the laws of a given country for the transfer and protection of sensitive Personal Data.

 

(e) To the Knowledge of the Company, all its officers, directors, managers, employees, agents, subcontractors, consultants, or vendors to whom Company has given access are held and contractually bound to the same standards of data subject protections as would be applied to the Company.

 

(f) The Company does not monetize the Personal Data of any data subjects, and it does not receive any payments, consideration or other form of non-monetary payment in exchange for the production of Personal Data to any third parties.

 

(g) The Company has implemented reasonable security measures to protect Personal Data.

 

(h) To the Knowledge of the Company, it has not experienced any data breaches or security incidents that have resulted in unauthorized access to Personal Data.

 

6.27 Investment Company Act. No Target Company is an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each case within the meaning of the Investment Company Act.

 

6.28 Finders and Brokers. Except as set forth in Schedule 6.28, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from Purchaser, any Target Company or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of the Company.

 

6.29 Independent Investigation. The Company has conducted its own independent investigation, review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of Purchaser, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of Purchaser for such purpose. The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of Purchaser set forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) and in any certificate delivered to the Company pursuant hereto; and (b) neither Purchaser nor any of its Representatives have made any representation or warranty as to Purchaser or this Agreement, except as expressly set forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) or in any certificate delivered to the Company pursuant hereto.

 

29

 

6.30 Information Supplied. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference: (a) in any report, form, registration or other filing made with any Governmental Authority (including SEC) with respect to the Transactions contemplated by this Agreement or any Ancillary Documents; (b) in the Registration Statement; or (c) in the mailings or other distributions to Purchaser’s stockholders and/or prospective investors with respect to the consummation of the Transactions contemplated by this Agreement or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the End Date Press Release and the End Date Filing will, when filed or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with respect to any information supplied by or on behalf of Purchaser or its Affiliates.

 

6.31 Disclosure. No representations or warranties by the Company in this Agreement (as modified by the Company Disclosure Schedules) or the Ancillary Documents, (a) contains or will contain any untrue statement of a material fact, or (b) omits or will omit to state, when read in conjunction with all of the information contained in this Agreement, the Company Disclosure Schedules and the Ancillary Documents, any fact necessary to make the statements or facts contained therein not materially misleading. Except for the representations and warranties expressly made by the Company in this ‎Article VI (as modified by the Company Disclosure Schedules) or as expressly set forth in an Ancillary Document, no Target Company nor any other Person on its behalf makes any express or implied representation or warranty with respect to any of the Target Companies, the Company Security Holders, the Company Share, the business of the Target Companies, or the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the Company hereby expressly disclaims any other representations or warranties, whether implied or made by any Target Company or any of its Representatives. Except for the representations and warranties expressly made by the Company in this ‎Article VI (as modified by the Company Disclosure Schedules) or in an Ancillary Document, the Company hereby expressly disclaims all liability and responsibility for any representation, warranty, projection, forecast, statement or information made, communicated or furnished (orally or in writing) to Purchaser, Purchaser Representative or any of their respective Representatives (including any opinion, information, projection or advice that may have been or may be provided to Purchaser, Purchaser Representative or any of their respective Representatives by any Representative of the Company), including any representations or warranties regarding the probable success or profitability of the businesses of the Target Companies.

 

6.32 Notice of Claims. If, after the date of this Agreement (a) Purchaser becomes aware of any matter that may give rise to a Warranty Claim, or (b) Purchaser becomes aware of a matter that may give rise to a Warranty Claim as a result of a Third Party Claim made or threatened by a Third Party against Purchaser or the Company, then Purchaser must notify the Company in writing with details of the matter and an estimate of the amount involved as soon as practicable, and in any event no more than 14 days, after Purchaser becomes aware of the matter. If Purchaser intends to make a Warranty Claim, it must notify the Company in writing of that Warranty Claim with details of the matter giving rise to the Claim and the amount claimed (“Claim Notice”).

 

6.33 Company to Consider Claims. The Company must notify Purchaser within 21 days after receipt of a Claim Notice, indicating whether it admits or denies the relevant Claim (in whole or in part).

 

6.34 Small Claims. Purchaser cannot make a Warranty Claim unless and until both: (i) the value of that Claim (including any one of a series of Claims arising from the same event or circumstance) is more than USD $250,000 (“Minimum Single Claim Amount”); and (ii) the aggregate of all of Purchaser’s Claims is more than USD $3,000,000 (“Minimum Aggregate Claim Amount”), in which event the Purchaser may claim the entire amount of the Claim. For the avoidance of doubt, this Section does not apply to any Warranty Claims arising from a breach of any Title and Capacity Warranty.

 

30

 

6.35 Time Limits for Claims. Purchaser cannot make a Warranty Claim unless it has complied with the notice requirements in Section 6.31 for any Warranty Claim and on or before the expiration of 2 years after Closing: (a) Purchaser has commenced court proceedings relating to the Warranty Claim; (b) if agreed between the parties, Purchaser has commenced an alternative dispute resolution process relating to the Warranty Claim; or (c) the Company admits the Warranty Claim.

 

6.36 General Limits on Types of Claims. To the maximum extent permitted by Law, Purchaser cannot make a Warranty Claim to the extent that:

 

(a) a provision, reserve or accrual has been made in the Company Financials in connection with the matter giving rise to the Claim;

 

(b) the Claim results from, or the amount of the Claim is increased because of, new Law or a change in the Law or in its interpretation, in each case taking effect on or after the date of this Agreement;

 

(c) the Claim results from, or the amount of the Claim is increased because of, an increase in a rate of Tax either in Australia, or additional Tax becoming payable in any other jurisdiction on or after the date of this Agreement;

 

(d) the Claim results from the loss of any, or the loss of access to any, Tax attribute including any losses, deductions, credits, rebates or offsets, as a result of the Closing;

 

(e) the Claim relates to a matter that is timing in nature such that a benefit arises to Purchaser in a different period;

 

(f) the Claim is in respect of a matter that results in: (i) a reduction in the Tax that would otherwise be payable by Purchaser; or (ii) an increase in any Tax attribute, including any losses, deductions, credits, rebates or offsets, to which Purchaser has access;

 

(g) the Claim arises from any act or omission by or on behalf of the Company before the Closing that was done or made with the written consent or at the written direction or instruction of Purchaser;

 

(h) the Claim results from, or the amount of the Claim is increased because of, any change in generally accepted accounting policies and practices on or after the date of this Agreement;

 

(i) the Claim arises directly or indirectly because of any voluntary, wrongful or negligent act or omission of Purchaser, its agents, employees or contractors on or after the date of this Agreement;

 

(j) the Claim arises because of a thing the Company did or did not do before Closing at Purchaser’s request or with its consent;

 

(k) the Claim increases because Purchaser has unreasonably failed to mitigate its loss;

 

(l) the matter giving rise to the Claim is remedied without cost to Purchaser;

 

(m) the Claim is for loss of profits, economic loss, loss of business opportunity, loss of anticipated profits, loss or damages resulting from wasted management time or any special, indirect or other consequential loss or damage;

 

(n) the Claim is in respect of any forecast, estimate, projection or other statement which relates to the future; or

 

31

 

(o) Purchaser is reasonably compensated (by any other person) for the matter giving rise to the Claim.

 

6.37 Purchaser Must Pursue Third Party. If Purchaser recovers an amount under Sections 6.32, 6.33, 6.34, 6.35, 6.36, 6.37, 6.38, 6.39 and 6.40 in connection with a matter and it subsequently becomes entitled to claim an amount from a Third Party in connection with that matter, Purchaser must use reasonable endeavors to enforce its Claim against the Third Party to a reasonable extent.

 

6.38 Benefits Received. Purchaser must promptly reimburse the Company if: (i) Purchaser recovers an amount under this Agreement in respect of a Warranty Claim; and (ii) Purchaser or the Company then receives an amount or reimbursement from a Third Party including a Government Authority and this amount or reimbursement would have reduced the amount recovered by Purchaser if it had been received before the recovery. The amount Purchaser must reimburse to the Company is equal to the amount Purchaser or the Company receives from the Third Party including a Government Authority (less any costs reasonably incurred in obtaining the amount).

 

6.39 Mitigation. Purchaser must take reasonable action to mitigate any loss, Liability, costs or other damage suffered as a result of a breach of a Company Warranty or any matter that is the subject of a Warranty Claim.

 

6.40 Other Actions. Purchaser must not and agrees that it will not commence any legal proceedings against the Company in respect of a Warranty Claim where that would be inconsistent with Sections 6.32, 6.33, 6.34, 6.35, 6.36, 6.37, 6.38, 6.39 and 6.40.

 

6.41 Materiality Adverse Effect. Any deviations from any of the foregoing Section 6.8, 6.9, 6.10, 6.11, 6.12, 6.13, 6.14, 6.15, 6.16, 6.17, 6.18, 6.19, 6.20, 6.21, 6.22, 6.24, and 6.25 would not reasonably be expected to have a Material Adverse Effect on (a) the Target Companies taken as a whole, or (b) the ability of the Company to perform its obligations under this Agreement or the Ancillary Documents to which it is or shall be a party.

 

ARTICLE VII COVENANTS

 

7.1 Access and Information.

 

(a) During the period from the date of this Agreement and continuing until the earlier of the termination of this Agreement in accordance with Section ‎10.1 or the End Date (the “Interim Period”), subject to Section ‎7.13, the Company shall give, and shall cause its Representatives to give, Purchaser and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial and operating data and other information (including Tax Returns, internal working papers, client files, client Contracts and director service agreements), of or pertaining to the Target Companies, as Purchaser or its Representatives may reasonably request regarding the Target Companies and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent or any other conditions required by such accountants, if any)) and cause each of the Company’s Representatives to reasonably cooperate with Purchaser and its Representatives in their investigation; provided, however, that Purchaser and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of the Target Companies.

 

(b) During the Interim Period, subject to Section ‎7.13, Purchaser shall give, and shall cause its Representatives to give, the Company and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial and operating data and other information (including Tax Returns, internal working papers, client files, client Contracts and director service agreements), of or pertaining to Purchaser or its Subsidiaries, as the Company or its Representatives may reasonably request regarding Purchaser, its Subsidiaries and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent or any other conditions required by such accountants, if any)) and cause each of Purchaser’s Representatives to reasonably cooperate with the Company and its Representatives in their investigation; provided, however, that the Company and its Representatives shall conduct any such activities in such a manner as not to unreasonably interfere with the business or operations of Purchaser or any of its Subsidiaries.

 

32

 

7.2 Conduct of Business of the Company.

 

(a) Unless Purchaser shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule ‎7.2, the Company shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to the Target Companies and their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, their respective business organizations, to keep available the services of their respective managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of their respective material assets, all as consistent with past practice.

 

(b) Without limiting the generality of Section 7.2(a) and except as contemplated by the terms of this Agreement or the Ancillary Documents as set forth on Schedule 7.2, during the Interim Period, without the prior written consent of Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall not, and shall cause its Subsidiaries to not:

 

(c) amend, waive or otherwise change, in any respect, its Organizational Documents, except as required by applicable Law;

 

(d) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities of any class and any other equity-based awards, other than the issuance of Company Share upon the exercise of Company options outstanding as of the date hereof in accordance with their existing terms, or engage in any hedging transaction with a third Person with respect to such securities;

 

(e) split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;

 

(f) incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of 25,000 individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party (other than advancement of expenses to employees in the ordinary course of business), or guarantee or endorse any Indebtedness, Liability or obligation of any Person in excess of $25,000 individually or $100,000 in the aggregate;

 

(g) increase the wages, salaries or compensation of its employees other than in the ordinary course of business, consistent with past practice, and in any event not in the aggregate by more than five percent (5%), or make or commit to make any bonus payment (whether in cash, property or securities) other than in the ordinary course of business consistent with past practice, to any employee, or materially increase other benefits of employees generally other than in the ordinary course of business consistent with past practice, or enter into, establish, materially amend or terminate any Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or employee, in each case other than as required by applicable Law, pursuant to the terms of any Company Benefit Plans, Contracts, or in the ordinary course of business consistent with past practice;

 

33

 

(h) make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation, audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting or Tax policies or procedures, in each case except as required by applicable Law or in compliance with IFRS;

 

(i) transfer or license to any Person or otherwise extend, materially amend or modify, permit to lapse or fail to preserve any material Company Registered IP, Company IP Licenses or other Company IP (excluding non-exclusive licenses of Company IP to Target Company customers in the ordinary course of business consistent with past practice), or disclose to any Person who has not entered into a confidentiality agreement any Trade Secrets;

 

(j) terminate, or waive or assign any material right under, any Company Material Contract or enter into any Contract that would be a Company Material Contract, in any case outside of the ordinary course of business consistent with past practice;

 

(k) fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;

 

(l) establish any Subsidiary or enter into any new line of business;

 

(m) fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage as are substantially similar to those currently in effect;

 

(n) revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required to comply with IFRS and after consulting with each Party’s outside auditors;

 

(o) waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by such Party or its Affiliates) not in excess of $25,000 (individually or $100,000 in the aggregate), or otherwise pay, discharge or satisfy any Actions, Liabilities or obligations, unless such amount has been reserved in the Company Financials;

 

(p) close or materially reduce its activities, or effect any layoff or other personnel reduction or change, at any of its facilities;

 

(q) acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside the ordinary course of business consistent with past practice;

 

(r) make capital expenditures in excess of $25,000 (individually for any project (or set of related projects) or $100,000 in the aggregate) other than pursuant to the terms of a Company Material Contract;

 

(s) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;

 

(t) voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $150,000 individually or $250,000 in the aggregate other than pursuant to the terms of a Company Material Contract or Company Benefit Plan;

 

34

 

(u) sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose of any material portion of its properties, assets or rights;

 

(v) enter into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company;

 

(w) take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement;

 

(x) accelerate the collection of any trade receivables or delay the payment of trade payables or any other Liability other than in the ordinary course of business consistent with past practice;

 

(y) enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person (other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course of business consistent with past practice); or

 

(z) authorize or agree to do any of the foregoing actions;

 

provided, that any actions reasonably taken in good faith by the Company or its Subsidiaries to the extent reasonably believed to be necessary to comply with Laws (including orders of Governmental Authorities) related to COVID-19 shall be deemed not to constitute a breach of the requirements set forth under this Section 7.2. The Company shall notify Purchaser in writing of any such actions taken in accordance with the foregoing proviso and shall use reasonable best efforts to mitigate any negative effects of such actions on the business of the Target Companies, in consultation with Purchaser whenever practicable.

 

7.3 Conduct of Business of Purchaser.

 

(a) Unless the Company and the Company Representative shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, except as expressly contemplated by this Agreement or any Ancillary Document or as set forth on Schedule ‎7.3, or as required by applicable Law, Purchaser shall (i) conduct its businesses, in all material respects, in the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to Purchaser and its businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, its respective business organizations, to keep available the services of its respective directors, officers, employees and consultants, and to preserve the possession, control and condition of its respective material assets, all as consistent with past practice. Notwithstanding anything to the contrary in this Section 7.3, nothing in this Agreement shall prohibit or restrict Purchaser from extending, in accordance with Purchaser’s Organizational Documents and the IPO Prospectus, the deadline by which it must complete its Business Combination (an “Extension”), including securing the release of all or a portion of the Escrow Amount pursuant to the Extension Escrow Agreement for deposit into the Trust Account in order to secure such extension and no consent of any other Party shall be required in connection therewith.

 

(b) Without limiting the generality of Section 7.3(a) and except as contemplated by the terms of this Agreement or any Ancillary Document (including as contemplated by any PIPE Investment consented to by the Company in accordance with Section 7.20) or as set forth on Schedule 7.3, as required by applicable Law, during the Interim Period, without the prior written consent of the Company and the Company Representative (such consent not to be unreasonably withheld, conditioned or delayed), Purchaser shall not, and shall cause its Subsidiaries to not:

 

(c) amend, waive or otherwise change, in any respect, its Organizational Documents except as required by applicable Law;

 

(d) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its equity securities or other security interests of any class and any other equity-based awards, other than the issuance of Purchaser securities issuable upon conversion or exchange of outstanding Purchaser securities in accordance with their terms, or engage in any hedging transaction with a third Person with respect to such securities;

 

35

 

(e) split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;

 

(f) incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $25,000 individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party, or guarantee or endorse any Indebtedness, Liability or obligation of any Person (provided, that this Section 7.3(b)(iv) shall not prevent Purchaser from borrowing funds necessary to finance its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation of the Business Combination and the other transactions contemplated by this Agreement (including any PIPE Investment and the costs and expenses necessary for an Extension (such expenses, “Extension Expenses”)), up to aggregate additional Indebtedness during the Interim Period of $10,000,000, provided that the Available Closing SPAC Cash shall not be less than USD $7,500,000;

 

(g) make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation, audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting or Tax policies or procedures, in each case except as required by applicable Law or in compliance with GAAP;

 

(h) amend, waive or otherwise change the Trust Agreement in any manner adverse to Purchaser;

 

(i) terminate, waive or assign any material right under any material agreement to which it is a party or any Purchaser Material Contract;

 

(j) fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;

 

(k) establish any Subsidiary or enter into any new line of business;

 

(l) fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to that which is currently in effect;

 

(m) revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required to comply with GAAP and after consulting Purchaser’s outside auditors;

 

(n) waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, Purchaser or its Subsidiary) not in excess of $25,000 individually or $100,000 in the aggregate), or otherwise pay, discharge or satisfy any Actions, Liabilities or obligations, unless such amount has been reserved in Purchaser Financials;

 

(o) acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside the ordinary course of business;

 

36

 

(p) make capital expenditures in excess of $25,000 individually for any project (or set of related projects) or $100,000 in the aggregate (excluding for the avoidance of doubt, incurring any Expenses);

 

(q) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization (other than with respect to the Business Combination);

 

(r) voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $25,000 individually or $100,000 in the aggregate (excluding the incurrence of any Expenses) other than pursuant to the terms of a Contract in existence as of the date of this Agreement or entered into in the ordinary course of business or in accordance with the terms of this Section 7.3 during the Interim Period;

 

(s) sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose of any material portion of its properties, assets or rights;

 

(t) enter into any agreement, understanding or arrangement with respect to the voting of its securities;

 

(u) take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement; or

 

(v) authorize or agree to do any of the foregoing actions;

 

provided, that any actions reasonably taken in good faith by Purchaser to the extent reasonably believed to be necessary to comply with Laws (including orders of Governmental Authorities) related to COVID-19 shall be deemed not to constitute a breach of the requirements set forth under this Section 7.3. Purchaser shall notify the Company in writing of any such actions taken in accordance with the foregoing proviso and shall use reasonable best efforts to mitigate any negative effects of such actions on Purchaser and its Subsidiaries.

 

7.4 Annual and Interim Financial Statements. During the Interim Period, within thirty (30) calendar days following the end of each calendar month, three-month quarterly period and each fiscal year, the Company shall deliver to Purchaser an unaudited consolidated income statement and an unaudited consolidated balance sheet of the Target Companies for the period from the Interim Balance Sheet Date through the end of such calendar month, quarterly period or fiscal year and the applicable comparative period in the preceding fiscal year, in each case accompanied by a certificate of the Chief Financial Officer of the Company to the effect that all such financial statements fairly present the consolidated financial position and results of operations of the Target Companies as of the date or for the periods indicated, in accordance with IFRS, subject to year-end audit adjustments and excluding footnotes. From the date of this Agreement through the End Date, the Company will also promptly deliver to Purchaser copies of any audited consolidated financial statements of the Target Companies that the Target Companies’ certified public accountants may issue.

 

7.5 Purchaser Public Filings. During the Interim Period, Purchaser will keep current and timely file all of its public filings with the SEC and otherwise comply in all material respects with applicable securities Laws and shall use its commercially reasonable efforts prior to the End Date to maintain the listing of Purchaser Public Units, Purchaser Common Stock and Purchaser Public Warrants on Nasdaq; provided, that the Parties acknowledge and agree that from and after the End Date, the Parties intend to list on Nasdaq only Purchaser Common Stock and Purchaser Public Warrants.

 

7.6 No Trading. Each of the Company , the Company Shareholders and the Company Representative acknowledges and agrees that it is aware, and that the their respective Affiliates are aware (and each of their respective Representatives is aware or, upon receipt of any material nonpublic information of Purchaser, will be advised) of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC and Nasdaq promulgated thereunder or otherwise (the “Federal Securities Laws”) and other applicable foreign and domestic Laws on a Person possessing material nonpublic information about a publicly traded company. The Company, the Company Shareholders and the Company Representative each hereby agrees that, while it is in possession of such material nonpublic information, it shall not purchase or sell any securities of Purchaser (other than pursuant to the Transactions), communicate such information to any third party, take any other action with respect to Purchaser in violation of such Laws, or cause or encourage any third party to do any of the foregoing.

 

37

 

7.7 Notification of Certain Matters. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party or its Affiliates (or, with respect to the Company, any Company Shareholder): (a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or its Affiliates (or, with respect to the Company, any Company Shareholder) hereunder in any material respect; (b) receives any notice or other communication in writing from any third party (including any Governmental Authority) alleging (i) that the Consent of such third party is or may be required in connection with the Transactions contemplated by this Agreement or (ii) any non-compliance with any Law by such Party or its Affiliates (or, with respect to the Company, any Company Shareholder); (c) receives any notice or other communication from any Governmental Authority in connection with the Transactions contemplated by this Agreement; (d) discovers any fact or circumstance that, or becomes aware of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which, would reasonably be expected to cause or result in any of the conditions to the End Date set forth in ‎Article IX not being satisfied or the satisfaction of those conditions being materially delayed; or (e) becomes aware of the commencement or threat, in writing, of any Action against such Party or any of its Affiliates (or, with respect to the Company, any Company Shareholder or the , or any of their respective properties or assets, or, to the Knowledge of such Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party or of its Affiliates (or, with respect to the Company, any Company Shareholder or the Company Representative) with respect to the consummation of the Transactions contemplated by this Agreement. No such notice shall constitute an acknowledgement or admission by the Party providing the notice regarding whether or not any of the conditions to the End Date have been satisfied or in determining whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.

 

7.8 Efforts.

 

(a) Subject to the terms and conditions of this Agreement, each Party shall use its commercially reasonable efforts, and shall cooperate fully with the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental Authorities applicable to the transactions contemplated by this Agreement.

 

(b) In furtherance and not in limitation of Section 7.8‎(a), to the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade (“Antitrust Laws”), each Party hereto agrees to make any required filing or application under Antitrust Laws, as applicable, at such Party’s sole cost and expense, with respect to the transactions contemplated hereby as promptly as practicable, to supply as promptly as reasonably practicable any additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other actions reasonably necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods under Antitrust Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the Antitrust Laws. Each Party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the transactions contemplated by this Agreement under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in all respects with each other Party or its Affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including any proceeding initiated by a private Person; (ii) keep the other Parties reasonably informed of any communication received by such Party or its Representatives from, or given by such Party or its Representatives to, any Governmental Authority and of any communication received or given in connection with any proceeding by a private Person, in each case regarding any of the transactions contemplated by this Agreement; (iii) permit a Representative of the other Parties and their respective outside counsel to review any communication given by it to, and consult with each other in advance of any meeting or conference with, any Governmental Authority or, in connection with any proceeding by a private Person, with any other Person, and to the extent permitted by such Governmental Authority or other Person, give a Representative or Representatives of the other Parties the opportunity to attend and participate in such meetings and conferences; (iv) in the event a Party’s Representative is prohibited from participating in or attending any meetings or conferences, the other Parties shall keep such Party promptly and reasonably apprised with respect thereto; and (v) use commercially reasonable efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or other written communications explaining or defending the transactions contemplated hereby, articulating any regulatory or competitive argument, and/or responding to requests or objections made by any Governmental Authority.

 

38

 

(c) As soon as reasonably practicable following the date of this Agreement, the Parties shall reasonably cooperate with each other and use (and shall cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental Authorities requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts to have such Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice to the other Parties if such Party or any of its Representatives (or, with respect to the Company, any Company Shareholder or the Company Representative) receives any notice from such Governmental Authorities in connection with the transactions contemplated by this Agreement, and shall promptly furnish the other Parties with a copy of such Governmental Authority notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions contemplated hereby, whether prior to the End Date or after the End Date, each Party shall arrange for Representatives of such Party to be present for such hearing or meeting. If any objections are asserted with respect to the transactions contemplated by this Agreement under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document as violative of any applicable Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions so as to timely permit consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order to resolve such objections or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened to be instituted) by a Governmental Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary Document, the Parties shall, and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement or the Ancillary Documents.

 

(d) Prior to the End Date, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or other third Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this Agreement or required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts.

 

7.9 Tax Matters.

 

(a) The Company shall prepare or cause to be prepared at its own expense and the Company shall file all Tax Returns of the Company for all taxable periods ending on or prior to the Closing (“Pre-Closing Periods”) that are filed after the Closing, other than any Tax Return due for the short tax period ending on the Closing (the “Final Pre-Closing Period”). The Company Representative shall provide Purchaser with a copy of the Tax Returns prepared under this Section 7.9(a) at least twenty (20) days prior to the filing of such Tax Returns, and the Company Shareholders will incorporate any reasonable comments made by Purchaser within such 20-day period; provided, that nothing herein shall require the Company to file any Tax Return that, in the opinion of Purchaser’s tax advisors, is not complete and accurate; provided, further, that the Company Shareholders shall not take any position or apply any methodology in preparing any such Tax Return that is not consistent with the Tax practices and methodologies consistently applied in the ordinary course of business by the Company and its Subsidiaries in the preparation of its Tax Returns relating to prior taxable periods (such as, for example and without limitation, practices with respect to the calculation of depreciation expense deductions), provided that such practices and methodologies comply with applicable Law. Except as required by Law, without the prior written consent of the Company Representative (which consent shall not be unreasonably withheld, conditioned or delayed), neither the Company, any of its Subsidiaries, Purchaser nor any Affiliate of the Company, the Subsidiaries or Purchaser shall file any amended Tax Return with respect to any such period. To the extent permitted by applicable Law, neither the Company nor its Subsidiaries shall carry back any Tax attribute to any such period. Purchaser shall have the right to handle, defend, conduct and control any Tax Claim relating to any Tax refund arising by operation of the preceding sentence; provided, that Purchaser shall consult periodically with the Company Representative as to strategic and tactical issues for pursuing any Tax Claim and shall consider in good faith any suggestions made by the Company Representative about the conduct of such Tax Claim. Purchaser shall not have the right to compromise or settle any such Tax Claim relating to a refund without the prior consent of the Company Representative, which consent shall not be unreasonably withheld, conditioned or delayed.

 

39

 

(b) Purchaser shall prepare (or cause to be prepared) and file (or cause to be filed) when due (taking into account all extensions properly obtained) all Tax Returns required to be filed by or with respect to the Company and its Subsidiaries relating to: (i) the Final Pre-Closing Period; and (ii) taxable periods that begin before and end after the Closing (“Straddle Periods”). Purchaser shall deliver to the Company Representative copies of each such Tax Return relating to the Final Pre-Closing Period and Straddle Periods, along with a statement (a “Tax Statement”) showing the pre-Closing portion of any Liability in respect of any Taxes required to be paid with such Tax Return (computed in accordance with Section 7.9(d)), at least twenty (20) days prior to the due date for filing such Tax Return, and shall permit the Company Representative to review and comment on such Tax Return and Tax Statement prior to filing. Purchaser shall not file any such Tax Return relating to the Final Pre-Closing Period and Straddle Periods without the prior written consent of the Company Representative (which shall not be unreasonably withheld, conditioned or delayed); provided that the failure of the Company Representative to deliver written consent to Purchaser prior to the due date for filing such Tax Return shall be deemed to constitute consent. If the parties have not resolved any dispute relating to any such Tax Return prior to the due date for filing such Tax Return, then Purchaser shall file such Tax Return as prepared, but such filing shall not prejudice the rights of any party to pursue such dispute.

 

7.10 Further Assurances. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their part under this Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable, including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings.

 

7.11 The Registration Statement.

 

(a) As promptly as practicable after the date of this Agreement, Purchaser shall prepare with the reasonable assistance of the Company, and file with the SEC a registration statement on Form S-4 (as amended or supplemented from time to time, and including the Proxy Statement contained therein, the “Registration Statement”) in connection with the registration under the Securities Act of Purchaser Common Stock to be issued under this Agreement as the Business Combination Consideration, which Registration Statement will also contain a proxy statement (as amended, the “Proxy Statement”) for the purpose of soliciting proxies from Purchaser stockholders for the matters to be acted upon at Purchaser Special Meeting and providing the Public Stockholders an opportunity in accordance with Purchaser’s Organizational Documents and the IPO Prospectus to have their Purchaser Common Stock redeemed (the “Redemption”) in conjunction with the stockholder vote on Purchaser Stockholder Approval Matters. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from Purchaser stockholders to vote, at a special meeting of Purchaser stockholders to be called and held for such purpose (the “Purchaser Special Meeting”), in favor of resolutions approving (i) the adoption and approval of this Agreement and the transactions contemplated hereby or referred to herein, including the Business Combination (and, to the extent required, the issuance of any shares in connection with the PIPE Investment), by the holders of Purchaser Common Stock in accordance with Purchaser’s Organizational Documents and IPO Prospectus, the Securities Act, the DGCL and the rules and regulations of the SEC and Nasdaq, (ii) the adoption and approval of the amended and restated Purchaser Certificate of Incorporation, including the change of name of Purchaser, (iii) adoption and approval of the New Equity Incentive Plan in substantially the form attached as Exhibit D hereto, and which will provide that (A) the total awards under such New Equity Incentive Plan will be a number of Purchaser Common Stock equal to ten percent (10%) of the aggregate number of Purchaser Common Stock issued and outstanding as of the End Date, and (B) the total awards under an Employee Stock Purchase Plan will be a number of Purchaser Common Stock equal to one percent (1%) of the aggregate number of Purchaser Common Stock issued and outstanding as of Closing; (iv) the appointment of the members of the Post-Closing Board in accordance with Section 7.16 hereof, (v) such other matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions (the approvals described in foregoing clauses (i) through (v), collectively, the “Purchaser Stockholder Approval Matters”), and (vi) the adjournment of Purchaser Special Meeting, if necessary or desirable in the reasonable determination of Purchaser. If on the date for which Purchaser Special Meeting is scheduled, Purchaser has not received proxies representing a sufficient number of shares to obtain the Required Purchaser Stockholder Approval, whether or not a quorum is present, Purchaser may make one or more successive postponements or adjournments of Purchaser Special Meeting. In connection with the Registration Statement, Purchaser will file with the SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and applicable proxy solicitation and registration statement rules set forth in Purchaser’s Organizational Documents, the Securities Act, the DGCL and the rules and regulations of the SEC and Nasdaq. Purchaser shall cooperate and provide the Company (and its counsel) with a reasonable opportunity to review and comment on the Registration Statement and any amendment or supplement thereto prior to filing the same with the SEC, and Purchaser shall consider any such comments timely made in good faith. The Company shall provide Purchaser with such information concerning the Target Companies and their stockholders, officers, directors, employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for inclusion in the Registration Statement, or in any amendments or supplements thereto, which information provided by the Company shall be true and correct and not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading.

 

40

 

(b) Purchaser shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange Act and other applicable Laws in connection with the Registration Statement, Purchaser Special Meeting and the Redemption. Each of Purchaser and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and employees, upon reasonable advance notice, available to the Company, Purchaser, the Company Representative, and their respective Representatives in connection with the drafting of the public filings with respect to the transactions contemplated by this Agreement, including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information is determined to have become false or misleading in any material respect or as otherwise required by applicable Laws. Purchaser shall amend or supplement the Registration Statement and cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to Purchaser stockholders, in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and Purchaser’s Organizational Documents; provided, however, that Purchaser shall not amend or supplement the Registration Statement without adequate notice to and prior consultation with the Company and the Company Representative as is reasonable under the circumstances.

 

(c) Purchaser, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall otherwise use its commercially reasonable efforts to cause the Registration Statement to “clear” comments from the SEC and become effective. Purchaser shall provide the Company with copies of any written comments, and shall inform the Company of any material oral comments, that Purchaser or its Representatives receive from the SEC or its staff with respect to the Registration Statement, Purchaser Special Meeting and the Redemption promptly after the receipt of such comments and shall give the Company a reasonable opportunity under the circumstances to review and comment on any proposed written or material oral responses to such comments, including to the extent possible, participation by the Company or its counsel in discussions with the SEC.

 

(d) As soon as practicable following the Registration Statement “clearing” comments from the SEC and becoming effective, Purchaser shall distribute the Registration Statement to Purchaser’s stockholders and the Company Shareholders, and, pursuant thereto, shall use commercially reasonable efforts to call Purchaser Special Meeting in accordance with the Securities Act for a date no later than thirty (30) days following the effectiveness of the Registration Statement, subject to any necessary adjournments or postponements as described in Section 7.10(a) above.

 

(e) Purchaser shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, Purchaser’s Organizational Documents and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder, the calling and holding of Purchaser Special Meeting and the Redemption. Purchaser shall apply for, and shall take commercially reasonable actions to cause, Purchaser Common Stock to be issued in connection with the Business Combination to be approved for listing on Nasdaq as of the End Date.

 

41

 

7.12 Public Announcements.

 

(a) The Parties agree that during the Interim Period no public release, filing or announcement concerning this Agreement or the Ancillary Documents or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior written consent of Purchaser and the Company (which consent shall not be unreasonably withheld, conditioned or delayed), except as such release or announcement may be required by applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or announcement in advance of such issuance.

 

(b) The Parties shall mutually agree upon and, as promptly as practicable after the execution of this Agreement (but in any event within four (4) Business Days thereafter), issue a press release announcing the execution of this Agreement (the “Signing Press Release”). Promptly after the issuance of the Signing Press Release, Purchaser shall file a current report on Form 8-K (the “Signing Filing”) with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing (with the Company reviewing, commenting upon and approving such Signing Filing in any event no later than the third (3rd) Business Day after the execution of this Agreement); provided that Purchaser provides the Company with a reasonable period of time to complete such review, comment and approval prior thereto. The Parties shall mutually agree upon and, as promptly as practicable after the End Date (but in any event within four (4) Business Days thereafter), issue a press release announcing the consummation of the transactions contemplated by this Agreement (the “Closing Press Release”). Promptly after the issuance of the End Date Press Release, Purchaser shall file a current report on Form 8-K (the “Closing Filing”) with the End Date Press Release and a description of the End Date as required by Federal Securities Laws which Purchaser and the Company shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing. In connection with the preparation of the Signing Press Release, the Signing Filing, the End Date Filing, the End Date Press Release, or any other report, statement, filing notice or application made by or on behalf of a Party to any Governmental Authority or other third party in connection with the transactions contemplated hereby, each Party shall, upon request by any other Party, furnish the Parties with all information concerning themselves, their respective directors, officers and equity holders, and such other matters as may be reasonably necessary or advisable in connection with the transactions contemplated hereby, or any other report, statement, filing, notice or application made by or on behalf of a Party to any third party and/ or any Governmental Authority in connection with the transactions contemplated hereby.

 

7.13 Confidential Information.

 

(a) The Company and the Company Representative each hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with ‎Article X, for a period of two (2) years after such termination, they shall, and shall cause their respective Representatives to: (i) treat and hold in strict confidence any Purchaser Confidential Information, and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing their obligations hereunder or thereunder, enforcing their rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of Purchaser Confidential Information without Purchaser’s prior written consent; and (ii) in the event that the Company, the Company Representative or any of their respective Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with ‎Article X, for a period of two (2) years after such termination, becomes legally compelled to disclose any Purchaser Confidential Information, (A) provide Purchaser to the extent legally permitted with prompt written notice of such requirement so that Purchaser or an Affiliate thereof may seek, at Purchaser’s cost, a protective Order or other remedy or waive compliance with this Section 7.12 ‎(a), and (B) in the event that such protective Order or other remedy is not obtained, or Purchaser waives compliance with this Section 7.12 ‎(a), furnish only that portion of such Purchaser Confidential Information which is legally required to be provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Purchaser Confidential Information. In the event that this Agreement is terminated, and the transactions contemplated hereby are not consummated, the Company, and the Company Representative shall, and shall cause their respective Representatives to, promptly deliver to Purchaser or destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Purchaser Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon.

 

42

 

(b) Purchaser hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with ‎Article X, for a period of two (2) years after such termination, it shall, and shall cause its Representatives to: (i) treat and hold in strict confidence any Company Confidential Information, and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing its obligations hereunder or thereunder or enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make available to any third party any of the Company Confidential Information without the Company’s prior written consent; and (ii) in the event that Purchaser or any of its Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with ‎Article X, for a period of two (2) years after such termination, becomes legally compelled to disclose any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt written notice of such requirement so that the Company may seek, at the Company’s sole expense, a protective Order or other remedy or waive compliance with this Section ‎7.12(a) and (B) in the event that such protective Order or other remedy is not obtained, or the Company waives compliance with this Section 7.12 ‎(b), furnish only that portion of such Company Confidential Information which is legally required to be provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated, and the transactions contemplated hereby are not consummated, Purchaser shall, and shall cause its Representatives to, promptly deliver to the Company or destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Company Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon. Notwithstanding the foregoing, Purchaser and its Representatives shall be permitted to disclose any and all Company Confidential Information to the extent required by the Federal Securities Laws, as advised by outside counsel, and after giving the Company a reasonable opportunity under the circumstances to review such disclosure and considering in good faith any comments made by the Company regarding such disclosure, and to enable the Company to seek confidential treatment of such Company Confidential Information, provided that (x) Purchaser shall, and shall cause its Representatives to, treat and hold in strict confidence any Confidential Company Information of any Target Company disclosed to such Person until such information ceases to be Confidential Company Information, and (y) Purchaser and its Representatives shall be permitted to retain copies of Company Confidential Information only to the extent required by internal compliance policies or applicable Laws or to satisfy requirements of a Governmental Authority.

 

7.14 Documents and Information. After the End Date, Purchaser and the Company shall, and shall cause their respective Subsidiaries to, until the seventh (7th) anniversary of the End Date, retain all books, records and other documents pertaining to the business of the Target Companies in existence on the End Date and make the same available for inspection and copying by Purchaser Representative during normal business hours of the Company and its Subsidiaries, as applicable, upon reasonable request and upon reasonable notice. No such books, records or documents shall be destroyed after the seventh (7th) anniversary of the End Date by Purchaser or its Subsidiaries (including any Target Company) without first advising Purchaser Representative in writing and giving Purchaser Representative a reasonable opportunity to obtain possession thereof.

 

7.15 Post-Closing Board of Directors and Executive Officers.

 

(a) The Parties shall take all necessary action, including causing the directors of Purchaser to resign, so that effective as of the End Date, the Purchaser’s board of directors (the “Post-Closing Board”) will consist of five (5) individuals as described in Section ‎7.14. Prior to the End Date, Purchaser will provide each Post-Closing Director with a customary director indemnification agreement, in form and substance reasonably acceptable to such Post-Closing Director.

 

(b) The officers of Purchaser shall consist of the offers of the Company as of immediately prior to the Effective Time, who shall serve in such capacity in accordance with the terms of Purchaser’s Organizational Documents following the Effective Time.

 

(c) The Parties shall take all action necessary, including causing the executive officers of Purchaser to resign, so that the individuals serving as the chief executive officer and chief financial officer, respectively, of Purchaser immediately after the End Date will be the same individuals (in the same office) as that of the Company immediately prior to the End Date (unless, at its sole discretion, the Company desires to appoint another qualified person to either such role, in which case, such other person identified by the Company shall serve in such role). Subject to the approval of Purchaser, the Company may enter into new employment agreements with such officers prior to the End Date.

 

43

 

7.16 Indemnification of Directors and Officers; Tail Insurance.

 

(a) The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors and officers of Purchaser or the Company and each Person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of the Company (the “D&O Indemnified Persons”) as provided in their respective Organizational Documents or under any indemnification, employment or other similar agreements between any D&O Indemnified Person and the Company, in each case as in effect on the date of this Agreement, shall survive the End Date and continue in full force and effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of six (6) years after the Effective Time, Purchaser shall cause the Organizational Documents of Purchaser to contain provisions no less favorable with respect to exculpation and indemnification of and advancement of expenses to D&O Indemnified Persons than are set forth as of the date of this Agreement in the Organizational Documents of the Company to the extent permitted by applicable Law. The provisions of this Section 7.16 shall survive the End Date and are intended to be for the benefit of, and shall be enforceable by, each of the D&O Indemnified Persons and their respective heirs and representatives.

 

(b) For the benefit of the Company’s directors and officers, the Company shall be permitted prior to the Effective Time to obtain and fully pay the premium for a “tail” insurance policy that provides coverage for up to a six-year period from and after the Effective Time for events occurring prior to the Effective Time (the “D&O Tail Insurance”) that is substantially equivalent to and in any event not less favorable in the aggregate than the Company’s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Purchaser shall maintain the D&O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and Purchaser shall timely pay or caused to be paid all premiums with respect to the D&O Tail Insurance.

 

7.17 Use of Trust Account Proceeds. Purchaser shall provide the Company with an estimated written statement of Expenses prepared in good faith (the “Purchaser Expenses Statement”), at least five (5) Business Days prior to the End Date, and shall deliver to the Company a final Purchaser Expenses Statement on or prior to the End Date, which shall be mutually agreed in writing by Purchaser and the Company prior to the payment of any such Expenses from the Trust Account. At the End Date, Purchaser shall cause the documents, certificates and notices required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered. The Parties agree that after the End Date, the funds in the Trust Account, after taking into account payments for the Redemption, and any proceeds received by Purchaser from any PIPE Investment shall first be used, and Purchaser will make all appropriate arrangements to cause the Trustee to pay (i) Purchaser’s accrued Expenses set forth on Purchaser Expenses Statement, (ii) Purchaser’s deferred Expenses set forth on the final Purchaser Expenses Statement (including cash amounts payable to its underwriter and any legal fees) of the IPO, and (iii) any loans owed by Purchaser to Sponsor for Expenses (including deferred Expenses) that are not converted into Purchaser Securities in the aggregate amount of the principal balance and accrued interest for such loans set forth on the final Purchaser Expenses Statement. Any remaining cash will be used for working capital and general corporate purposes of Purchaser.

 

7.18 PIPE Investment. Without limiting anything to the contrary contained herein, during the Interim Period, Purchaser may use commercially reasonable efforts as practicable, after the date of this Agreement and at or prior to the End Date, to enter into and consummate subscription agreements with investors relating to a private equity investment in Purchaser to purchase shares of Purchaser in connection with a private placement, and/or enter into backstop arrangements with potential investors, in either case on terms mutually agreeable to the Company and Purchaser, acting reasonably (a “PIPE Investment”), and, if Purchaser elects to seek a PIPE Investment, Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective Representatives in connection with such PIPE Investment, and use their respective commercially reasonable efforts to cause such PIPE Investment to occur (including having the Company’s senior management participate in any investor meetings and roadshows as reasonably requested by Purchaser). If Purchaser elects to seek a PIPE Investment, Purchaser shall use its commercially reasonable efforts to satisfy the conditions of the PIPE Investors’ closing obligations contained in the Subscription Agreements and consummate the transactions contemplated thereby. Purchaser shall not terminate, or amend or waive in any manner materially adverse to Purchaser, any Subscription Agreement without the Company’s prior written consent (not to be unreasonably withheld, delayed or conditioned), other than (i) as expressly provided for by the terms of the Subscription Agreements or (ii) to reflect any permitted assignments or transfers of the Subscription Agreements by the applicable PIPE Investors pursuant to the Subscription Agreements. Each of Purchaser and, as applicable, the Company, shall, and shall cause its Affiliates to, use commercially reasonable efforts to avoid being in breach or default under the Subscription Agreements. Additionally, during the Interim Period, Purchaser may, but shall not be required to, enter into and consummate additional Subscription Agreements with additional PIPE Investors, including in the event that there is an actual or threatened material breach or default by a PIPE Investor under a Subscription Agreement, or Purchaser reasonably believes in good faith that such PIPE Investor otherwise is not willing or able to consummate the transactions contemplated thereby upon the satisfaction of the conditions of such PIPE Investor’s closing obligations thereunder, which additional Subscription Agreements shall become part of the PIPE Investment hereunder; provided, that the terms of such additional Subscription Agreements shall not, without the Company’s prior written consent (not to be unreasonably withheld, delayed or conditioned), be materially worse to Purchaser or the Company than those set forth in existing Subscription Agreements. If Purchaser elects to seek such additional Subscription Agreements (containing, solely with respect to any additional Subscription Agreements, terms that are substantially different from the terms of Subscription Agreements then in effect), with the Company’s prior written consent, not to be unreasonably withheld, delayed or conditioned, Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective Representatives in connection with such additional Subscription Agreements and use their respective reasonable efforts to cause such additional Subscription Agreements to be executed and the transactions contemplated thereby to occur (including having the Company’s senior management participate in any investor meetings and roadshows as reasonably requested by Purchaser). Purchaser will deliver to the Company true, correct and complete copies of each Subscription Agreement entered into by Purchaser and any other Contracts between Purchaser and PIPE Investors that could affect the obligation of such PIPE Investors to contribute to Purchaser their applicable portion of the aggregate gross proceeds of the PIPE Investment as set forth in the Subscription Agreement of such PIPE Investor. The Company shall not enter into any Contract with a PIPE Investor during the Interim Period without the prior written consent of Purchaser, not to be unreasonably withheld, delayed or conditioned.

 

44

 

7.19 New Equity Incentive Plan. Prior to the End Date, Purchaser and the Company shall approve, and Purchaser shall adopt, an equity incentive plan in the form attached hereto as Exhibit D (the “Equity Incentive Plan”), which will provide that (i) the total awards under such Equity Incentive Plan will be a number of shares of Purchaser Common Stock equal to ten percent (10%) of the aggregate number of shares of Purchaser Common Stock issued and outstanding immediately after the End Date, and (ii) the total awards under an Employee Stock Purchase Plan will be a number of shares of Purchaser Common Stock equal to one percent (1%) of the aggregate number of shares of Purchaser Common Stock issued and outstanding as of Closing. Within 30 days after the End Date, Purchaser shall file a registration statement on Form S-8 (or other applicable form) with respect to the Shares issuable under the Equity Incentive Plan. Purchaser shall use commercially reasonable efforts to maintain the effectiveness of such registration statement (and maintain the current status of the prospectus contained therein) for so long as awards granted pursuant to the Equity Incentive Plan remain outstanding.

 

7.20 Purchaser Completion Obligation. On or before the End Date, Purchaser must, or must procure that each of the following steps are taken or actions be done:

 

(a) Agreements and Covenants. Purchaser and Purchaser Representative shall perform in all material respects all of their respective obligations and comply in all material respects with all of their respective agreements and covenants under this Agreement to be performed or complied with thereby on or prior to the End Date.

 

(b) New Incentive Plan. The new Equity Incentive Plan be adopted and approved by Purchaser.

 

(c) Secretary Certificate. Purchaser shall deliver to the Company a certificate from its secretary or other executive officer certifying as to, and attaching, (A) copies of Purchaser’s Organizational Documents as in effect as of the End Date (immediately prior to the Effective Time), (B) the resolutions of Purchaser’s board of directors authorizing and approving the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is bound, and the consummation of the transactions contemplated hereby and thereby, (C) evidence that the Required Purchaser Stockholder Approval has been obtained and (D) the incumbency of officers authorized to execute this Agreement or any Ancillary Document to which Purchaser is or is required to be a party or otherwise bound.

 

45

 

(d) Good Standing. Purchaser shall deliver to the Company a good standing certificate (or similar documents applicable for such jurisdictions) for Purchaser certified as of a date no earlier than thirty (30) days prior to the End Date from the proper Governmental Authority of Purchaser’s jurisdiction of incorporation and from each other jurisdiction in which Purchaser is qualified to do business as a foreign entity as of the End Date, in each case to the extent that good standing certificates or similar documents are generally available in such jurisdictions.

 

(e) Ancillary Documents. Purchaser shall duly execute all Ancillary Documents and those Ancillary Documents shall be in full force and effect accordance with their terms of as of the Closing.

 

(f) Amended and Restated Purchaser Certificate of Incorporation. At or prior to the Closing, Purchaser must deliver to the Company its amended and restated the Purchaser’s Certificate of Incorporation in form and substance mutually acceptable in good faith to Purchaser and the Company.

 

(g) Officer Certificate. Purchaser must deliver to Company a certificate, dated as at the End Date, signed by an executive officer of Purchaser in such capacity, certifying as to the satisfaction of the obligations specified in this Section 7.19.

 

(h) Company Convertible Notes. Purchaser shall assume Company Convertible Notes set forth in the Schedule 7.20(h).

 

7.21 Company Closing Obligations. Prior to the End Date, Company must, or must procure that each of the following steps are taken or actions be done:

 

(a) Agreements and Covenants. The Company and the Company Representative shall perform in all material respects all of their respective obligations and comply in all material respects with all of their respective agreements and covenants under this Agreement to be performed or complied with thereby on or prior to the End Date.

 

(b) Retention Compensation. The Company terminates or extinguishes any accrued stay or change of control bonuses or incentives and/or any obligations of the Company under any equity or deferred compensation plan, obtained a release of claims from the relevant beneficiary and paid any amounts necessary to obtain such releases.

 

(c) Pre-Closing Taxes. The Company shall pay or cause to be paid any Pre-Closing Taxes.

 

(d) Termination of the Shareholders Agreement and Waiver of Pre-emptive Rights. Company shall enter into a deed of termination in respect of the shareholders agreement dated October 31, 2020 (on terms reasonably satisfactory to Purchaser) and the Company shall procure a Pre-emptive Waiver duly executed by each Company Shareholder in respect of the transfer of Company Shares pursuant to the Takeover Offer (if required).

 

(e) Ancillary Documents. Company shall duly execute all Ancillary Documents and those Ancillary Documents shall be in full force and effect accordance with their terms of as of the Closing.

 

(f) Transmittal Documents. The Company shall procure that each Company Shareholder deliver to the Exchange Agent its duly executed Transmittal Documents.

 

(g) Options of the Company. The Company must procure that all of the vested and unvested options of the Company shall be cancelled for nil consideration with the agreement of the corresponding option holders.

 

46

 

(h) Termination of Certain Contracts. The Company has (to the reasonable satisfaction of Purchaser) terminated the Contracts set forth on Schedule 9.3(i) involving any of the Target Companies and/or other related Persons with no further obligation or Liability of the Target Companies thereunder.

 

(i) Non-Competition and Non-Solicitation Agreement. The Company must procure that each Significant Company Holder enters into the Non-Competition and Non-Solicitation Agreement.

 

(j) Joinder Agreement. The Company must procure that each Significant Company Holder enters into the Joinder Agreement.

 

(k) Termination of ESOP Rules. The Company shall take all required actions to terminate the ESOP Rules at least one (1) Business Days before the Closing and provide evidence satisfactory to Purchaser that all of the vested and unvested options of the Company are cancelled for nil consideration with the agreement of the corresponding option holders.

 

(l) Secretary Certificate. The Company shall deliver to Purchaser a certificate a certificate from its secretary or other executive officer certifying as to, and attaching, (A) copies of the Company Organizational Documents as in effect as of the End Date (immediately prior to the Effective Time), (B) the resolutions of the Company’s board of directors authorizing and approving the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is bound, and the consummation of the transactions contemplated hereby and thereby, and (C) the incumbency of officers authorized to execute this Agreement or any Ancillary Document to which Purchaser is or is required to be a party or otherwise bound.

 

(m) Good Standing. The Company shall deliver to Purchaser good standing certificates (or similar documents applicable for such jurisdictions) for each Target Company certified as of a date no earlier than three (3) days prior to the End Date from the proper Governmental Authority of the Target Company’s jurisdiction of organization and from each other jurisdiction in which the Target Company is qualified to do business as a foreign corporation or other entity as of the End Date, in each case to the extent that good standing certificates or similar documents are generally available in such jurisdictions.

 

(n) Officer Certificate. The Company shall deliver to Purchaser a certificate, dated the End Date, signed by an executive officer of the Company in such capacity, certifying as to the satisfaction of the conditions specified in this Section 7.20 with respect to Company.

 

ARTICLE VIII

NON-SURVIVAL OF REPRESENTATIONS, WARRANTIES AND COVENANTS

 

8.1 Except (a) as otherwise contemplated by Section 10.2, . or (b) in the case of claims against a Person in respect of such Person’s knowing and intentional fraud, none of the representations, warranties, covenants, obligations or other agreements in this Agreement or in any certificate, statement or instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such representations, warranties, covenants, obligations, agreements and other provisions, shall survive the Closing and each such representation, warranty, covenant, obligation, agreement and provision shall terminate and expire upon the occurrence of the Effective Time (and there shall be no liability after the closing in respect thereof), except for (i) those covenants and agreements contained herein that by their terms expressly apply in whole or in part after the closing and then only with respect to any breaches occurring after the closing and (ii) this Article VIII.

 

ARTICLE IX

CLOSING CONDITIONS

 

9.1 Conditions to Each Party’s Obligations. The obligations of each Party to consummate the Transactions (the “Closing”) shall be subject to the satisfaction or written waiver (where permissible) by the Purchaser (but solely with consent of the Company, in respect of Sections 9.1(b),9.1(f), 9.1(g) and 9.1(j) of the following conditions:

 

47

 

(a) Required Purchaser Stockholder Approval. Purchaser Stockholder Approval Matters that are submitted to the vote of the stockholders of Purchaser at the Purchaser Special Meeting in accordance with the Proxy Statement shall have been approved by the requisite vote of the stockholders of Purchaser at the Purchaser Special Meeting in accordance with Purchaser’s Organizational Documents, applicable Law and the Proxy Statement (the “Required Purchaser Stockholder Approval”).

 

(b) Minimum Acceptance. At or before the end of the Takeover Offer Period, Purchaser has a Relevant Interest in the number of Company Shares that represents at least 90% of the aggregate of all the Company Shares on issue (on a fully diluted basis).

 

(c) Requisite Regulatory Approvals. All Consents required to be obtained from or made with any Governmental Authority in order to consummate the Transactions contemplated by this Agreement shall have been obtained or made.

 

(d) Requisite Consents. The Consents required to be obtained from or made with any third Person (other than a Governmental Authority) in order to consummate the Transactions contemplated by this Agreement that are set forth in Schedule 9.1(d) shall have each been obtained or made.

 

(e) No Adverse Law or Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements contemplated by this Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this Agreement.

 

(f) Minimum Cash Requirement. The Available Closing SPAC Cash shall not be less than USD $7,500,000.

 

(g) No Superior Proposal. That between the date of the Bidder’s Statement and the end of the Offer Period, no bidder’s statement detailing a Superior Proposal by a third party for New Quantum Shares is dispatched to any holders of Company Securities;

 

(h) Net Tangible Assets Test. Upon the End Date, after giving effect to the Redemption and any PIPE Investment, Purchaser shall have net tangible assets of at least $5,000,001.

 

(i) Registration Statement. The Registration Statement shall have been declared effective by the SEC and shall remain effective as of the End Date, and no stop order or similar order shall be in effect with respect to the Registration Statement.

 

(j) Nasdaq Listing. The shares of Purchaser Common Stock issued as Business Combination Consideration shall have been approved for listing on Nasdaq, subject to official notice of issuance.

 

9.2 Frustration of Conditions. Notwithstanding anything contained herein to the contrary, no Party may rely on the failure of any condition set forth in this ‎Article IX to be satisfied if such failure was caused by the failure of such Party or its Affiliates (or with respect to the Company, any Target Company or Company Shareholder) to comply with or perform any of its covenants or obligations set forth in this Agreement.

 

ARTICLE X

TERMINATION AND EXPENSES

 

10.1 Termination. This Agreement may be terminated, and the transactions contemplated hereby may be abandoned at any time prior to the End Date as follows:

 

(a) by mutual written consent of Purchaser and the Company;

 

(b) by written notice by Purchaser or the Company if Purchaser withdraws the Takeover Bid as permitted by the Australian Act for any reason, including non-satisfaction of any of the Conditions or if the Takeover Bid lapses;

 

48

 

(c) by written notice by either Purchaser or the Company if a Governmental Authority of competent jurisdiction shall have issued an Order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement, and such Order or other action has become final and non-appealable; provided, however, that the right to terminate this Agreement pursuant to this Section 10.1‎(c) shall not be available to a Party if the failure by such Party or its Affiliates to comply with any provision of this Agreement has been a substantial cause of, or substantially resulted in, such action by such Governmental Authority;

 

(d) by written notice by the Company to Purchaser, if (i) there has been a material breach by Purchaser of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of Purchaser shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 9.1(l), (m) or (n) to be satisfied (treating the End Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) calendar days after written notice of such breach or inaccuracy is provided to Purchaser or (B) the Outside Date; provided, that the Company shall not have the right to terminate this Agreement pursuant to this Section 10.1(d) if at such time the Company is in material uncured breach of this Agreement;

 

(e) by written notice by Purchaser to the Company, if (i) there has been a material breach by the Company of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 9.1(l), (m) or (n) to be satisfied (treating the End Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) calendar days after written notice of such breach or inaccuracy is provided to the Company or (B) the Outside Date; provided, that Purchaser shall not have the right to terminate this Agreement pursuant to this Section 10.1(e) if at such time Purchaser is in material uncured breach of this Agreement;

 

(f) by written notice by Company to Purchaser or by Purchaser to Company if a Superior Proposal is publicly announced for Company by a Third Party and a majority of the Company Board recommends that the Superior Proposal be accepted by Company Security Holders provided that always ‎Article III has been complied with and Purchaser has decided not to match the Superior Proposal in accordance with Section ‎3.8;

 

(g) by written notice by Purchaser to the Company, if there shall have been a Material Adverse Effect on the Target Companies taken as a whole, following the date of this Agreement which is uncured for at least ten (10) calendar days after written notice of such Material Adverse Effect is provided by Purchaser to the Company; or

 

(h) by written notice by either Purchaser or the Company to the other, if Purchaser Special Meeting is held (including any adjournment or postponement thereof) and has concluded, Purchaser’s stockholders have duly voted, and the Required Purchaser Stockholder Approval was not obtained.

 

10.2 Effect of Termination. This Agreement may only be terminated in the circumstances described in Section 10.1 and pursuant to a written notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination, including the provision of Section 10.1 under which such termination is made. In the event of the valid termination of this Agreement pursuant to Section 10.1, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party or any of their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) Sections 7.13, 7.14, ‎10.3, ‎11.1, ‎Article XIII and this Section 10.2 shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from Liability for any willful breach of any representation, warranty, covenant or obligation under this Agreement or any Fraud Claim against such Party, in either case, prior to termination of this Agreement (in each case of clauses (i) and (ii) above, subject to Section ‎11.1). Without limiting the foregoing, and except as provided in Sections 10.3 and this Section 10.2 (but subject to Section ‎11.1) and subject to the right to seek injunctions, specific performance or other equitable relief in accordance with Section 12.7, the Parties’ sole right prior to the End Date with respect to any breach of any representation, warranty, covenant or other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by this Agreement shall be the right, if applicable, to terminate this Agreement pursuant to Section 10.1. Upon the termination of this Agreement for any reason, the Extension Escrow Amount shall be distributed as provided in the Extension Escrow Agreement.

 

49

 

10.3 Fees and Expenses. Subject to Sections ‎11.1 and ‎12.15, all Expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the Party incurring such expenses. As used in this Agreement, “Expenses” shall include all out-of-pocket expenses (including all fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a Party hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the consummation of this Agreement. With respect to Purchaser, Expenses shall include any and all deferred expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO upon consummation of a Business Combination and any Extension Expenses, as well as any costs and expenses incurred in connection with any PIPE Investment.

 

10.4 Reserved. [Reserved].

 

10.5 Limitation of Liability for Acquisition Parties. Notwithstanding any other provision of this Agreement, except in relation to a willful or intentional breach of any provision of this Agreement by a Party:

 

(a) the maximum liability of an Acquisition Party to all other parties under or in connection with this Agreement including in respect of any breach of this Agreement will be USD $3,000,000;

 

(b) a payment by an Acquisition Party in accordance with this ‎Article X represents the sole and absolute liability of that Acquisition Party under or in connection with this Agreement and no further damages, fees, expenses or reimbursements of any kind will be payable by that Acquisition Party in connection with this Agreement; and

 

(c) the amount paid to the recipient under this ‎Article X shall be reduced by the amount of any loss or damage recovered by the other Acquisition Party in relation to a breach of this Agreement.

 

10.6 Limitation of Liability of Company Representative and Purchaser Representative. Except in relation to a willful or intentional breach of any provision of this Agreement, Company Representative and Purchaser Representative will have no liability to either Acquisition Party and no Acquisition Party will have any liability to Company Representative or Purchaser Representative.

 

ARTICLE XI

WAIVERS AND RELEASES

 

11.1 Waiver of Claims Against Trust. Reference is made to the IPO Prospectus. The Company, the Company Shareholders and the Company Representative hereby each represents and warrants that it/he has read the IPO Prospectus and understands that Purchaser has established the Trust Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser’s underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser’s public stockholders (including overallotment shares acquired by Purchaser’s underwriters) (including any successors after the Business Combination, the “Public Stockholders”) and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the Public Stockholders in the event they elect to redeem their Purchaser Common Stock in connection with the consummation of its initial business combination (as such term is used in the IPO Prospectus) (“Business Combination”) or in connection with an amendment to Purchaser’s Organizational Documents to extend Purchaser’s deadline to consummate a Business Combination, (b) to the Public Stockholders if Purchaser fails to consummate a Business Combination within twelve (12) months after the End Date of the IPO (provided such date may be extended by an additional six (6) months), subject to further extension by amendment to Purchaser’s Organizational Documents, (c) with respect to any interest earned on the amounts held in the Trust Account, amounts necessary to pay for any taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company, each Company Shareholder, and the Company Representative hereby agrees on behalf of themselves and their Affiliates that, notwithstanding anything to the contrary in this Agreement, none of the Company, any Company Shareholder, or the Company Representative nor any of their respective Affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the one hand, and the Company, the Company Representative or any of their respective Representatives, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Released Claims”). The Company, each Company Shareholder, and the Company Representative on behalf of themselves and their Affiliates hereby irrevocably waives any Released Claims that any such Party or any of its Affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements hereunder and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its Affiliates). The Company, each Company Shareholder, and the Company Representative each agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter in this Agreement, and the Company, each Company Shareholder, and the Company Representative each further intends and understands such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent that any Party or any of its respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to this Agreement or Transactions, which proceeding seeks, in whole or in part, monetary relief against the Trust Account, the Parties each hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on any of their behalf or in lieu of them) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. In the event that any Party or any of its respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to this Agreement and the Transactions which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions therefrom) or the Public Stockholders, whether in the form of money damages or injunctive relief, the Party or parties defending such claim, shall be entitled to recover from the Party commencing such Action the associated legal fees and costs in connection with any such Action, in the event the Party defending such Action prevails in such Action. This Section 11.1 shall survive termination of this Agreement for any reason and continue indefinitely.

 

50

 

11.2 Release and Covenant Not to Sue.

 

(a) Effective as of the End Date, to the fullest extent permitted by applicable Law, each Company Shareholder, on behalf of itself and its Affiliates that owns any share or other equity interest in or of such Company Shareholder (the “Releasing Persons”), hereby releases and discharges the Target Companies from and against any and all Actions, obligations, agreements, debts and Liabilities whatsoever, whether known or unknown, both at law and in equity, which such Releasing Person now has, has ever had or may hereafter have against the Target Companies arising on or prior to the End Date or on account of or arising out of any matter occurring on or prior to the End Date, including any rights to indemnification or reimbursement from a Target Company, whether pursuant to its Organizational Documents, Contract or otherwise, and whether or not relating to claims pending on, or asserted after, the End Date. From and after the End Date, each Releasing Person hereby irrevocably covenants to refrain from, directly or indirectly, asserting any Action, or commencing or causing to be commenced, any Action of any kind against the Target Companies or their respective Affiliates, based upon any matter purported to be released hereby. Notwithstanding anything herein to the contrary, the releases and restrictions set forth herein shall not apply to any claims a Releasing Person may have against any party pursuant to the terms and conditions of this Agreement or any Ancillary Document or any of the other matters set forth on Schedule ‎11.2.

 

ARTICLE XII

MISCELLANEOUS

 

12.1 Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including e-mail), with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

 

51

 

 

If to Purchaser at or prior to the End Date, to:

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, California 90292

Attention: J. Gerald Combs, CEO

Tel: (917)576-2537

Email: gerry@gcombs.com

 

with a copy (which will not constitute notice) to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie Klis

Facsimile No.: (202) 935-3390

Telephone No.: (202) 935-3390

E-mail: debbie.klis@rimonlaw.com

 

 

If to Purchaser Representative, to:

 

J. Gerald Combs, as Purchaser Representative

4640 Admiralty Way, Suite 500

Marina Del Rey, California 90292

Tel: (917)576-2537

E-mail: gerry@gcombs.com

 

with a copy (which will not constitute notice) to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie Klis

Telephone No.: (202) 935-3390

E-mail: debbie.klis@rimonlaw.com

 

 

If to the Company, to:

 

New Quantum Holdings Pty Ltd

Level 21, 207 Kent St., Sydney

New South Wales, Australia, 2000

Mobile: 703-939-4708

Attn: Hyun Jong Chung, Managing Director

Telephone No.: +61 430 228 328

E-mail: jong@newquantum.com

 

 

with a copy (which will not constitute notice) to:

 

K&L Gates

Level 31, 1 O’Connell Street

Sydney NSW 2000, Australia

Attn: Russell Lyons

Facsimile No.: +61 2 9513 2399

Telephone No.: +61 2 9513 2510

E-mail: Russell.Lyons@klgates.com

 

 

If to the Company Representative, to:

 

Hyun Jong Chung

Suite 2101, Level 21, 207 Kent Street

Sydney NSW 2000, Australia

Attn: Hyun Jong Chung

Telephone No.: +61 430 228 328

E-mail: jong@newquantum.com

 

 

with a copy (which will not constitute notice) to:

 

K&L Gates

Level 31, 1 O’Connell Street, Sydney NSW 2000, Australia

Attn: Russell Lyons

Facsimile No.: +61 2 9513 2399

Telephone No.: +61 2 9513 2510

E-mail: Russell.Lyons@klgates.com

 

 

If to Purchaser or the Company after the End Date, to:

 

New Quantum Holdings, Inc.

Level 21, 207 Kent St., Sydney

New South Wales, Australia, 2000

Mobile: 703-939-4708

Attn: Hyun Jong Chung, Managing Director

Tel:

E-mail:

 

 

with a copy (which will not constitute notice) to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie Klis

Facsimile No.: (202) 935-3390

Telephone No.: (202) 935-3390

E-mail: debbie.klis@rimonlaw.com

 

 

52

 

12.2 Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or otherwise without the prior written consent of Purchaser, and the Company (and after the End Date, the Purchaser Representative and the Company Representative), and any assignment without such consent shall be null and void; provided that no such assignment shall relieve the assigning Party of its obligations hereunder.

 

12.3 Third Parties. Except for the rights of the D&O Indemnified Persons set forth in Section ‎7.16 ‎(a), which the Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

 

12.4 Arbitration. Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent injunction or other equitable relief or application for enforcement of a resolution under this Section 12.4, arising out of, related to, or in connection with this Agreement or the transactions contemplated hereby (a “Dispute”) shall be governed by this Section 12.4. A Party must, in the first instance, provide written notice of any Disputes to the other Parties subject to such Dispute, which notice must provide a reasonably detailed description of the matters subject to the Dispute. The Parties involved in such Dispute shall seek to resolve the Dispute on an amicable basis within twenty (20) Business Days of the notice of such Dispute being received by such other Parties subject to such Dispute (the “Resolution Period”); provided, that if any Dispute would reasonably be expected to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence of such Dispute, then there shall be no Resolution Period with respect to such Dispute. Any Dispute that cannot be resolved during the Resolution Period may immediately be referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined in the AAA Procedures) of the Commercial Arbitration Rules (the “AAA Procedures”) of the AAA. Any Party involved in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted by one arbitrator nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to the AAA and reasonably acceptable to each Party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration process promptly (but in any event within five (5) Business Days) after his or her nomination and acceptance by the Parties subject to the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive law of the state of Delaware. Time is of the essence. Each Party subject to the Dispute shall submit a proposal for resolution of the Dispute to the arbitrator within twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the power to order any Party to do, or to refrain from doing, anything consistent with this Agreement, the Ancillary Documents and applicable Law, including to perform its contractual obligation(s); provided, that the arbitrator shall be limited to ordering pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant Party (or Parties, as applicable) to comply with only one or the other of the proposals. The arbitrator’s award shall be in writing and shall include a reasonable explanation of the arbitrator’s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in New York, New York. The language of the arbitration shall be English.

 

12.5 Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without regard to the conflict of laws principles thereof. Subject to Section 12.4, all Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in the Chancery Court of the State of Delaware (or in any other court in the State of Delaware or any appellate court thereof) (the “Specified Courts”). Subject to Section 12.4, each Party hereto hereby (a) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address set forth in Section 12.1. Nothing in Section 12.5 shall affect the right of any Party to serve legal process in any other manner permitted by Law.

 

53

 

12.6 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 12.6.

 

12.7 Specific Performance. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching Parties may have not adequate remedy at law, and agree that irreparable damage could occur in the event that any of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise breached. Accordingly, each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement and to seek to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.

 

12.8 Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

 

12.9 Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by Purchaser, the Company, Purchaser Representative and the Company Representative; provided that any amendment, supplement or modification of this Agreement after the End Date shall also require the prior written consent of the Purchaser Representative.

 

12.10 Waiver. Each of Purchaser and the Company on behalf of itself and its Affiliates, and the Company Representative on behalf of itself, may in its sole discretion (i) extend the time for the performance of any obligation or other act of any other non-Affiliated Party hereto, (ii) waive any inaccuracy in the representations and warranties by such other non-Affiliated Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance by such other non-Affiliated Party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party or Parties to be bound thereby (including by Purchaser Representative or the Company Representative in lieu of such Party to the extent provided in this Agreement). Notwithstanding the foregoing, no failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. Notwithstanding the foregoing, any waiver of any provision of this Agreement after the End Date shall also require the prior written consent of Purchaser Representative.

 

12.11 Entire Agreement. This Agreement and the documents or instruments referred to herein, including any exhibits, annexes, and schedules attached hereto, which exhibits, annexes, and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations, warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter contained herein.

 

54

 

12.12 Interpretation. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement, unless the context otherwise requires: (a) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and words in the singular, including any defined terms, include the plural and vice versa; (b) reference to any Person includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with GAAP or IFRS, as applicable, based on the accounting principles used by the applicable Person; (d) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (e) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (f) the word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and only if”; (g) the term “or” means “and/or”; (h) any reference to the term “ordinary course” or “ordinary course of business” shall be deemed in each case to be followed by the words “consistent with past practice”; (i) any agreement, instrument, insurance policy, Law or Order defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument, insurance policy, Law or Order as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes, regulations, rules or orders) by succession of comparable successor statutes, regulations, rules or orders and references to all attachments thereto and instruments incorporated therein; (j) except as otherwise indicated, all references in this Agreement to the words “Section,” “Article,” “Annex”, “Schedule” and “Exhibit” are intended to refer to Sections, Articles, Annexes, Schedules and Exhibits to this Agreement; and (k) the term “Dollars” or “$” means United States dollars. Any reference in this Agreement to a Person’s directors shall include any member of such Person’s governing body and any reference in this Agreement to a Person’s officers shall include any Person filling a substantially similar position for such Person. Any reference in this Agreement or any Ancillary Document to a Person’s shareholders or stockholders shall include any applicable owners of the equity interests of such Person, in whatever form, including with respect to Purchaser its stockholders under the DGCL, as then applicable, or its Organizational Documents. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. To the extent that any Contract, document, certificate or instrument is represented and warranted to by the Company to be given, delivered, provided or made available by the Company, in order for such Contract, document, certificate or instrument to have been deemed to have been given, delivered, provided and made available to Purchaser or its Representatives, such Contract, document, certificate or instrument shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of Purchaser and its Representatives and Purchaser and its Representatives have been given access to the electronic folders containing such information.

 

12.13 Counterparts. This Agreement and each Ancillary Document may be executed and delivered (including by facsimile or other electronic transmission) in one or more counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

 

12.14 Purchaser Representative.

 

(a) Purchaser, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby irrevocably appoints J. Gerald Combs in his capacity as Purchaser Representative, as its agent, attorney-in-fact and representative, with full power of substitution to act in the name, place and stead of Purchaser, to act on behalf of Purchaser from and after the End Date in connection with: (i) bringing, managing, controlling, defending and settling on behalf of an Indemnitee any indemnification claims by any of them in accordance with Article 7, including controlling, defending, managing, settling and participating in any Third Party Claim in accordance with Section 7.16; (ii) acting on behalf of Purchaser under the Extension Escrow Agreement; (iii) terminating, amending or waiving on behalf of Purchaser any provision of this Agreement or any Ancillary Documents to which the Purchaser Representative is a party or otherwise has rights in such capacity (together with this Agreement, the “Purchaser Representative Documents”); (iv) signing on behalf of Purchaser any releases or other documents with respect to any dispute or remedy arising under any Purchaser Representative Documents; (v) employing and obtaining the advice of legal counsel, accountants and other professional advisors as the Purchaser Representative, in its reasonable discretion, deems necessary or advisable in the performance of its duties as the Purchaser Representative and to rely on their advice and counsel; (vi) incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable out-of-pocket fees and expenses allocable or in any way relating to such transaction or any indemnification claim; and (vii) otherwise enforcing the rights and obligations of Purchaser under any Purchaser Representative Documents, including giving and receiving all notices and communications hereunder or thereunder on behalf of Purchaser. All decisions and actions by the Purchaser Representative shall be binding upon Purchaser and its successors and assigns, and neither they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section ‎12.14 are irrevocable and coupled with an interest. The Purchaser Representative hereby accepts its appointment and authorization as the Purchaser Representative under this Agreement.

 

55

 

(b) The Company Representative and Company may conclusively and absolutely rely, without inquiry, upon any actions of the Purchaser Representative as the acts of the Purchaser under any Purchaser Representative Documents. The Company Representative and Company shall be entitled to rely conclusively on the instructions and decisions of the Purchaser Representative as to any actions required or permitted to be taken by the Purchaser Representative hereunder, and the Purchaser shall not have any cause of action against the Purchaser Representative or the Purchaser for any reasonable action taken by any of them in reliance upon the instructions or decisions of the Purchaser Representative. All notices or other communications required to be made or delivered to the Purchaser under any Purchaser Representative Document shall be made to the Purchaser Representative for the benefit of the Company, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to the Purchaser with respect thereto. All notices or other communications required to be made or delivered by the Purchaser shall be made by the Purchaser Representative.

 

(c) The Purchaser Representative shall not be liable for any act done or omitted under any Purchaser Representative Document as Purchaser Representative while acting in good faith and without willful misconduct or gross negligence on behalf of Purchaser, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. Purchaser shall indemnify, defend and hold harmless the Purchaser Representative from and against any and all Losses incurred without gross negligence, bad faith or willful misconduct on the part of the Purchaser Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Purchaser Representative’s duties under any Purchaser Representative Document, including the reasonable fees and expenses of any legal counsel retained by the Purchaser Representative. In no event shall the Purchaser Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Purchaser Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Purchaser Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Purchaser Representative shall have the right at any time and from time to time to select and engage, at the cost and expense of Purchaser, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other out-of-pocket expenses, as the Purchaser Representative may deem reasonably necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Purchaser Representative under this Section ‎12.14 shall survive the End Date and continue indefinitely.

 

(d) The Person serving as the Purchaser Representative may resign upon ten (10) days’ prior written notice to Purchaser, the Company and the Company Representative, provided, that the Purchaser Representative appoints in writing a replacement Purchaser Representative. Each successor Purchaser Representative shall have all of the power, authority, rights and privileges conferred by this Agreement upon the original Purchaser Representative, and the term “Purchaser Representative” as used herein shall be deemed to include any such successor Purchaser Representatives.

 

56

 

12.15 Company Representative.

 

(a) The Company, by execution and delivery of this Agreement, hereby irrevocably constitutes and appoints Hyun Jong Chung, in his capacity as the Company Representative, as the agent and attorney-in-fact of Company with full powers of substitution to act in the name, place and stead of the Company under the terms and provisions of this Agreement and the Ancillary Documents to which the Company Representative is a party or otherwise has rights in such capacity (together with this Agreement, the “Company Representative Documents”), as the same may be from time to time amended, and to do or refrain from doing all such further acts and things, and to execute all such documents on behalf of the Company, if any, as the Company Representative will deem reasonably necessary or appropriate in connection with any of the Transactions contemplated under the Company Representative Documents, including: (i) bringing, managing, controlling, defending and settling on behalf of an Indemnitee any indemnification claims by any of them in accordance with Article 7, including controlling, defending, managing, settling and participating in any Third Party Claim in accordance with Section 7.16; (ii) acting on behalf of the Company under the Extension Escrow Agreement; (iii) terminating, amending or waiving on behalf of the Company any provision of any Company Representative Document (provided, that any such action, if material to the rights and obligations of the Company in the reasonable judgment of the Company Representative; (iv) signing on behalf of the Company any releases or other documents with respect to any dispute or remedy arising under any Company Representative Document; (v) employing and obtaining the advice of legal counsel, accountants and other professional advisors as the Company Representative, in its reasonable discretion, deems necessary or advisable in the performance of its duties as the Company Representative and to rely on their advice and counsel; (vi) incurring and paying reasonable costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable fees and expenses allocable or in any way relating to such transaction or any indemnification claim, whether incurred prior or subsequent to Closing;; and (viii) otherwise enforcing the rights and obligations of the Company under any Company Representative Document, including giving and receiving all notices and communications hereunder or thereunder on behalf of the Company. All decisions and actions by the Company Representative shall be binding upon the Company . The provisions of this Section 12.15 are irrevocable and coupled with an interest. The Company Representative hereby accepts its appointment and authorization as the Company Representative under this Agreement.

 

(b) The Purchaser Representative and Purchaser may conclusively and absolutely rely, without inquiry, upon any actions of the Company Representative as the acts of the Company under any Company Representative Documents. The Purchaser Representative and Purchaser shall be entitled to rely conclusively on the instructions and decisions of the Company Representative as to any actions required or permitted to be taken by the Company Representative hereunder, and the Company shall not have any cause of action against the Purchaser Representative or the Purchaser for any reasonable action taken by any of them in reliance upon the instructions or decisions of the Company Representative. All notices or other communications required to be made or delivered to the Company under any Company Representative Document shall be made to the Company Representative for the benefit of the Company, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to the Company with respect thereto. All notices or other communications required to be made or delivered by the Company shall be made by the Company Representative.

 

(c) The Company Representative will act for the Company on all of the matters set forth in this Agreement in the manner the Company Representative believes to be in the best interest of the Company, but the Company Representative will not be responsible to the Company for any Losses that the Company may suffer by reason of the performance by the Company Representative of the Company Representative’s duties under this Agreement, other than losses arising from the bad faith, gross negligence or willful misconduct by the Company Representative in the performance of its duties under this Agreement. From and after the End Date, the Company shall indemnify, defend and hold the Company Representative harmless from and against any and all Losses reasonably incurred without gross negligence, bad faith or willful misconduct on the part of the Company Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Company Representative’s duties under any Company Representative Document, including the reasonable fees and expenses of any legal counsel retained by the Company Representative. In no event shall the Company Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Company Representative shall not be liable for any act done or omitted under any Company Representative Document as the Company Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. The Company Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Company Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Company Representative shall have the right at any time and from time to time to select and engage, at the reasonable cost and expense of the Company, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other reasonable out-of-pocket expenses, as the Company Representative may reasonably deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Company Representative under this Section 12.15 shall survive the End Date and continue indefinitely.

 

57

 

(d) The Person serving as the Company Representative may resign upon ten (10) days’ prior written notice to Company, the Purchaser and the Purchaser Representative, provided, that the Company Representative appoints in writing a replacement Company Representative. Each successor Company Representative shall have all of the power, authority, rights and privileges conferred by this Agreement upon the original Company Representative, and the term “Company Representative” as used herein shall be deemed to include any such successor Company Representatives.

 

12.16 Legal Representation.

 

(a) The Parties agree that, notwithstanding the fact that Rimon, P.C. may have, prior to Closing, jointly represented Purchaser, Purchaser Representative and the Sponsor in connection with this Agreement, the Ancillary Documents and the Transactions, and has also represented Purchaser and its Affiliates in connection with matters other than the transaction that is the subject of this Agreement, Rimon, P.C. will be permitted in the future, after Closing, to represent Purchaser, the Sponsor, or their respective Affiliates, in connection with matters in which such Persons are adverse to Purchaser or any of its Affiliates, including any disputes arising out of, or related to, this Agreement. The Company and the Company Representative, who are or have the right to be represented by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with Rimon, P.C.’s future representation of one or more of Purchaser, the Sponsor, or their respective Affiliates, in which the interests of such Person are adverse to the interests of Purchaser, the Company, and/or the Company Representative or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by Rimon, P.C. of the Sponsor, Purchaser, or any of their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Sponsor and the Purchaser Representative shall be deemed the clients of Rimon, P.C. with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the End Date and the privilege and the expectation of client confidence relating thereto shall belong to the Sponsor and the Purchaser Representative, shall be controlled by the Sponsor and the Purchaser Representative, and shall not pass to or be claimed by Purchaser; provided, further, that nothing contained herein shall be deemed to be a waiver by Purchaser, or any of its Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.

 

58

 

(b) The Parties agree that, notwithstanding the fact that K&L Gates may have, prior to Closing, represented the Company in connection with this Agreement, the Ancillary Documents and the Transactions, and may have also represented the Company the Company Shareholders, the Company Representative and/or their respective Affiliates in connection with matters other than the transaction that is the subject of this Agreement, K&L Gates will be permitted in the future, after Closing, to represent the Company the Company Shareholders or their respective Affiliates in connection with matters in which such Persons are adverse to any other party to the Agreement, or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. Purchaser, who is or has the right to be represented by independent counsel in connection with the transactions contemplated by this Agreement, hereby agrees, in advance, to waive and to cause its Affiliates (including the Sponsor and the Purchaser Representative after the End Date) to waive any actual or potential conflict of interest that may hereafter arise in connection with K&L Gates’s future representation of one or more of the Company Shareholders or their Affiliates in which the interests of such Person are adverse to the interests of Purchaser, the Purchaser Representative, Sponsor and/or the Company and/or other Company Shareholders or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by K&L Gates of the Company the Company Shareholders or any of their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Company Shareholders and the Company Representative shall be deemed the clients of K&L Gates with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the End Date and the privilege and the expectation of client confidence relating thereto shall belong to each such respective party, shall be controlled thereby and shall not pass to or be claimed by any other party; provided, further, that nothing contained herein shall be deemed to be a waiver by any party or any of their respective Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.

 

59

 

ARTICLE XIII

DEFINITIONS

 

13.1 Certain Definitions. For purpose of this Agreement, the following capitalized terms have the following meanings:

 

“AAA” means the American Arbitration Association or any successor entity conducting arbitrations.

 

“Acceptable Confidentiality Agreement” means a confidentiality agreement that contains provisions that are no less favorable in the aggregate to the Company than those contained in its confidentiality agreements with Purchaser; provided that such agreement and any related agreements (i) need not contain “standstill” provisions and (ii) shall not include any provision calling for any exclusive right to negotiate with such party or having the effect of prohibiting the Company from satisfying its obligations under this Agreement.

 

“Accounting Principles” means in accordance with GAAP as in effect at the date of the financial statement to which it refers or if there is no such financial statement, then as of the End Date, using and applying the same accounting principles, practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation and estimation methodologies) used and applied by the Target Companies in the preparation of the latest audited Company Financials.

 

“Acquisition Party” has the meaning set forth in Section 1.2(a).

 

“Action” means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint, stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation, by or before any Governmental Authority.

 

“Advisers” means, in relation to an entity, its legal, financial and other expert advisers.

 

“Affiliate” means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such Person. For the avoidance of doubt, Canna-Global LLC shall be deemed to be an Affiliate of Purchaser prior to the End Date.

 

“Aggregate PIPE Proceeds” means the cash proceeds actually received by Purchaser in respect of the PIPE Investment and held in a bank account owned and controlled by Purchaser on Closing.

 

“Ancillary Documents” means each agreement, instrument or document attached hereto as an Exhibit, and the other agreements, certificates and instruments to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement.

 

“ASIC” means the Australian Securities and Investments Commission.

 

“Available Closing SPAC Cash” means all amounts in the Trust Account, after reduction for the aggregate amount of payments required to be made in connection with the Redemption and consummation by Purchaser of the transactions contemplated herein, including the Aggregate PIPE Proceeds and excluding the SPAC Closing Net Debt.

 

“Australian Act” means the Corporations Act 2001 (Cth), which is the principal legislation regulating business entities (primarily companies) in Australia..

 

“Benefit Plans” of any Person means any and all deferred compensation, executive compensation, incentive compensation, equity purchase or other equity-based compensation plan, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization or other medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program, agreement, commitment or arrangement, and each other employee benefit plan, program, agreement or arrangement, including each “employee benefit plan” as such term is defined under Section 3(3) of ERISA, maintained or contributed to or required to be contributed to by a Person for the benefit of any employee or terminated employee of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether formal or informal, and whether legally binding or not.

 

60

 

“Bidder’s Statement” means Purchaser’s statement to be issued by Purchaser in respect of the Takeover Bid in accordance with Chapter 6 of the Australian Act.

 

“Business Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York are authorized to close for business, excluding as a result of “stay at home,” “shelter-in-place,” “non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially banking institutions in New York, New York are generally open for use by customers on such day.

 

“Claim” includes a claim, notice, demand, action, proceeding, litigation, prosecution, arbitration, investigation, judgment, award, damage, loss, cost, expense or liability however arising, whether present, unascertained, immediate, future or contingent, whether based in contract, tort or statute and whether involving a Third Party or a Party to this Agreement or otherwise.

 

“Closing” has the meaning set forth in Section ‎9.1.

 

“Closing Filing” has the meaning as defined in Section 7.13(b) of this Agreement.

 

“Closing Press Release” has the meaning as defined in Section 7.13(b) of this Agreement.

 

“Code” means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended. Reference to a specific section of the Code shall include such section and any valid treasury regulation promulgated thereunder.

 

“Company Acquisition Agreement” has the meaning set forth in Section 3.8‎(a).

 

“Company Adverse Recommendation Change” means any change in the recommendation of the Company’s Board described in Section 3.4(a), as a result of which the Company’s Board is no longer recommending, or has qualified its recommendation that the Company’s Shareholders approve the Transactions.

 

“Company Board” means the board of directors of Company.

 

“Company Constitution” means the Company’s constitution, as amended and effective under the Australian Act, prior to the Effective Time.

 

“Company Confidential Information” means all confidential or proprietary documents and information concerning the Target Companies or any of their respective Representatives, furnished in connection with this Agreement or the transactions contemplated hereby; provided, however, that Company Confidential Information shall not include any information which, (i) at the time of disclosure by Purchaser or its Representatives, is generally available publicly and was not disclosed in breach of this Agreement or (ii) at the time of the disclosure by the Company or its Representatives to Purchaser or its Representatives was previously known by such receiving party without violation of Law or any confidentiality obligation by the Person receiving such Company Confidential Information.

 

“Company Convertible Notes” means convertible notes set forth on Schedule 7.20(h).

 

“Company Director” means a director of Company.

 

61

 

“Company Ordinary Share” means a fully paid ordinary share in the capital of the Company.

 

“Company Shares” means the Company Ordinary Shares.

 

“Company Security Holders” means, collectively, the holders of Company Shares.

 

“Company Shareholders” means, collectively, the holders of Company Shares.

 

“Company Warranty” means each of the warranties and representations given by the Company in Article VI.

 

“Competing Proposal” means any expression of interest, proposal, offer or transaction notified to the Company Board which, if completed substantially in accordance with its terms, would mean a person (other than Purchaser or its Affiliates) would:

 

(a) directly or indirectly, acquire an interest or Relevant Interest in or become the holder of:

 

(i) 90% or more of all Company Shares;

 

(ii) voting power of more than 90% in Company;

 

(iii) all or substantially all of the business conducted by the Target Companies.

 

(b) acquire control of Company, within the meaning of section 50AA of the Australian Act; or

 

(c) otherwise directly or indirectly acquire or merge with Company or acquire an economic interest in the whole or a substantial part of Company or its businesses or assets (including by takeover offer, scheme of arrangement, capital reduction, sale of assets, strategic alliance, joint venture, partnership or reverse takeover bid).

 

“Consent” means any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority or any other Person.

 

“Contracts” means all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses (and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments or obligations of any kind, written or oral (including any amendments and other modifications thereto).

 

“Conditions” means the conditions to the Takeover Offer which are set out in ‎Article IX.

 

“Control” of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled,” “Controlling” and “under common Control with” have correlative meanings. Without limiting the foregoing a Person (the “Controlled Person”) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange Act, securities entitling such Person to cast ten percent (10%) or more of the votes for election of directors or equivalent governing authority of the Controlled Person or (ii) entitled to be allocated or receive ten percent (10%) or more of the profits, losses, or distributions of the Controlled Person; (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person; or (c) a spouse, parent, lineal descendant, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an Affiliate of the Controlled Person or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the Controlled Person is a trustee.

 

62

 

“Copyrights” means any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations and applications for registration and renewal, and non-registered copyrights.

 

“Cut-Off Time” means 5.00pm June 15, 2023 Eastern Standard Time.

 

“Data Room” means the electronic data room hosted by SecureDocs at https://newquantum.securedocs.com/folders/64212c71f05a6f6159272525.

 

“DGCL” means Delaware General Corporations Law.

 

“End Date” means the earlier of:

 

(a) date of termination of this Agreement in accordance with its terms; and

 

(b) the end of the Takeover Offer Period,

 

or such other date as the Parties agree.

 

“Environmental Law” means any Law in any way relating to (a) the protection of human health and safety, (b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource), or (c) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of Hazardous Materials, including the Comprehensive Environmental Response, Compensation and Liability Act, 42 USC. Section 9601 et. seq., the Resource Conservation and Recovery Act, 42 USC. Section 6901 et. seq., the Toxic Substances Control Act, 15 USC. Section 2601 et. seq., the Federal Water Pollution Control Act, 33 USC. Section 1151 et seq., the Clean Air Act, 42 USC. Section 7401 et seq., the Federal Insecticide, Fungicide and Rodenticide Act, 7 USC. Section 111 et. seq., Occupational Safety and Health Act, 29 USC. Section 651 et. seq. (to the extent it relates to exposure to Hazardous Substances), the Asbestos Hazard Emergency Response Act, 15 USC. Section 2601 et. seq., the Safe Drinking Water Act, 42 USC. Section 300f et. seq., the Oil Pollution Act of 1990 and analogous state acts.

 

“Environmental Liabilities” means, in respect of any Person, all Liabilities, obligations, responsibilities, Remedial Actions, losses, damages, costs, and expenses (including all reasonable fees, disbursements, and expenses of counsel, experts, and consultants and costs of investigation and feasibility studies), fines, penalties, sanctions, and interest incurred as a result of any claim or demand by any other Person or in response to any violation of Environmental Law, whether known or unknown, accrued or contingent, whether based in contract, tort, implied or express warranty, strict liability, criminal or civil statute, to the extent based upon, related to, or arising under or pursuant to any Environmental Law, Environmental Permit, Order, or Contract with any Governmental Authority or other Person, that relates to any environmental, health or safety condition, violation of Environmental Law, or a Release or threatened Release of Hazardous Materials.

 

“Equity Incentive Plan” has the meaning set forth in Section ‎7.19.

 

“Escrow Agent” means Rimon, P.C., the law firm of the Purchaser, which will hold, disburse and invest funds deposited by the Company in accordance with the Extension Escrow Agreement.

 

“Escrow Amount” means a maximum amount of USD$639,693.90, to be remitted by the Company to the Escrow Agent with a first installment in the amount of USD$319,846.95 to be paid to the Escrow Agent on or before July 1, 2023, and subsequent equal monthly installments in the amount of USD$106,615.65 no later than seven (7) business days before the first of the month beginning on September 1, 2023 with such monthly installments terminating on the earlier of: (i) Closing; (ii) the termination of this Agreement; and (iii) 31 December 2023, pursuant to the Extension Escrow Agreement fund the Extension Expenses.

 

“ESOP Rules” means the Employee Option Plan Rules of the Company dated June 29, 2020.

 

63

 

“ERISA” means the U.S. Employee Retirement Income Security Act of 1974, as amended.

 

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

 

“Extension Escrow Agreement” means the extension escrow agreement by and among Purchaser, the Company and Escrow Agent.

 

“Extension Expenses” has the meaning set forth in Section 7.3(b)(iv).

 

“Foreign Plan” means any plan, fund (including any superannuation fund) or other similar program or arrangement established or maintained outside the United States by the Company or any one or more of its Subsidiaries primarily for the benefit of employees of the Company or such Subsidiaries residing outside the United States, which plan, fund or other similar program or arrangement provides, or results in, retirement income, a deferral of income in contemplation of retirement or payments to be made upon termination of employment, and which plan is not subject to ERISA or the Code.

 

“Fraud” means actual and intentional fraud, with elements of scienter and reliance, under the Laws of the State of Delaware, in the making of any representations and warranties contained in this Agreement.

 

“Fraud Claim” means any claim based in whole or in part upon fraud, willful misconduct or intentional misrepresentation.

 

“GAAP” means generally accepted accounting principles as in effect in the United States of America.

 

“Governmental Authority” means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving panel or body.

 

“Hazardous Material” means any waste, gas, liquid or other substance or material that is defined, listed or designated as a “hazardous substance,” “pollutant,” “contaminant,” “hazardous waste,” “regulated substance,” “hazardous chemical,” or “toxic chemical” (or by any similar term) under any Environmental Law, or any other material regulated, or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum and its by-products, asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.

 

“IFRS” means international financial reporting standards, as adopted by the International Accounting Standards Board.

 

“Indebtedness” of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture, credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in accordance with GAAP, (e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit, banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed against, (f) all obligations of such Person in respect of acceptances issued or created, (g) all interest rate and currency swaps, caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically or upon the happening of a contingency, (h) all obligations secured by any Lien on any property of such Person, (i) any premiums, prepayment fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (j) all obligation described in clauses (a) through (i) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against loss.

 

64

 

“Insider Letter” means the Letter Agreement dated November 29, 2021 to Purchaser from Canna-Global LLC and other parties, as filed as Exhibit 10.7 to the Current Report on Form 8-K filed by Purchaser with the SEC on November 30, 2021.

 

“Intellectual Property” means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights, Trade Secrets, Internet Assets, Software and other intellectual property, and all licenses, sublicenses and other agreements or permissions related to the preceding property.

 

“Internet Assets” means any and all domain name registrations, web sites and web addresses and related rights, items and documentation related thereto, and applications for registration therefor.

 

“Investment Company Act” means the U.S. Investment Company Act of 1940, as amended.

 

“IPO” means the initial public offering of Purchaser Public Units pursuant to the IPO Prospectus.

 

“IPO Prospectus” means the final prospectus of Purchaser, dated as of November 29, 2021, and filed with the SEC on November 30, 2021 (File No. 333-258619).

 

“IPO Underwriter” means EF Hutton, a division of Benchmark Investments, LLC.

 

“IRS” means the U.S. Internal Revenue Service (or any successor Governmental Authority).

 

“Key Executive” means Hyun Jong Chung, Kar Chua, Babar Ali.

 

“Key Employee” means Babar Ali.

 

“Knowledge” means, with respect to (i) the Company, the actual knowledge of the executive officers or directors of any Target Company, after reasonable inquiry, and (ii) the Purchaser, the actual knowledge of its directors or officers, after reasonable inquiry.

 

“Law” means any federal, state, local, municipal, foreign or other law (including the Australian Act), statute, legislation, principle of common law, ordinance, code, edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority.

 

“Leased Real Property” has the meaning set forth in Section ‎6.15.

 

“Letter of Transmittal” has the meaning set forth in Recitals.

 

“Liabilities” means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise, whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required to be recorded or reflected on a balance sheet under GAAP or other applicable accounting standards), including Tax liabilities due or to become due.

 

“Lien” means any mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.

 

“Lock-up Shareholder” means Company Shareholder that owns more than one percent (1%) of the issued and outstanding shares of the Company at Closing.

 

“Lodgment Date” means the date Purchaser lodges the Bidder’s Statement with ASIC.

 

65

 

“Material Adverse Effect” means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities, results of operations, prospects or condition (financial or otherwise) of such Person and its Subsidiaries, taken as a whole, or (b) the ability of such Person or any of its Subsidiaries on a timely basis to consummate the transactions contemplated by this Agreement or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; provided, however, that for purposes of clause (a) above, any changes or effects directly or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any other, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse Effect: (i) general changes in the financial or securities markets or general economic or political conditions in the country or region in which such Person or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries in which such Person or any of its Subsidiaries principally operate; (iii) changes in IFRS, GAAP or other applicable accounting principles or mandatory changes in the regulatory accounting requirements applicable to any industry in which such Person and its Subsidiaries principally operate; (iv) conditions caused by acts of God, terrorism, war (whether or not declared) or natural disaster; (v) any failure in and of itself by such Person and its Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period (provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not excluded by another exception herein) and (vi) with respect to Purchaser, the consummation and effects of the Redemption (or any redemption in connection with the Extension); provided further, however, that any event, occurrence, fact, condition, or change referred to in clauses (i) - (iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change has a disproportionate effect on such Person or any of its Subsidiaries compared to other participants in the industries in which such Person or any of its Subsidiaries primarily conducts its businesses. Notwithstanding the foregoing, with respect to Purchaser, the amount of the Redemption (or any redemption in connection with the Extension, if any) or the failure to obtain the Required Purchaser Stockholder Approval shall not be deemed to be a Material Adverse Effect on or with respect to Purchaser.

 

“Material Contract” means any contract or other arrangement to which Purchaser or a Target Company, as applicable, is a party and for which breach, nonperformance, cancellation or failure to renew could have a Material Adverse Effect.

 

“Nasdaq” means the Nasdaq Global Market.

 

“New Incentive Equity Plan” means the incentive equity plan attached hereto as Exhibit F.

 

“Officers” means, in relation to an entity, its directors, officers, and employees.

 

“Order” means any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.

 

“Organizational Documents” means, with respect to any Person that is an entity, its certificate of incorporation or formation, bylaws, operating agreement, memorandum and articles of association or similar organizational documents, in each case, as amended.

 

“Owned Real Property” has the meaning set forth in Section ‎6.15.

 

“Patents” means any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions, and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof, whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn, or refiled).

 

“PCAOB” means the U.S. Public Company Accounting Oversight Board (or any successor thereto).

 

66

 

“Per Share Consideration” means the quotient of (i) the Common Consideration divided by (ii) the sum, without duplication, of the aggregate number of shares of Company Common Stock that are issued and outstanding immediately prior to the Effective Time (other than shares to be cancelled in accordance with Section ‎Article IV).

 

“Permits” means all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions, licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations, ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.

 

“Permitted Liens” means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not delinquent or (ii) being contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto, (b) other Liens imposed by operation of Law arising in the ordinary course of business for amounts which are not due and payable and as would not in the aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property subject thereto, (c) Liens incurred or deposits made in the ordinary course of business in connection with social security, (d) Liens on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, or (e) Liens arising under this Agreement or any Ancillary Document.

 

“Person” means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.

 

“Personal Data” means, with respect to any natural Person, such Person’s name, street address, telephone number, e-mail address, photograph, social security number, tax identification number, driver’s license number, passport number, credit card number, bank account number and other financial information, customer or account numbers, account access codes and passwords, any other information that allows the identification of such Person or enables access to such Person’s financial information or that is defined as “personal data,” “personally identifiable information,” “personal information,” “sensitive personal information” such as geolocation, race, religion and union membership, genetics, or biometrics, “protected health information” or similar term under any applicable Privacy Laws.

 

“Personal Property” means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts and other tangible personal property.

 

“PIPE Investor” means additional investment obtained by Purchaser and the Company after the date of the Agreement and prior to the Closing, by entering into subscription agreements with investors relating to a private equity investment in Purchaser to purchase shares of Purchaser in connection with a private placement, and/or entering into backstop arrangements with potential investors, in either case on terms mutually agreeable to the Company and Purchaser, acting reasonably.

 

“Post-Closing Board” has the meaning set forth in Section ‎7.15‎(a).

 

“Post-Closing Directors” has the meaning set forth in Section ‎1.4(b).

 

“Pre-Closing Taxes” means any (a) U.S. federal, state, or local or non-U.S. tax obligations owed by any company of the Company Group for any taxable period (or portion thereof) ending at or before the Effective Time.

 

“Pre-emptive Waiver” means the pre-emptive waiver to be executed by each Company Shareholder as part of the Takeover Acceptance Form waiving all of their pre-emptive rights in connection with the transfer of Company Shares pursuant to the Takeover Offer.

 

“Preference Shares” or “Redeemable Preference Shares” shall mean the redeemable preference shares on issue in the Company, which in accordance with their terms of issue have: (a) a face value of $1.00 per share; (b) a maturity date after which the shares will be redeemed by the Company; (c) a specified coupon rate of interest that is payable on the face value; (d) no voting rights in the Company; and (e) no right to be converted into ordinary shares in the capital of the Company, and for which all intents and purposes the parties agree will be treated as debt of the Company.

 

67

 

“Preference Shareholder” means the holder of one or more Preference Shares of the Company.

 

“Privacy Laws” means all applicable United States state and federal Laws, and the laws of applicable international jurisdictions, relating to privacy and protection of Personal Data and/or Protected Health Information, including, without limitation, Australian Privacy Principles under the Privacy Act 1988, the EU’s General Data Protection Regulation, the UK’s General Data Protection Regulation, the US Health Insurance Portability and Accountability Act of 1996 (“HIPAA”); the Health Information Technology for Economic and Clinical Health Act, ; and any and all similar international, state and federal Laws relating to data subject privacy rights, security, data protection, data availability and destruction and data breach, including security incident notification.

 

“Pro Rata Share” means with respect to each Company Shareholder, a fraction expressed a percentage equal to (i) the portion of the Shareholder Business Combination Consideration payable by Purchaser to such Company Shareholder in accordance with the terms of this Agreement, divided by (ii) the total Shareholder Business Combination Consideration payable by Purchaser to all Company Shareholders in accordance with the terms of this Agreement.

 

“Proceeding” means any action, suit, proceeding, complaint, claim, charge, hearing, labor dispute, inquiry or investigation before or by a Governmental Authority or an arbitrator.

 

“Protected Health Information” has the meaning given to such term under HIPAA, including all such information in electronic form.

 

“Purchaser” means Canna-Global Acquisition Corp. a Delaware corporation

 

“Purchaser Board” means the board of directors of Purchaser.

 

“Purchaser Certificate of Incorporation” means the Second Amended and Restated Certificate of Incorporation filed in the office of the Secretary of State of the State of Delaware pursuant to the DGCL on December 1, 2021. as amended in part by the First Amendment to the Second Amended and Restated Certificate of Incorporation filed in the office of the Secretary of State of the State of Delaware pursuant to the DGCL on November 30, 2022.

 

“Purchaser Class A Common Stock” means the shares of Class A common stock, par value $0.000001 per share, of Purchaser.

 

“Purchaser Class B Common Stock” means the shares of Class B common stock, par value $0.000001 per share, of Purchaser.

 

“Purchaser Common Stock” means the shares of Purchaser Class A Common Stock and Purchaser Class B Common Stock, collectively.

 

“Purchaser Confidential Information” means all confidential or proprietary documents and information concerning Purchaser or any of its Representatives; provided, however, that Purchaser Confidential Information shall not include any information which, (i) at the time of disclosure by the Company, the Company Representative or any of their respective Representatives, is generally available publicly and was not disclosed in breach of this Agreement or (ii) at the time of the disclosure by Purchaser or its Representatives to the Company, the Company Representative or any of their respective Representatives, was previously known by such receiving party without violation of Law or any confidentiality obligation by the Person receiving such Purchaser Confidential Information. For the avoidance of doubt, from and after the End Date, Purchaser Confidential Information will include the confidential or proprietary information of the Target Companies.

 

68

 

“Purchaser’s Organizational Documents” means the Purchaser Certificate of Incorporation and Bylaws of Purchaser.

 

“Purchaser Preferred Shares” means preferred shares, par value $0.000001 per share, of Purchaser.

 

“Purchaser Private Units” means the units issued by Purchaser in a private placement to Canna-Global LLC at the time of the consummation of the IPO with each unit consisting of one (1) share of Purchaser Class A Common Stock and one Purchaser Private Warrant.

 

“Purchaser Private Warrants” means one whole warrant that was included in as part of each Purchaser Private Unit, entitling the holder thereof to purchase one (1) share of Purchaser Class A Common Stock at a purchase price of $11.50 per share.

 

“Purchaser Public Units” means the units issued in the IPO (including overallotment units acquired by Purchaser’s underwriter) consisting of one (1) share of Purchaser Class A Common Stock and one Purchaser Public Warrant.

 

“Purchaser Public Warrants” means one whole warrant that was included in as part of each Purchaser Public Unit, entitling the holder thereof to purchase one (1) share of Purchaser Class A Common Stock at a purchase price of $11.50 per share.

 

“Purchaser Securities” means Purchaser Units, Purchaser Common Stock, Purchaser Preferred Shares and Purchaser Warrants, collectively.

 

“Purchaser Security Holders” means, collectively, the holders of Company Securities.

 

“Purchaser Units” means Purchaser Private Units and Purchaser Public Units, collectively.

 

“Purchaser Warrants” means Purchaser Private Warrants and Purchaser Public Warrants, collectively.

 

“Purchaser’s Organizational Documents” means Purchaser’s Certificate of Incorporation and Bylaws, each as amended to date.

 

“Record Date” means the Record Date as nominated in the Bidder’s Statement in accordance with the Australian Act.

 

“Redemption Price” means an amount equal to the price at which each share of Purchaser Common Stock is redeemed or converted pursuant to the Redemption (as equitably adjusted for stock splits, stock dividends, combinations, recapitalizations and the like after the End Date).

 

“Register” means the share register of Company and Registry has a corresponding meaning.

 

“Register Date” means the date set by Purchaser pursuant to section 633(2) of the Australian Act.

 

“Registration Rights Agreement” means the Registration Rights Agreement in the form of Exhibit G hereto.

 

“Regulatory Permits” means all permits, licenses, certifications, approvals, registrations, consents, orders, clearances, franchises, variances, exemptions and similar authorizations required from Governmental Authorities that are necessary and material for the conduct of the business of the Company Group as currently conducted.

 

“Reference Time” means the close of business of the Company on the End Date (but without giving effect to the transactions contemplated by this Agreement, including any payments by Purchaser hereunder to occur at the End Date, but treating any obligations in respect of Indebtedness, Transaction Expenses or other liabilities that are contingent upon the consummation of the End Date as currently due and owing without contingency as of the Reference Time).

 

69

 

“Release” means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor or outdoor environment, or into or out of any property.

 

“Relevant Interest” means directly or indirectly, acquire an interest or Relevant Interest in or become the holder of:

 

(i) 90% or more of all Company Shares;

 

(ii) voting power of more than 90% in Company;

 

(iii) all or substantially all of the business conducted by the Target Companies.

 

“Remedial Action” means all actions to (i) clean up, remove, treat, or in any other way address any Hazardous Material, (ii) prevent the Release of any Hazardous Material so it does not endanger or threaten to endanger public health or welfare or the indoor or outdoor environment, (iii) perform pre-remedial studies and investigations or post-remedial monitoring and care, or (iv) correct a condition of noncompliance with Environmental Laws.

 

“Representatives” means, as to any Person, such Person’s Affiliates and the respective managers, directors, officers, employees, independent contractors, consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person or its Affiliates.

 

“Requisite Company Vote” means, in relation to the Takeover Bid, obtaining a Relevant Interest in the number of Company Shares that represents at least 90% of the aggregate of all the Company Shares on issue (on a fully diluted basis).

 

“SEC” means the U.S. Securities and Exchange Commission (or any successor Governmental Authority).

 

“SEC Reports” has the meaning set forth in Section 5.6‎(a).

 

“Securities Act” means the Securities Act of 1933, as amended.

 

“Shareholder Business Combination Consideration” means as defined in Section 1.7.

 

“Significant Company Holder” means any Company Shareholder who (i) is an executive officer or director of the Company or (ii) owns more than five percent (5%) of the issued and outstanding shares of the Company.

 

Significant Purchaser Holder” means any Purchaser Shareholder who (i) is an executive officer or director of the Purchaser or (ii) owns more than ten percent (10%) of the issued and outstanding shares of the Purchaser.

 

“Signing Filing” means as defined in Section 7.13(b).

 

“Signing Press Release” means as defined in Section 7.13(b).

 

“Software” means any computer software programs, including all source code, object code, and documentation related thereto and all software modules, tools and databases.

 

“SOX” means the U.S. Sarbanes-Oxley Act of 2002, as amended.

 

“Sponsor” means Canna-Global LLC.

 

70

 

“Subscription Agreement” means one or more subscription agreements received by Purchaser or the Company in connection with a PIPE Investment or alternative financing

 

“Subsidiary” means, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

 

“Superior Proposal” means a Competing Proposal with respect to which the Company’s Board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to take such action would cause the Company Board to be in breach of its fiduciary duties under applicable Law, and which is:

 

(a) reasonably capable of being completed considering all aspects of the Competing Proposal; and

 

(b) more favorable to Company Shareholders than the Takeover Bid, considering all terms and conditions of the Competing Proposal.

 

“Superior Proposal Notice Period” means as defined in Section 3.8(d)(i).

 

“Takeover Bid” means the off-market takeover bid by Purchaser for all Company Shares to be implemented in accordance with Chapter 6 of the Australian Act.

 

“Takeover Offer” means the offer to Company Shareholders by way of the Takeover Bid in respect of the Company Shares on issue as at the date of the Takeover Offer.

 

“Takeover Offer Date” means:

 

(a) the date which is 5 Business Days after the Lodgment Date, unless the parties otherwise agree on an earlier dispatch date for the Takeover Offer following lodgment of the Bidder’s Statement with ASIC, in which case the Takeover Offer Date will be the earlier dispatch date agreed by the parties; or

 

(b) such other date agreed on in writing by the parties.

 

“Takeover Offer Period” means the period during which the Takeover Offer is open for acceptance.

 

“Target Companies” means the Company and its direct and indirect Subsidiaries, if any.

 

“Target’s Statement” means the target’s statement to be issued by Company in respect of the Takeover Bid under section 638 of the Australian Act.

 

“Tax Return” means any return, declaration, report, claim for refund, information return or other documents (including any related or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.

 

71

 

“Taxes” means (a) all direct or indirect federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, value-added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social security and related contributions due in relation to the payment of compensation to employees, excise, severance, stamp, occupation, premium, property, windfall profits, alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, (b) any Liability for payment of amounts described in clause (a) whether as a result of being a member of an affiliated, consolidated, combined or unitary group for any period or otherwise through operation of law and (c) any Liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing, tax group, tax indemnity or tax allocation agreement (excluding commercial agreements entered into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with, or any other express or implied agreement to indemnify, any other Person.

 

“Third Party” means a person other than Company, Purchaser or their respective

Affiliates.

 

“Third Party Claim” means a Claim made or threatened by any person other than the Company or Purchaser against Purchaser or the Company.

 

“Timetable” means the timetable to be agreed by the parties in writing within 5 Business Days of the signing of this Agreement.

 

“Title and Capacity Warranties” means the Company Warranties contained in Sections 6.1, 6.2, 6.3 and 6.4.

 

“Trade Secrets” means any trade secrets, confidential business information, concepts, ideas, designs, research or development information, processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods, know-how, data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or not patentable or subject to copyright, trademark, or trade secret protection).

 

“Trademarks” means any trademarks, service marks, trade dress, trade names, brand names, internet domain names, designs, logos, or corporate names (including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications for registration and renewal thereof.

 

“Transaction Expenses” means all fees and expenses of any of the Target Companies incurred or payable as of the End Date and not paid prior to the End Date (i) in connection with the consummation of the transactions contemplated hereby, including any amounts payable to professionals (including investment bankers, brokers, finders, attorneys, accountants and other consultants and advisors) retained by or on behalf of any Target Company, (ii) any change in control bonus, transaction bonus, retention bonus, termination or severance payment or payment relating to terminated options, warrants or other equity appreciation, phantom equity, profit participation or similar rights, in any case, to be made to any current or former employee, independent contractor, director or officer of any Target Company at or after the End Date pursuant to any agreement to which any Target Company is a party prior to the End Date which become payable (including if subject to continued employment) as a result of the execution of this Agreement or the consummation of the transactions contemplated hereby and (iii) any sales, use, real property transfer, stamp, stock transfer or other similar transfer Taxes imposed on Purchaser or any Target Company in connection with the Business Combination or the other transactions contemplated by this Agreement, but for the avoidance of doubt excludes any non-cash payments that are made by the Company prior to closing (such as the issue of equity securities in the Company).

 

“Transmittal Documents” has the meaning set forth in Recitals.

 

“Trust Account” means the trust account established by Purchaser with the proceeds from the IPO pursuant to the Trust Agreement in accordance with the IPO Prospectus.

 

72

 

“Trust Agreement” means that certain Investment Management Trust Agreement, dated as of November 29, 2021, as it may be amended, by and between Purchaser and the Trustee, as well as any other agreements entered into related to or governing the Trust Account.

 

“Trustee” means Continental Stock Transfer and Trust Company, in its capacity as trustee under the Trust Agreement.

 

“Warranty Claim” means any Claim brought or instituted by Purchaser (or any person making a Claim through or on behalf of Purchaser) against the Company or any of them for breach of any of the Company Warranties or for breach of any other obligation of the Company expressed or implied by this Agreement.

 

{REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS}

 

73

 

IN WITNESS WHEREOF, each Party hereto has caused this Bid Implementation and Business Combination Agreement to be signed and delivered as of the date first written above.

 

  Purchaser:
     
  Canna-Global Acquisition Corp.
     
  By: /s/ J. Gerald Combs
  Name: J. Gerald Combs
  Title: Chief Executive Officer
     
  Purchaser Representative:
     
 

J. Gerald Combs, solely in his capacity as Purchaser

Representative hereunder

     
  By: /s/ J. Gerald Combs
  Name: J. Gerald Combs
  Title: Chief Executive Officer
     
  The Company:
     
  New Quantum Holdings Pty Ltd.
     
  By: /s/ Hyun Jong Chung
  Name: Hyun Jong Chung
  Title: Managing Director
     
  The Company Representative:
     
 

Hyun Jong Chung, solely in his capacity as the Company

Representative hereunder

     
  By: /s/ Hyun Jong Chung
  Name: Hyun Jong Chung
  Title: Managing Director

 

74

 

ANNEX I

 

 

 

ANNEX II

 

 

 

ANNEX III

 

 

 

EX-2.1 3 ex2-1.htm

 

Exhibit 2.1

 

Execution Copy

Exhibit A

 

SPONSOR SUPPORT AGREEMENT

 

This SPONSOR SUPPORT AGREEMENT (this “Agreement”), is made and entered into as of _________, 2023, by and among Canna-Global LLC, a Delaware limited liability company (“Sponsor”), and Canna-Global Acquisition Corp., a Delaware corporation (the “Purchaser”), and New Quantum Holdings Pty Ltd, an Australian Company with Australian Company Number (ACN) 628 253 743 (the “Company”). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BIBCA (as defined below).

 

WHEREAS, contemporaneously herewith, the Purchaser, the Company, J. Gerald Combs, solely in his capacity as representative from and after the Effective Time (as defined in the BIBCA) for the stockholders of the Purchaser (the “Purchaser Representative”), Hyun Jong Chung, solely in his capacity as the representative from and after the Effective Time (as defined below) for the Company (as defined in the BIBCA) in accordance with the terms and conditions of the BIBCA (the “Company Representative”), have entered into that certain Bid Implementation and Business Combination Agreement (the “BIBCA”), pursuant to which Purchaser proposes to acquire all of the Company Shares by way of a Takeover Bid and to effect a business combination transaction upon the terms and subject to the conditions of the BIBCA (the “Business Combination”), as a result of which, all of the issued and outstanding ordinary shares of the Company immediately prior to the Effective Time of the Business Combination shall be exchanged for the Takeover Offer Consideration;

 

WHEREAS, as of the date hereof, Sponsor owns 6,552,500 shares of Purchaser Common Stock (all such shares of Purchaser Common Stock and any shares of Purchaser Common Stock of which ownership of record or the power to vote is hereafter acquired by Sponsor prior to the termination of this Agreement being referred to herein as the “Shares”); and

 

WHEREAS, in order to induce the Company and Purchaser to enter into the BIBCA, Sponsor is executing and delivering this Agreement to the Company.

 

NOW, THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:

 

1. Agreement to Vote. Sponsor, with respect to the Shares, hereby agrees (and agrees to execute such documents or certificates evidencing such agreement as Purchaser and/or the Company may reasonably request in connection therewith) to vote at any meeting of the stockholders of Purchaser, and in any action by written consent of the stockholders of Purchaser, to approve the BIBCA, all of the Shares (a) in favor of the approval and adoption of the BIBCA, the transactions contemplated by the BIBCA and this Agreement, (b) in favor of any other matter reasonably necessary to the consummation of the transactions contemplated by the BIBCA and considered and voted upon by the stockholders of Purchaser (including the Purchaser Stockholder Approval Matters), (c) in favor of the approval and adoption of the Incentive Plan, (d) for the appointment, and designation of classes, of the members of the Post-Closing Purchaser Board and (e) against any action, agreement or transaction (other than the BIBCA or the transactions contemplated thereby) or proposal that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of Purchaser under the BIBCA or that would reasonably be expected to result in the failure of the transactions contemplated by the BIBCA from being consummated. Sponsor acknowledges receipt and review of a copy of the BIBCA.

 

     

 

2. Transfer of Shares. Sponsor agrees that it shall not, directly or indirectly, except as otherwise contemplated pursuant to the BIBCA, (a) sell, assign, transfer (including by operation of law), redeem, lien, pledge, distribute, dispose of or otherwise encumber any of the Shares or otherwise agree to do any of the foregoing (unless the transferee agrees to be bound by this Agreement), (b) deposit any Shares into a voting trust, enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, (c) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer (including by operation of law), redemption or other disposition of any Shares (unless the transferee agrees to be bound by this Agreement) or (d) take any action that would have the effect of preventing or disabling Sponsor from performing its obligations hereunder. From time to time, at the request of Purchaser, Sponsor shall take all such further actions as may be necessary or appropriate to effect the purposes of this Agreement, and execute customary documents incident to the consummation of the Business Combination.

 

3. Representations and Warranties. Sponsor represents and warrants for and on behalf of itself to Purchaser and the Company as follows:

 

(a) The execution, delivery and performance by Sponsor of this Agreement and the consummation by Sponsor of the transactions contemplated hereby do not and will not (i) conflict with or violate any Law or Order applicable to Sponsor, (ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person or entity, (iii) result in the creation of any Lien on any Shares (other than pursuant to this Agreement or transfer restrictions under applicable securities laws or the Organizational Documents of Sponsor), or (iv) conflict with or result in a breach of or constitute a default under any provision of Sponsor’s Organizational Documents.

 

(b) Sponsor owns of record and has good, valid and marketable title to the Shares free and clear of any Lien (other than pursuant to this Agreement or transfer restrictions under applicable securities Laws or the Organizational Documents of Sponsor) and has the sole power (as currently in effect) to vote and has the full right, power and authority to sell, transfer and deliver such Shares. Sponsor does not own, directly or indirectly, any other shares of Purchaser capital stock other than the Shares, or any options, warrants or other rights to acquire any additional shares of the capital stock of Purchaser or any security exercisable for or convertible into the capital stock of Purchaser.

 

(c) Sponsor has the power, authority and capacity to execute, deliver and perform this Agreement, and this Agreement has been duly authorized, executed and delivered by Sponsor.

 

(d) There is no Action pending, or, to the knowledge of Sponsor, threatened, against Sponsor that would reasonably be expected to materially impair or materially adversely affect the ability of Sponsor to perform its obligations hereunder or to consummate the transactions contemplated by this Agreement.

 

2

 

4. Other Covenants and Agreements.

 

(a) At the Effective Time, Sponsor will deliver to Purchaser a duly executed copy of the Lock-Up Agreement and Registration Rights Agreement in substantially the forms attached as Exhibits B and E to the BIBCA.

 

(b) Sponsor agrees to and shall be bound by and subject to Section 7.15 (Confidential Information) and Section 7.14 (Public Announcements), Section 7.6 (No Solicitation), and Section 11.1 (Waiver of Claims Against Trust) of the BIBCA to the same extent as such provisions apply to the parties to the BIBCA, as if Sponsor is directly party thereto.

 

(c) Sponsor hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent from the Business Combination that Sponsor may have by virtue of ownership of the Shares and agrees not to commence or participate in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the BIBCA or the consummation of the Business Combination.

 

5. Termination. This Agreement and the obligations of Sponsor under this Agreement shall automatically terminate upon the earliest of: (a) the Effective Time; (b) the termination of the BIBCA in accordance with its terms; or (c) the mutual written agreement of the Company and Purchaser. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, such termination or expiration shall not relieve any party from liability for any willful breach of this Agreement occurring prior to its termination.

 

6. Miscellaneous.

 

(a) Except as otherwise provided herein or in the BIBCA or any Ancillary Document, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or not the transactions contemplated hereby are consummated.

 

(b) All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by telecopy, e-mail, facsimile or other electronic means, with affirmative confirmation of receipt, one (1) Business Day after being sent, if sent by reputable, nationally recognized overnight courier service, or three (3) Business Days after being mailed, if sent by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 6(b)):

 

If to the Purchaser, to:

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, CA 90292

Attention: J. Gerald Combs, CEO

Telephone: (917) 675-2537

E-mail: gerry@cgcombs.com

 

3

 

with a copy to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie A. Klis, Esq.

Telephone: (202) 935-3390

E-mail: deborrah.klis@rimonlaw.com

 

If to the Sponsor, to:

 

Canna-Global LLC

4640 Admiralty Way, Suite 500

Marina Del Rey, CA 90292

Attention: J. Gerald Combs

Telephone: (917) 675-2537

E-mail: gerry@cgcombs.com

 

with a copy to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie A. Klis, Esq.

Telephone: (202) 935-3390

E-mail: deborrah.klis@rimonlaw.com

 

If to the Company, to:

 

New Quantum Holdings Pty Ltd

Level 21, 207 Kent St

Sydney, New South Wales, Australia, 2000

Attention: Jong Chung, Managing Director

Telephone: +61 430 228 328

E-mail: jong@newquantum.com

 

with a copy to:

 

K&L Gates

Level 31, 1 O’Connell Street
Sydney NSW 2000, Australia

Attention: Russell Lyons

Telephone: +61 2 9513 2510

E-mail: Russell.Lyons@klgates.com

 

4

 

(c) If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

 

(d) This Agreement, the BIBCA and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise).

 

(e) This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

(f) The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement was not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any such Order.

 

(g) This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”) arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction within the State of Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in Section 6(b). Nothing in this Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

5

 

(h) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.

 

(i) This Agreement may be executed and delivered (including by facsimile or portable document format (pdf) transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

 

(j) Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by this Agreement.

 

(k) This Agreement shall not be effective or binding upon Sponsor until such time as the BIBCA is executed by each of the parties thereto.

 

(l) If, and as often as, there are any changes in Purchaser or the Purchaser Common Stock by way of stock split, stock dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means, equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and obligations hereunder shall continue with respect to Purchaser, Sponsor and the Shares as so changed.

 

(m) The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 

(n) Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Purchaser, the Company and the Sponsor. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 

[Signature pages follow]

 

6

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

  PURCHASER:
     
  CANNA-GLOBAL ACQUISITION CORP.
     
  By:

                     

  Name:  
  Title:  
     
  SPONSOR:
     
  CANNA-GLOBAL LLC
     
  By:  
  Name:  
  Title:  
     
  COMPANY:
     
  NEW QUANTUM HOLDINGS PTY LTD
     
  By:

 

  Name:  
  Title:  

 

[Signature Page to Sponsor Support Agreement]

 

     

 

EX-2.2 4 ex2-2.htm

 

Exhibit 2.2

 

Exhibit B

 

LOCK-UP AGREEMENT

 

This LOCK-UP AGREEMENT (this “Agreement”), is made and entered into as of [date], 2023, by and between (i) Canna-Global Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) the Shareholder of New Quantum Holdings Pty Ltd, an Australian Company with Australian Company Number (ACN) 628 253 743 listed at Annexure 1 (the “Subject Party”). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BIBCA (as defined below).

 

WHEREAS, contemporaneously herewith, the Purchaser, the Company, J. Gerald Combs, solely in his capacity as representative from and after the Effective Time (as defined in the BIBCA) for the stockholders of the Purchaser (the “Purchaser Representative”), Hyun Jong Chung, solely in his capacity as the representative from and after the Effective Time (as defined in the BIBCA) for the Company in accordance with the terms and conditions of the BIBCA (the “Company Representative”), have entered into that certain Bid Implementation and Business Combination Agreement (the “BIBCA”), pursuant to which Purchaser proposes to acquire all of the Company Shares (as defined in the BIBCA) by way of a Takeover Bid and to effect a business combination transaction whereby upon the terms and subject to the conditions of the BIBCA (the “Business Combination”), all of the issued and outstanding ordinary shares of the Company immediately prior to the Effective Time of the Business Combination shall be exchanged for the Takeover Offer Consideration;

 

WHEREAS, pursuant to the BIBCA, and in view of the valuable consideration to be received by the Subject Party thereunder, the parties desire to enter into this Agreement, pursuant to which the Purchaser Common Stock received by the Subject Party in the Business Combination (all such securities, together with any securities paid as dividends or distributions with respect to such securities or into which such securities are exchanged or converted, the “Restricted Securities”) shall become subject to limitations on disposition as set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:

 

1. Lock-Up Provisions.

 

(a) The Subject Party hereby agrees not to (i) lend, offer, pledge, hypothecate, encumber, donate, assign, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Restricted Securities, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Restricted Securities, or (iii) publicly disclose the intention to do any of the foregoing, whether any such transaction described in clauses (i), (ii), or (iii) above is to be settled by delivery of Restricted Securities or other securities, in cash or otherwise (any of the foregoing described in clauses (i), (ii), or (iii), a “Prohibited Transfer”) for the duration of the “Lock-Up Period”, as follows:

 

 

 

i) in relation to 100% of the Restricted Securities, for the period commencing on and from the Closing and ending twelve (12) months after the date of the Closing (the “Initial Lock-up Period”); and

 

ii) once the Initial Lock-up Period has expired, in relation to 25% of the Restricted Securities, for the period commencing on and from the end of the Initial Lock-Up Period and ending six (6) months after that date, (together, the “Lock-up Period”).

 

(b) The foregoing shall not apply to the transfer of any or all of the Restricted Securities (I) to any Permitted Transferee or (II) pursuant to a court order or settlement agreement related to the distribution of assets in connection with the dissolution of marriage or civil union; provided, however, that in either of cases (I) or (II), it shall be a condition to such transfer that such transfer complies with the Securities Act of 1933, as amended, and other applicable law, and that the transferee executes and delivers to the Purchaser an agreement stating that the transferee is receiving and holding the Restricted Securities subject to the provisions of this Agreement applicable to the Subject Party, and there shall be no further transfer of such Restricted Securities except in accordance with this Agreement. As used in this Agreement, the term “Permitted Transferee” shall mean: (1) the members of the Subject Party’s immediate family (for purposes of this Agreement, “immediate family” shall mean with respect to any natural person, any of the following: such person’s spouse or domestic partner, the siblings of such person and his or her spouse or domestic partner, and the direct descendants and ascendants (including adopted and step children and parents) of such person and his or her spouses or domestic partners and siblings), (2) any trust for the direct or indirect benefit of the Subject Party or the immediate family of the Subject Party, (3) if the Subject Party is a trust, to the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust, (4) in the case of an entity, officers, directors, general partners, limited partners, members, or stockholders of such entity that receive such transfer as a distribution, or related investment funds or vehicles controlled or managed by such persons or their respective affiliates, (5) to any affiliate of the Subject Party, (6) any transferee whereby there is no change in beneficial ownership, (7) to a third-party who receives the Subject Party’s Restricted Securities as part of a share exchange, notwithstanding Section 2(a)(iii), provided that the purpose of the share exchange is the furtherance of the Company’s business and is assented to by the Company, and the recipient party agreed to be bound by the terms as those contained in this Agreement. The Subject Party further agrees to execute such agreements as may be reasonably requested by the Purchaser that are consistent with the foregoing or that are necessary to give further effect thereto.

 

(c) If any Prohibited Transfer is made or attempted contrary to the provisions of this Agreement, such purported Prohibited Transfer shall be null and void ab initio, and the Purchaser shall refuse to recognize any such purported transferee of the Restricted Securities as one of its equity holders for any purpose, and shall refuse to record any such purported transfer of the Restricted Securities in the books of the Company. In order to enforce the terms of this Section 1, the Purchaser may impose stop-transfer instructions with respect to the Restricted Securities of the Subject Party (and Permitted Transferees and assigns thereof) until the end of the Lock-Up Period.

 

2

 

(d) During the Lock-Up Period, each certificate evidencing any Restricted Securities shall be stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●], 2023, BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN, AS AMENDED TO DATE. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”

 

(e) For the avoidance of any doubt, the Subject Party shall retain all of its rights as a stockholder of the Purchaser during the Lock-Up Period, including the right to vote any Restricted Securities.

 

(f) The foregoing notwithstanding, to the extent any Subject Party is granted a release or waiver from the restrictions contained in this Section 1 prior to the expiration of the Lock-Up Period, then all Subject Parties shall be automatically granted a release or waiver from the restrictions contained in this Section to the same extent, on substantially the same terms as and on a pro rata basis with, the Subject Party to which such release or waiver is granted.

 

2. Miscellaneous.

 

(a) Binding Effect; Assignment. This Agreement and all of the provisions herein shall be binding upon and inure to the benefit of the parties hereto and their respective permitted successors and assigns. This Agreement and all rights and obligations of a party are personal and may not be transferred or delegated at any time. Notwithstanding the foregoing, the Purchaser may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether by merger, consolidation, equity sale, asset sale, or otherwise) without obtaining the consent or approval of the Subject Party. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision herein be enforced by, any other person.

 

(b) Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not a party hereto or thereto or a successor or permitted assign of such a party.

 

(c) Governing Law; Jurisdiction. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. All Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in the State of Delaware (or in any appellate courts thereof) (the “Specified Courts”). Each party hereto hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in Section 2(f). Nothing in this Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

3

 

(d) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.

 

(e) Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 

(f) Notices. All notices, consents, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one (1) Business Day after being sent, if sent by reputable, nationally recognized overnight courier service, or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):

 

4

 

If to the Purchaser to:

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, CA 90292

Attention: J. Gerald Combs, CEO

Tel: (917) 675-2537

E-mail: gerry@cgcombs.com

 

If to the Company to:

 

New Quantum Holdings Pty Ltd

Level 21, 207 Kent St

Sydney, New South Wales, Australia, 2000

Attention: Jong Chung, Managing Director

Telephone: +61 430 228 328

E-mail: jong@newquantum.com

with a copy to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie A. Klis, Esq.

Tel: (202) 935-3390

E-mail: deborrah.klis@rimonlaw.com;

 

with a copy to:

 

K&L Gates

Level 31, 1 O’Connell Street

Sydney NSW 2000, Australia

Attention: Russell Lyons

Telephone: +61 2 9513 2510

E-mail: Russell.Lyons@klgates.com

 

If to the Subject Party, to the address set forth below the Subject Party’s name on the signature page to this Agreement.

 

(g) Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Purchaser and the Subject Party. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 

(h) Authorization on Behalf of the Purchaser. The parties acknowledge and agree that notwithstanding anything to the contrary contained in this Agreement, any and all determinations, actions, or other authorizations under this Agreement on behalf of the Purchaser, including enforcing the Purchaser’s rights and remedies under this Agreement, or providing any waivers with respect to the provisions hereof, shall solely be made, taken, and authorized by a majority of the disinterested independent directors of the Purchaser’s board of directors. In the event that the Purchaser at any time does not have any disinterested directors, so long as the Subject Party has any remaining obligations under this Agreement, the Purchaser will promptly appoint one in connection with this Agreement. Without limiting the foregoing, in the event that an affiliate of a Subject Party serves as a director, officer, employee, or other authorized agent of the Purchaser or any of its current or future affiliates, neither the Subject Party nor its affiliate shall have authority, express or implied, to act or make any determination on behalf of the Purchaser or any of its current or future affiliates in connection with this Agreement or any dispute or Action with respect hereto.

 

5

 

(i) Severability. In case any provision in this Agreement shall be held invalid, illegal, or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal, and enforceable, and the validity, legality, and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality, or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or incapable of being enforced, the parties will substitute for any invalid, illegal, or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal, and enforceable, the intent and purpose of such invalid, illegal, or unenforceable provision.

 

(j) Specific Performance. Each party acknowledges that its obligations under this Agreement are unique, recognizes and affirms that, in the event of a breach of this Agreement, money damages will be inadequate and there will be no adequate remedy at law, and agrees that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the adversely affected party or parties shall be entitled to an injunction or restraining order to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security, this being in addition to any other right or remedy available under this Agreement, at law or in equity.

 

(k) Entire Agreement. This Agreement, the BIBCA and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies or any of the obligations of the parties hereto under any other agreement between a Subject Party and the Purchaser or any certificate or instrument delivered in connection with the Transactions, and nothing in any other agreement, certificate, or instrument shall limit any of the rights or remedies or any of the obligations under this Agreement.

 

(l) Further Assurances. From time to time, at another party’s request and without further consideration (but at the requesting party’s reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

 

(m) Counterparts; Facsimile. This Agreement may also be executed and delivered by facsimile signature or by email in portable document format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

[Signature Pages Follow]

 

6

 

IN WITNESS WHEREOF, the parties have executed this Lock-Up Agreement as of the date first written above.

 

  PURCHASER:
   
  CANNA-GLOBAL ACQUISITION CORP.
   
  By:                     
  Name:  
  Title:  

 

[Signature Page to Lock-Up Agreement]

 

Annexure 1- Subject Party details

 

Subject Party

 

 
Restricted Securities  
Notice details

[insert contact name]

Email: [insert email address]

 

Dated:__________________________

 

CHOOSE ONE SIGNING CLAUSE

 

Signed by Shareholder - Individual in the presence of:    
    Signature
     
Signature of witness    
     
     

Name of witness

(please print)

   

 

Executed by Shareholder - Company in accordance with section 127(1) of the Corporations Act 2001 (Cth):    
     
     
Signature of director  

Signature of director or secretary*

*delete whichever does not apply

     
     
Name (please print)   Name (please print)

 

[Signature Page to Lock-Up Agreement]

EX-2.3 5 ex2-3.htm

 

Exhibit 2.3

 

Execution Copy

Exhibit C

 

NON-COMPETITION AND NON-SOLICITATION AGREEMENT

 

This NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this “Agreement”), is made and entered into as of ____, 2023, by and between the undersigned (the “Subject Party”), a shareholder of New Quantum Holdings Pty Ltd, an Australian company with Australian Company Number (ACN) 628 253 743 (the “Company”), in favor of and for the benefit of Canna-Global Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and each of the Purchaser’s Affiliates (as defined in the BIBCA (as defined below)), successors, and direct and indirect Subsidiaries (as defined in the BIBCA) (collectively with the Purchaser, the “Covered Parties”). Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to such terms in the BIBCA (as defined herein).

 

WHEREAS, contemporaneously herewith, the Purchaser, Company, J. Gerald Combs, solely in his capacity as representative from and after the Effective Time (as defined in BIBCA) for the stockholders of the Purchaser (the “Purchaser Representative”), Hyun Jong Chung, solely in his capacity as the representative from and after Effective Time for the Company (the “Company Representative”), have entered into that certain Bid Implementation and Business Combination Agreement (the “BIBCA”), pursuant to which Purchaser proposes to acquire all of the Company Securities by way of a Takeover Bid and to effect a business combination transaction whereby upon the terms and subject to the conditions of the BIBCA (the “Business Combination”), all of the issued and outstanding ordinary shares of the Company immediately prior to the Effective Time of the Business Combination shall be exchanged for the Takeover Offer Consideration, all upon the terms and subject to the conditions set forth in the BIBCA;

 

WHEREAS, the Company directly and indirectly through its subsidiaries, is a provider of a core and digital wealth management platform that offers Software-as-a-Service products to manage investment portfolios efficiently for the financial services industry (the “Business”);

 

WHEREAS, in connection with, and as a condition to the consummation of the Business Combination and the other transactions contemplated by the BIBCA (the “Transactions”), and to enable the Purchaser to secure more fully the benefits of the Transactions, including the protection and maintenance of the goodwill and confidential information of the Company, the Purchaser has required that the Subject Party enter into this Agreement;

 

WHEREAS, the Subject Party is entering into this Agreement in order to induce the Purchaser to consummate the Transactions, pursuant to which the Subject Party will directly or indirectly receive a material benefit; and

 

WHEREAS, the Subject Party has contributed to the value of the Company and has obtained extensive and valuable knowledge and confidential information concerning the Company and the Business.

 

 
 

 

NOW, THEREFORE, in order to induce the Purchaser to consummate the Transactions, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Subject Party hereby agrees as follows:

 

1. Restriction on Competition.

 

(a) Restriction. The Subject Party hereby agrees that during the period from the Closing until the three (3) year anniversary of the Closing Date (the “Termination Date,” and such period from the Closing until the Termination Date, the “Restricted Period”), the Subject Party will not, and will cause its Affiliates not to, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), (i) anywhere in Australia, and (ii) in any other jurisdictions in which the Covered Parties are engaged, or are actively contemplating to become engaged, in the Business as of the Closing Date or during the Restricted Period (clauses (i) and (ii), collectively, the “Territory”), directly or indirectly engage in the Business (other than through a Covered Party) or own, manage, finance, or control, or participate in the ownership, management, financing, or control of, or become engaged or serve as an officer, director, member, partner, employee, agent, consultant, advisor, or representative of, a business or entity (other than a Covered Party) that engages in the Business (a “Competitor”). Notwithstanding the foregoing, the Subject Party and its Affiliates may own passive investments of no more than two percent (2%) of any class of outstanding equity interests in a Competitor that is publicly traded, so long as the Subject Party and its Affiliates and immediate family members are not involved in the management or control of such Competitor (“Permitted Ownership”).

 

(b) Acknowledgment. The Subject Party acknowledges and agrees that (i) the Subject Party possesses knowledge of confidential information of the Company and the Business, (ii) the Subject Party’s execution of this Agreement is a material inducement to the Purchaser to consummate the Transactions and to realize the goodwill of the Company, for which the Subject Party and/or its Affiliates will receive a substantial direct or indirect financial benefit, and that the Purchaser would not have entered into the BIBCA or consummated the Transactions but for the Subject Party’s agreements set forth in this Agreement, (iii) it would substantially impair the goodwill of the Company and materially reduce the value of the assets of the Company and cause serious and irreparable injury if the Subject Party were to use its ability and knowledge by engaging in the Business in competition with a Covered Party, and/or to otherwise breach the obligations contained herein and that the Covered Parties would not have an adequate remedy at law because of the unique nature of the Business, (iv) the Subject Party and its Affiliates have no intention of engaging in the Business (other than through the Covered Parties) during the Restricted Period other than through Permitted Ownership, (v) the relevant public policy aspects of restrictive covenants, covenants not to compete, and non-solicitation provisions have been discussed, and every effort has been made to limit the restrictions placed upon the Subject Party to those that are reasonable and necessary to protect the Covered Parties’ legitimate interests, (vi) the Covered Parties conduct and intend to conduct the Business everywhere in the Territory and compete with other businesses that are or could be located in any part of the Territory, (vii) the foregoing restrictions on competition are fair and reasonable in type of prohibited activity, geographic area covered, scope, and duration, (viii) the consideration provided to the Subject Party under this Agreement and the BIBCA is not illusory, and (ix) such provisions do not impose a greater restraint than is necessary to protect the goodwill or other business interests of the Covered Parties.

 

2
 

 

2. No Solicitation; No Disparagement.

 

(a) No Solicitation of Employees and Consultants. The Subject Party agrees that, during the Restricted Period, the Subject Party will not, and will not permit its Affiliates to, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), either on its own behalf or on behalf of any other Person (other than, if applicable, a Covered Party in the performance of the Subject Party’s duties on behalf of the Covered Parties), directly or indirectly: (i) hire or engage as an employee, independent contractor, consultant, or otherwise any Covered Personnel (as defined below); (ii) solicit, induce, encourage, or otherwise knowingly cause (or attempt to do any of the foregoing) any Covered Personnel to leave the service (whether as an employee, consultant, or independent contractor) of any Covered Party; or (iii) in any way interfere with or attempt to interfere with the relationship between any Covered Personnel and any Covered Party; provided, however, the Subject Party and its Affiliates will not be deemed to have violated this Section 2(a) if any Covered Personnel voluntarily and independently solicits an offer of employment from the Subject Party or any of its Affiliates by responding to a general advertisement or solicitation program conducted by or on behalf of the Subject Party or any of its Affiliates (or such other Person on whose behalf any of them is acting) that is not targeted at such Covered Personnel or Covered Personnel generally, so long as such Covered Personnel are not hired. For purposes of this Agreement, “Covered Personnel” shall mean any Person who is or was an employee, consultant, or independent contractor of the Covered Parties, as of the Closing Date, at any time during the Restricted Period, or as of the relevant time of determination.

 

(b) Non-Solicitation of Customers and Suppliers. The Subject Party agrees that, during the Restricted Period, the Subject Party and its Affiliates will not, without the prior written consent of the Purchaser (which may be withheld in its sole discretion), individually or on behalf of any other Person (other than, if applicable, a Covered Party in the performance of the Subject Party’s duties on behalf of the Covered Parties), knowingly and for a purpose competitive with a Covered Party as it related to the Business: (i) solicit, induce, encourage, or otherwise knowingly cause (or attempt to do any of the foregoing) any Covered Customer (as defined below) to (A) cease being, or not become, a client or customer of any Covered Party with respect to the Business or (B) reduce the amount of business of such Covered Customer with any Covered Party, or otherwise alter such business relationship in a manner adverse to any Covered Party, in either case, with respect to or relating to the Business; (ii) interfere with or disrupt (or attempt to interfere with or disrupt) the contractual relationship between any Covered Party and any Covered Customer; (iii) divert any business with any Covered Customer relating to the Business from a Covered Party; (iv) solicit for business, provide services to, engage in or do business with, any Covered Customer for products or services that are part of the Business; or (v) interfere with or disrupt (or attempt to interfere with or disrupt), any Person that was a vendor, supplier, distributor, agent, or other service provider of a Covered Party at the time of such interference or disruption. For purposes of this Agreement, a “Covered Customer” shall mean any Person who is or was an actual customer or client (or prospective customer or client with whom a Covered Party actively marketed or made or taken specific action to make a proposal) of a Covered Party, as of the Closing Date, at any time during the Restricted Period, or as of the relevant time of determination.

 

(c) Mutual Non-Disparagement. The Subject Party and the Covered Parties each agrees that neither will, and each will cause its respective Affiliates not to, directly or indirectly engage in any conduct that involves the making or publishing (including through electronic mail distribution or online social media) of any written or oral statements or remarks (including the repetition or distribution of derogatory rumors, allegations, negative reports, or comments) that are disparaging, deleterious, or damaging to the integrity, reputation, or good will of the other or their respective management, officers, employees, independent contractors, or consultants. Notwithstanding the foregoing, subject to Section 3 below, the provisions of this Section 2(c) shall not restrict the Subject Party or the Covered Parties from providing truthful testimony or information in response to a subpoena or investigation by a Governmental Authority or in connection with any legal action under this Agreement, the BIBCA, or any other Ancillary Document that is asserted in good faith.

 

3
 

 

3. Confidentiality. From and after the Closing Date, the Subject Party will, and will cause its Representatives (as defined in the BIBCA) to, keep confidential and not (except, if applicable, in the performance of the Subject Party’s duties on behalf of the Covered Parties) directly or indirectly use, disclose, reveal, publish, transfer, or provide access to, any and all Covered Party Information without the prior written consent of the Purchaser (which may be withheld in its sole discretion). As used in this Agreement, “Covered Party Information” means all material and information relating to the Business, including material and information that concerns or relates to such Covered Party’s bidding and proposal, technical, computer hardware or software, administrative, management, operational, data processing, financial, marketing, sales, human resources, business development, planning, and/or other business activities, regardless of whether such material and information is maintained in physical, electronic, or other form, that is: (A) gathered, compiled, generated, produced, or maintained by such Covered Party through its Representatives, or provided to such Covered Party by its suppliers, service providers, or customers; and (B) intended and maintained by such Covered Party or its Representatives, suppliers, service providers, or customers to be kept in confidence. The obligations set forth in this Section 3 will not apply to any Covered Party Information where the Subject Party can prove that such material or information: (i) is known or available through other lawful sources not bound by a confidentiality agreement with, or other confidentiality obligation to, any Covered Party; (ii) is or becomes publicly known through no violation of this Agreement or other non-disclosure obligation of the Subject Party or any of its Representatives; (iii) is already in the possession of the Subject Party at the time of disclosure through lawful sources not bound by a confidentiality agreement or other confidentiality obligation as evidenced by the Subject Party’s documents and records; or (iv) is required to be disclosed pursuant to an order of any administrative body or court of competent jurisdiction (provided that (A) the applicable Covered Party is given reasonable prior written notice, (B) the Subject Party cooperates (and causes its Representatives to cooperate) with any reasonable request of any Covered Party to seek to prevent or narrow such disclosure and (C) if after compliance with clauses (A) and (B) such disclosure is still required, the Subject Party and its Representatives only disclose such portion of the Covered Party Information that is expressly required by such order, as it may be subsequently narrowed).

 

4. Representations and Warranties. The Subject Party hereby represents and warrants, to and for the benefit of the Covered Parties as of the date of this Agreement and as of the Closing Date, that: (a) the Subject Party has full power and capacity to execute and deliver, and to perform all of the Subject Party’s obligations under, this Agreement; and (b) neither the execution and delivery of this Agreement nor the performance of the Subject Party’s obligations hereunder will result directly or indirectly in a violation or breach of any agreement or obligation by which the Subject Party is a party or otherwise bound. By entering into this Agreement, the Subject Party certifies and acknowledges that the Subject Party has carefully read all of the provisions of this Agreement, and that the Subject Party voluntarily and knowingly enters into this Agreement.

 

4
 

 

5. Remedies. The covenants and undertakings contained in this Agreement relate to matters which are of a special, unique, and extraordinary character and a violation of any of the terms of this Agreement may cause irreparable injury, the amount of which may be impossible to estimate or determine and which cannot be adequately compensated. In the event of any breach or threatened breach of any covenant or obligation contained in this Agreement, the adversely affected party or parties will be entitled to seek the following remedies (in addition to, and not in lieu of, any other remedy at law or in equity or pursuant to the BIBCA or the other Ancillary Documents that may be available, including monetary damages), and a court of competent jurisdiction may award: (i) an injunction, restraining order, or other equitable relief restraining or preventing such breach or threatened breach, without the necessity of posting bond or security, which each party expressly waives; and (ii) recovery of attorneys’ fees and costs incurred in enforcing the party’s rights under this Agreement. The Subject Party hereby acknowledges and agrees that in the event of any breach of this Agreement, any value attributed or allocated to this Agreement (or any other non-competition agreement with the Subject Party) under or in connection with the BIBCA shall not be considered a measure of, or a limit on, the damages of the Covered Parties.

 

6. Survival of Obligations. The expiration of the Restricted Period will not relieve the Subject Party of any obligation or liability arising from any breach by the Subject Party of this Agreement during the Restricted Period. The Subject Party further agrees that the time periods during which the covenants contained in this Agreement will be effective will be computed by excluding from such computation any time during which the Subject Party is in violation of any provision of such Sections.

 

7. Miscellaneous.

 

(a) Notices. All notices, consents, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):

 

If to the Purchaser to:

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, CA 90292

Attention: J. Gerald Combs, CEO

Telephone: (917) 675-2537

E-mail: gerry@cgcombs.com

with a copy to:

 

Rimon, P.C.
1990 K Street NW, Suite 420

Washington, DC 20006

Attention: Debbie A. Klis, Esq.

Telephone: (202) 935-3390

E-mail: deborrah.klis@rimonlaw.com

 

If to the Subject Party, to the address set forth below the Subject Party’s name on the signature page to this Agreement.

 

5
 

 

(b) Integration and Non-Exclusivity. This Agreement, the BIBCA, and the other Ancillary Documents contain the entire agreement between the Subject Party and the Covered Parties concerning the subject matter hereof. Notwithstanding the foregoing, the rights and remedies of the Covered Parties under this Agreement are not exclusive of or limited by any other rights or remedies which they may have, whether at law, in equity, by contract or otherwise, all of which will be cumulative (and not alternative). Without limiting the generality of the foregoing, the rights, remedies, obligations, and liabilities of the parties under this Agreement are in addition to their respective rights, remedies, obligations, and liabilities (i) under the laws of unfair competition, misappropriation of trade secrets, or other requirements of statutory or common law, or any applicable rules and regulations and (ii) otherwise conferred by contract, including the BIBCA and any other written agreement between the Subject Party or its Affiliates and any of the Covered Parties. Nothing in the BIBCA will limit any of the obligations, liabilities, rights, or remedies of the Subject Party or the Covered Parties under this Agreement, nor will any breach of the BIBCA or any other agreement between the Subject Party or its Affiliates and any of the Covered Parties limit or otherwise affect any right or remedy under this Agreement. If any covenant set forth in any other agreement between the Subject Party or its Affiliates and any of the Covered Parties conflicts or is inconsistent with the terms and conditions of this Agreement, the more restrictive terms will control as to the Subject Party or its Affiliate, as applicable.

 

(c) Severability; Reformation. Each provision of this Agreement is separable from every other provision of this Agreement. If any provision of this Agreement is found or held to be invalid, illegal, or unenforceable, in whole or in part, by a court of competent jurisdiction, then (i) such provision will be deemed amended to conform to applicable laws so as to be valid, legal, and enforceable to the fullest possible extent, (ii) the invalidity, illegality, or unenforceability of such provision will not affect the validity, legality, or enforceability of such provision under any other circumstances or in any other jurisdiction, and (iii) the invalidity, illegality, or unenforceability of such provision will not affect the validity, legality, or enforceability of the remainder of such provision or the validity, legality, or enforceability of any other provision of this Agreement. The Subject Party and the Covered Parties will substitute for any invalid, illegal, or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal, and enforceable, the intent and purpose of such invalid, illegal, or unenforceable provision. Without limiting the foregoing, if any court of competent jurisdiction determines that any part hereof is unenforceable because of the duration, geographic area covered, scope of such provision, or otherwise, such court will have the power to reduce the duration, geographic area covered, or scope of such provision, as the case may be, and, in its reduced form, such provision will then be enforceable. The Subject Party will, at a Covered Party’s request, join such Covered Party in requesting that such court take such action.

 

(d) Specific Performance. Each party acknowledges that its obligations under this Agreement are unique, recognizes and affirms that, in the event of a breach of this Agreement, money damages will be inadequate and there will be no adequate remedy at law, and agrees that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the adversely affected party or parties shall be entitled to an injunction or restraining order to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security, this being in addition to any other right or remedy available under this Agreement, at law or in equity.

 

6
 

 

(e) Amendment; Waiver. This Agreement may not be amended or modified in any respect, except by a written agreement executed by the Subject Party, the Purchaser, and a majority of the disinterested independent directors of the Purchaser’s board of directors (or their respective permitted successors or assigns). No waiver will be effective unless it is expressly set forth in a written instrument executed by the waiving party (and if such waiving party is a Covered Party, by a majority of the disinterested independent directors of the Purchaser’s board of directors) and any such waiver will have no effect except in the specific instance in which it is given. Any delay or omission by a party in exercising its rights under this Agreement, or failure to insist upon strict compliance with any term, covenant, or condition of this Agreement will not be deemed a waiver of such term, covenant, condition, or right, nor will any waiver or relinquishment of any right or power under this Agreement at any time or times be deemed a waiver or relinquishment of such right or power at any other time or times.

 

(f) Dispute Resolution. Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent injunction or other equitable relief or application for enforcement of a resolution under this Section 7(f), arising out of, related to, or in connection with this Agreement or the transactions contemplated hereby (a “Dispute”) shall be governed by this Section 7(f). A party must, in the first instance, provide written notice of any Disputes to the other parties subject to such Dispute, which notice must provide a reasonably detailed description of the matters subject to the Dispute. The parties involved in such Dispute shall seek to resolve the Dispute on an amicable basis within twenty (20) Business Days of the notice of such Dispute being received by such other parties subject to such Dispute (the “Resolution Period”); provided, that if any Dispute would reasonably be expected to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence of such Dispute, then there shall be no Resolution Period with respect to such Dispute. Any Dispute that cannot be resolved during the Resolution Period may immediately be referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined in the AAA Procedures) of the Commercial Arbitration Rules (the “AAA Procedures”) of the AAA. Any party involved in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted by one arbitrator nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to the AAA and reasonably acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration process promptly (but in any event within five (5) Business Days) after his or her nomination and acceptance by the Parties subject to the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive law of the state of Delaware. Time is of the essence. Each party subject to the Dispute shall submit a proposal for resolution of the Dispute to the arbitrator within twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the power to order any party to do, or to refrain from doing, anything consistent with this Agreement, the Ancillary Documents and applicable Law, including to perform its contractual obligation(s); provided, that the arbitrator shall be limited to ordering pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant party (or Parties, as applicable) to comply with only one or the other of the proposals. The arbitrator’s award shall be in writing and shall include a reasonable explanation of the arbitrator’s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in Sydney, New South Wales, Australia. The language of the arbitration shall be English.

 

7
 

 

(g) Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”) arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction within the State of Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in Section 7(a). Nothing in this Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

(h) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.

 

(i) Successors and Assigns; Third Party Beneficiaries. This Agreement will be binding upon, and will inure to the benefit of the parties, and their respective successors and assigns. No Covered Party may assign any or all of its rights under this Agreement, at any time, in whole or in part, to any Person without first obtaining the consent or approval of the Subject Party (which consent shall not be unreasonably withheld, conditioned or delayed). The Subject Party agrees that the obligations of the Subject Party under this Agreement are specific to each of them and will not be assigned by the Subject Party.

 

8
 

 

(j) Disinterested Director Majority Authorized to Act on Behalf of Covered Parties. The parties acknowledge and agree that notwithstanding anything to the contrary contained in this Agreement, any and all determinations, actions, or other authorizations under this Agreement on behalf of the Purchaser, including enforcing the Purchaser’s rights and remedies under this Agreement, or providing any waivers with respect to the provisions hereof, shall solely be made, taken, and authorized by a majority of the disinterested independent directors of the Purchaser’s board of directors. In the event that the Purchaser at any time does not have any disinterested directors, so long as the Subject Party has any remaining obligations under this Agreement, the Purchaser will promptly appoint one in connection with this Agreement. Without limiting the foregoing, in the event that an affiliate of a Subject Party serves as a director, officer, employee, or other authorized agent of the Purchaser or any of its current or future affiliates, neither the Subject Party nor its affiliate shall have authority, express or implied, to act or make any determination on behalf of the Purchaser or any of its current or future affiliates in connection with this Agreement or any dispute or Action with respect hereto.

 

(k) Construction. The Subject Party acknowledges that the Subject Party has been represented by counsel, or had the opportunity to be represented by counsel of the Subject Party’s choice. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party will not be applied in the construction or interpretation of this Agreement. Neither the drafting history nor the negotiating history of this Agreement will be used or referred to in connection with the construction or interpretation of this Agreement.

 

(l) Interpretation. The headings and subheadings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. In this Agreement: (i) the words “include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation”; (ii) the definitions contained herein are applicable to the singular as well as the plural forms of such terms; (iii) whenever required by the context, any pronoun shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (iv) the words “herein,” “hereto,” and “hereby” and other words of similar import shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (v) the word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and only if”; (vi) the term “or” means “and/or”; and (vii) any agreement or instrument defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified, or supplemented, including by waiver or consent and references to all attachments thereto and instruments incorporated therein.

 

(m) Counterparts. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. A photocopy, faxed, scanned, and/or emailed copy of this Agreement or any signature page to this Agreement, shall have the same validity and enforceability as an originally signed copy.

 

(n) Effectiveness. This Agreement shall be binding upon the Subject Party upon the Subject Party’s execution and delivery of this Agreement, but this Agreement shall only become effective upon the consummation of the Transactions. In the event that the BIBCA is validly terminated in accordance with its terms prior to the consummation of the Transactions, this Agreement shall automatically terminate and become null and void, and the parties shall have no obligations hereunder.

 

(o) Further Assurances. From time to time, at another party’s request and without further consideration (but at the requesting party’s reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

 

[Signature Pages Follow]

 

9
 

 

IN WITNESS WHEREOF, the undersigned has duly executed and delivered this Non-Competition and Non-Solicitation Agreement as of the date first written above.

 

  SUBJECT PARTY:
     
   
     
  By:  
  Name:  
  Title:  
     
  Address:  
     
   
  E-Mail:  

 

[Signature Page to the Non-Competition Agreement]

 

 
 

 

Acknowledged and accepted as of the date first written above:  
   
PURCHASER:  
   
CANNA-GLOBAL ACQUISITION CORP.  
   
By:    
Name:                
Title:    

 

[Signature Page to the Non-Competition Agreement]

 

 

 

 

 

EX-2.4 6 ex2-4.htm

 

Exhibit 2.4

 

Execution Copy

Exhibit G

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of _____, 2023 (the “Effective Date”) by and among (i) Canna-Global Acquisition Corp., a Delaware corporation (including its successors, the “Purchaser”), (ii) and the undersigned parties listed on Exhibit A hereto (each such party, together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”). Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to such terms in the BIBCA (as defined herein).

 

WHEREAS, contemporaneously herewith, the Purchaser, New Quantum Holdings Pty Ltd, an Australian company with Australian Company Number (ACN) 628 253 743 (the “Company”), J. Gerald Combs, solely in his capacity as representative from and after the Effective Time (as defined in BIBCA) for the stockholders of the Purchaser (the “Purchaser Representative”), and Hyun Jong Chung, solely in his capacity as the representative from and after Effective Time for the Company (the “Company Representative”), have entered into that certain Bid Implementation and Business Combination Agreement (the “BIBCA”), pursuant to which Purchaser proposes to acquire all of the Company Securities by way of a Takeover Bid and to effect a business combination transaction upon the terms and subject to the conditions of the BIBCA (the “Business Combination”);

 

WHEREAS, pursuant to the BIBCA, subject to the terms and conditions thereof, upon the consummation of the transactions contemplated thereby (the “Closing”), among other matters, all of the issued and outstanding ordinary shares of the Company shall be exchanged for Purchaser’s Class A common stock (the “Offer Shares”), all upon the terms and subject to the conditions set forth in the BIBCA and in accordance with the provisions of applicable law;

 

WHEREAS, the Purchaser is a party to that certain Registration Rights Agreement dated as of November 29, 2021, entered into with the Founders with regard to the Founder Securities (each as such term is defined below) (the “Existing Agreement”); and

 

WHEREAS, the parties desire to enter into this Agreement, and terminate the Existing Agreement, to provide the Holders and Founders with certain rights relating to the registration of the Offer Shares and Founder Securities.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1. DEFINITIONS. The following capitalized terms used herein have the following meanings:

 

“Affiliate” means, with respect to any specified Person, any Person that, directly or indirectly through one or more entities, controls or is controlled by, or is under common control with, such specified Person. The term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by Contract or otherwise.

 

 

 

“Agreement” means this Agreement, as amended, restated, supplemented, or otherwise modified from time to time.

 

“Business Combination” means the acquisition of direct or indirect ownership through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar type of transaction, of one or more businesses or entities.

 

“Commission” means the Securities and Exchange Commission, or any other Federal agency then administering the Securities Act or the Exchange Act.

 

“Common Stock” means the Class A common stock, par value $0.000001 per share, of the Purchaser and the Class B common stock, par value $0.000001 per share of the Purchaser, along with any equity securities paid as dividends or distributions after the Closing with respect to such shares or into which such shares are exchanged or converted after the Closing.

 

“Company” is defined in the preamble to this Agreement.

 

“Demand Registration” is defined in Section 2.2.1.

 

“Demanding Holder” is defined in Section 2.2.1.

 

“Effectiveness Date” means, with respect to the Initial Registration Statement, the 90th calendar day following the Filing Date (or in the event the Registration Statement receives a “full review” by the Commission, the 120th day following the Filing Date) and with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and 2.3, the 90th calendar day following the date on which an additional Registration Statement is required to be filed hereunder; provided, however, that in the event the Purchaser is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Business Day following the date on which the Purchaser is so notified if such date precedes the dates otherwise required above; provided, further, that, if the Effectiveness Date falls on a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the Effectiveness Date shall be the following Business Day.

 

“Effectiveness Period” shall have the meaning set forth in Section 2.1.1

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.

 

2

 

“Filing Date” means, with respect to the Initial Registration Statement required hereunder, the 30th calendar day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and 2.3, the earliest practical date on which the Purchaser is permitted by Commission Guidance to file such additional Registration Statement related to the Registrable Securities; provided, however, that, if the Filing Date falls on a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the Filing Date shall be the following Business Day.

 

“Form S-3” is defined in Section 2.3.5.

 

“Founder Registration Rights Agreement” means that certain Registration Rights Agreement, dated as of November 29, 2021, by and among Purchaser, Canna-Global LLC and certain directors of Purchaser.

 

“Founder Securities” means all shares of Class B Common Stock, and all securities convertible into or exercisable for shares of Class B Common Stock, held by the Founders as of the Effective Date of this Agreement.

 

“Founders” means Canna-Global LLC, J. Gerald Combs, Sharwin Sinnan, Dr. Wian Stander, Subramaniam Thavaraj, Peng Kong and Kah Yong Tham, and any successors in interest thereto with respect to any Founder Securities.

 

“Holder” is defined in the preamble to this Agreement.

 

“Indemnified Party” is defined in Section 4.3.

 

“Indemnifying Party” is defined in Section 4.3.

 

“Initial Registration Statement” means the Registration Statement required to be filed pursuant to Section 2.1.

 

“Holder Indemnified Party” is defined in Section 4.1.

 

“Maximum Number of Shares” is defined in Section 2.2.4.

 

“Offer Shares” means the shares of Class A Common Stock of the Purchaser issued or issuable to the Holders pursuant to the terms of the BIBCA.

 

“Notices” is defined in Section 6.3.

 

“Piggy-Back Registration” is defined in Section 2.3.1.

 

“Pro Rata” is defined in Section 2.2.4.

 

“Purchaser” is defined in the preamble to this Agreement.

 

“Register,” “Registered” and “Registration” mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

 

3

 

“Registrable Securities” means (i) the Shares and any shares of Common Stock held by the Holders and Founders immediately following the closing of the Business Combination, and (ii) any warrants, shares of capital stock or other securities of the Purchaser acquired by a Holder or Founder after the Closing, or issued as a dividend or other distribution with respect to or in exchange for or in replacement of such Shares. As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when: (a) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (b) such securities shall have been otherwise transferred, new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Purchaser and subsequent public distribution of them shall not require registration under the Securities Act; (c) such securities shall have ceased to be outstanding; or (d) the Registrable Securities are freely saleable under Rule 144 without volume limitations.

 

“Registration Statement” means a registration statement filed by the Purchaser with the Commission in compliance with the Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities (other than a registration statement on Form S-4 or Form S-8, or their successors, or any registration statement covering only securities proposed to be issued in exchange for securities or assets of another entity).

 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.

 

“Selling Shareholder Questionnaire” means [___]

 

“Shares” means the Offer Shares and the Founder Securities.

 

“Underwriter” means, solely for the purposes of this Agreement, a securities dealer who purchases any Registrable Securities as principal in an underwritten offering and not as part of such dealer’s market-making activities.

 

4

 

2. REGISTRATION RIGHTS.

 

2.1 Shelf Registration.

 

2.1.1 On or prior to each Filing Date, the Purchaser shall prepare and file with the Commission a Registration Statement covering the resale of all or such maximum portion of the Registrable Securities as permitted by SEC Guidance (provided that, the Purchaser shall use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 (except if the Purchaser is then eligible to register for resale the Registrable Securities on Form S-3, such registration shall be on Form S-3 in accordance herewith). Subject to the terms of this Agreement, the Purchaser shall use its commercially reasonable efforts to cause a Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof, but in any event prior to the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement have been sold, or may be sold without volume or manner-of-sale restrictions pursuant to Rule 144, without the requirement for the Purchaser to be in compliance with the current public information requirement under Rule 144, as determined by the counsel to the Purchaser pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the “Effectiveness Period”). The Purchaser shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. New York City time on a Business Day. The Purchaser shall promptly notify the Holders by e- mail of the effectiveness of a Registration Statement on the same Business Day that the Purchaser telephonically confirms effectiveness with the Commission. The Purchaser shall, no later than the second Business Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424.

 

2.1.2 Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement (and notwithstanding that the Purchaser used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable Securities to be registered shall be reduced on a on a pro rata basis based on the total number of Registrable Securities held by such Holders (such proportion is referred to herein as “Pro Rata”). In the event of a reduction hereunder, the Purchaser shall give the Holder and Founders, as applicable, at least five (5) Business Days prior written notice along with the calculations as to such Holder’s or Founder’s allotment. Promptly after such SEC Guidance is no longer applicable with respect to some or all of the remaining unregistered Registrable Securities, the Purchaser shall file an additional Registration Statement in accordance with this Section 2 to with respect to such shares.

 

2.1.3 Each Holder agrees to furnish to the Purchaser a completed Selling Stockholder Questionnaire within five (5) Business Days following the date of this Agreement. Each Holder further acknowledges and agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time unless such Holder has returned to the Purchaser a completed and signed Selling Stockholder Questionnaire. If a Holder of Registrable Securities returns a Selling Stockholder Questionnaire after the deadline specified in the previous sentence, the Purchaser shall use its commercially reasonable efforts to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or post- effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable Securities identified in such late Selling Stockholder Questionnaire; provided that the Purchaser shall not be required to file an additional Registration Statement solely for such shares. Each Holder acknowledges and agrees that the information in the Selling Stockholder Questionnaire will be used by the Purchaser in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement. In the event that due to a change in the Holder’s business or circumstances, any information in the Selling Shareholder Questionnaire becomes materially misleading, regardless of the cause, the Holder shall update the Purchaser within one (1) Business Day.

 

5

 

2.2 Demand Registration.

 

2.2.1 Request for Registration. At any time and from time to time on or after the date of this Agreement, the Holders of twenty-five percent (25%) of the Registrable Securities may make a written demand for registration under the Securities Act of all or part of their Registrable Securities, as the case may be (a “Demand Registration”). Any demand for a Demand Registration shall specify the number of shares of Registrable Securities proposed to be sold and the intended method(s) of distribution thereof. The Purchaser will within ten (10) days of the Purchaser’s receipt of the Demand Registration notify all holders of Registrable Securities of the demand, and each holder of Registrable Securities who wishes to include all or a portion of such holder’s Registrable Securities in the Demand Registration (each such holder including shares of Registrable Securities in such registration, a “Demanding Holder”) shall so notify the Purchaser within five (5) days after the receipt by the holder of the notice from the Purchaser. Upon any such request, the Demanding Holders shall be entitled to have their Registrable Securities included in the Demand Registration, subject to Section 2.1.4 and the provisos set forth in Section 3.1.1. The Purchaser shall not be obligated to effect more than an aggregate of two (2) Demand Registrations under this Section 2.1.1 in respect of all Registrable Securities.

 

2.2.2 Effective Registration. A registration will not count as a Demand Registration until the Registration Statement filed with the Commission with respect to such Demand Registration has been declared effective and the Purchaser has complied with all of its obligations under this Agreement with respect thereto; provided, however, that if, after such Registration Statement has been declared effective, the offering of Registrable Securities pursuant to a Demand Registration is interfered with by any stop order or injunction of the Commission or any other governmental agency or court, the Registration Statement with respect to such Demand Registration will be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders thereafter elect to continue the offering and accordingly notify the Purchaser in writing, but in no event later than five (5) days, of such election; provided, further, that the Purchaser shall not be obligated to file a second Registration Statement until a Registration Statement that has been filed is counted as a Demand Registration or is terminated.

 

2.2.3 Underwritten Offering. If a majority-in-interest of the Demanding Holders so elect and such holders so advise the Purchaser as part of their written demand for a Demand Registration, the offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an underwritten offering; provided that the total offering price is reasonably expected to exceed, in the aggregate, $50 million. In such event, the right of any holder to include its Registrable Securities in such registration shall be conditioned upon such holder’s participation in such underwriting and the inclusion of such holder’s Registrable Securities in the underwriting to the extent provided herein. All Demanding Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such underwriting by a majority-in-interest of the holders initiating the Demand Registration.

 

6

 

2.2.4 Reduction of Offering. If the managing Underwriter or Underwriters for a Demand Registration that is to be an underwritten offering, in good faith, advises the Purchaser and the Demanding Holders in writing that the dollar amount or number of shares of Registrable Securities which the Demanding Holders desire to sell, taken together with all other shares of Class A Common Stock or other securities which the Purchaser desires to sell and the shares of Class A Common Stock, if any, as to which registration has been requested pursuant to written contractual piggy-back registration rights held by other shareholders of the Purchaser who desire to sell, exceeds the maximum dollar amount or maximum number of shares that can be sold in such offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of shares, as applicable, the “Maximum Number of Shares” ), then the Purchaser shall include in such registration: (i) first, the Registrable Securities as to which Demand Registration has been requested by the Demanding Holders (Pro Rata in accordance with the number of shares that each such Person has requested be included in such registration, regardless of the number of shares held by each such Person) that can be sold without exceeding the Maximum Number of Shares; (ii) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (i), the Registrable Securities of Holders exercising their rights to register their Registrable Securities that can be sold without exceeding the Maximum Number of Shares; and (iii) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i) and (ii), shares of Class A Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares.

 

2.2.5 Withdrawal. If, prior to filing of the applicable “red herring prospectus” or prospectus supplement used for marketing such registration, a majority-in-interest of the Demanding Holders disapprove of the terms of any underwriting or are not entitled to include all of their Registrable Securities in any offering, such majority-in-interest of the Demanding Holders may elect to withdraw from such offering by giving written notice to the Purchaser and the Underwriter or Underwriters of their request to withdraw prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Demand Registration. If the majority-in-interest of the Demanding Holders withdraws from a proposed offering relating to a Demand Registration, then such registration shall not count as a Demand Registration provided for in Section 2.1.

 

2.3 Piggy-Back Registration.

 

2.3.1 Piggy-Back Rights. If at any time on or after the date of this Agreement the Purchaser proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Purchaser for its own account or for shareholders of the Purchaser for their account (or by the Purchaser and by shareholders of the Purchaser including, without limitation, pursuant to Section 2.1), other than a Registration Statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or offering of securities solely to the Purchaser’s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Purchaser or (iv) for a dividend reinvestment plan, then the Purchaser shall (x) give written notice of such proposed filing to the holders of Registrable Securities as soon as practicable but in no event less than ten (10) days before the anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, of the offering, and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of such number of shares of Registrable Securities as such holders may request in writing within ten (10) days following receipt of such notice (a “Piggy- Back Registration” ). The Purchaser shall, in good faith, cause such Registrable Securities to be included in such registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed underwritten offering to permit the Registrable Securities requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Purchaser and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All holders of Registrable Securities proposing to distribute their securities through a Piggy-Back Registration that involves an Underwriter or Underwriters shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such Piggy-Back Registration.

 

7

 

2.3.2 Reduction of Offering. If the managing Underwriter or Underwriters for a Piggy-Back Registration that is to be an underwritten offering advises the Purchaser and the holders of Registrable Securities in writing that the dollar amount or number of shares of the Class A Common Stock which the Purchaser desires to sell, taken together with the shares of the Class A Common Stock, if any, as to which registration has been demanded pursuant to written contractual arrangements with persons other than the holders of Registrable Securities hereunder, the Registrable Securities as to which registration has been requested under this Section 2.2, and the shares of the Class A Common Stock, if any, as to which registration has been requested pursuant to the terms hereof exceeds the Maximum Number of Shares, then the Purchaser shall include in any such registration:

 

a) If the registration is undertaken for the Purchaser’s account: (A) first, the shares of the Class A Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares; and (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of Common Stock or other securities, if any, comprised of Registrable Securities as to which registration has been requested pursuant to the terms hereof, Pro Rata, that can be sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of the Class A Common Stock or other securities for the account of other persons that the Purchaser is obligated to register pursuant to written contractual piggy-back registration rights with such persons and that can be sold without exceeding the Maximum Number of Shares;

 

b) If the registration is a “demand” registration undertaken at the demand of persons other than the holders of Registrable Securities, (A) first, the shares of the Class A Common Stock or other securities for the account of the demanding persons that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of the Class A Common Stock or other securities comprised of Registrable Securities, Pro Rata, as to which registration has been requested pursuant to the terms hereof, that can be sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of the Class A Common Stock or other securities that the Purchaser desires to sell that can be sold without exceeding the Maximum Number of Shares; and (D) fourth, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A), (B) and (C), the shares of the Class A Common Stock or other securities for the account of other persons that the Purchaser is obligated to register pursuant to written contractual arrangements with such persons, that can be sold without exceeding the Maximum Number of Shares.

 

8

 

2.3.3 Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of Registrable Securities in any Piggy-Back Registration by giving written notice to the Purchaser of such request to withdraw prior to the effectiveness of the Registration Statement. The Purchaser (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the Purchaser shall pay all expenses incurred by the holders of Registrable Securities in connection with such Piggy-Back Registration as provided in Section 3.3.

 

2.3.4 Unlimited Piggy-Back Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof. The Holders shall have unlimited Piggy-Back Registration Rights.

 

2.3.5 Registrations on Form S-3. The holders of Registrable Securities may at any time and from time to time, request in writing that the Purchaser register the resale of any or all of such Registrable Securities on Form S-3 or any similar short-form registration which may be available at such time (“Form S-3”); provided, however, that the Purchaser shall not be obligated to effect such request through an underwritten offering. Upon receipt of such written request, the Purchaser will promptly give written notice of the proposed registration to all other holders of Registrable Securities, and, as soon as practicable thereafter, effect the registration of all or such portion of such holder’s or holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities or other securities of the Purchaser, if any, of any other holder or holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Purchaser; provided, however, that the Purchaser shall not be obligated to effect any such registration pursuant to this Section 2.3: (i) if Form S-3 is not available for such offering; or (ii) if the holders of the Registrable Securities, together with the holders of any other securities of the Purchaser entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at any aggregate price to the public of less than $10,000,000. Registrations effected pursuant to this Section 2.3 shall not be counted as Demand Registrations effected pursuant to Section 2.1.

 

9

 

2.4 Block Trades; Other Coordinated Offerings.

 

2.4.1 Notwithstanding any other provision of this Section 2.4, at any time and from time to time when an effective Shelf Registration is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering (whether firm commitment or otherwise) not involving a “road show” or other substantial marketing efforts prior to pricing (commonly referred to as a “Block Trade”) or (b) an otherwise coordinated “at the market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal (an “Other Coordinated Offering”), in each case, with a total offering price reasonably expected to exceed, in the aggregate, either (x) $10 million or (y) all remaining Registrable Securities held by the Demanding Holder, then such Demanding Holder shall notify the Purchaser of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is expected to commence, and the Purchaser shall as expeditiously as possible use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts to work with the Purchaser and any Underwriters, brokers, sales agents or placement agents prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated Offering.

 

2.4.2 The Purchaser may facilitate a Block Trade or Other Coordinated Offering if it determines that sufficient shares shall be traded by any Holder or Holders that would be more efficiently traded as a block trade.

 

2.4.3 Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, a majority-in- interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right to submit a notice to the Purchaser and the Underwriter(s) if any, of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, the Purchaser shall be responsible for the Registration Expenses incurred in connection with a block trade prior to its withdrawal under this Section 2.4.3.

 

2.4.4 Notwithstanding anything to the contrary in this Agreement, Section 2.3 shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder pursuant to this Section 2.4.

 

2.4.5 The Purchaser shall have the right to select the Underwriters, and brokers, sale agents or placement agents (if any) for such Block Trade or Other Coordinated Offering, in each case, which shall consist of one or more reputable nationally recognized investment bank.

 

2.4.6 A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.4 in any twelve (12) month period.

 

3. REGISTRATION PROCEDURES.

 

3.1 Filings; Information. Whenever the Purchaser is required to effect the registration of any Registrable Securities pursuant to Section 2, the Purchaser shall use its best efforts to effect the registration and sale of such Registrable Securities in accordance with the intended method(s) of distribution thereof as expeditiously as practicable, and in connection with any such request:

 

3.1.1 Filing Registration Statement. The Purchaser shall use its best efforts to, as expeditiously as possible after receipt of a request for a Demand Registration pursuant to Section 2.1, prepare and file with the Commission a Registration Statement on any form for which the Purchaser then qualifies or which counsel for the Purchaser shall deem appropriate and which form shall be available for the sale of all Registrable Securities to be registered thereunder in accordance with the intended method(s) of distribution thereof, and shall use its best efforts to cause such Registration Statement to become effective and use its best efforts to keep it effective for the period required by Section 3.1.3; provided, however, that the Purchaser shall have the right to defer any Demand Registration for up to ninety (90) days, and any Piggy-Back Registration for such period as may be applicable to deferment of any demand registration to which such Piggy-Back Registration relates, in each case if the Purchaser shall furnish to the holders a certificate signed by Chief Executive Officer or Chairman of the Purchaser stating that, in the good faith judgment of the Board of Directors of the Purchaser, it would be materially detrimental to the Purchaser and its shareholders for such Registration Statement to be effected at such time; provided further, however, that the Purchaser shall not have the right to exercise the right set forth in this provision more than once in any 365-day period in respect of a Demand Registration hereunder.

 

10

 

3.1.2 Copies. The Purchaser shall, prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the holders of Registrable Securities included in such registration, and such holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including each preliminary prospectus), and such other documents as the holders of Registrable Securities included in such registration or legal counsel for any such holders may request in order to facilitate the disposition of the Registrable Securities owned by such holders.

 

3.1.3 Amendments and Supplements. The Purchaser shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective and in compliance with the provisions of the Securities Act until all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such securities have been withdrawn.

 

3.1.4 Notification. After the filing of a Registration Statement, the Purchaser shall promptly, and in no event more than two (2) business days after such filing, notify the holders of Registrable Securities included in such Registration Statement of such filing, and shall further notify such holders promptly and confirm such advice in writing in all events within two (2) business days of the occurrence of any of the following: (i) when such Registration Statement becomes effective; (ii) when any post-effective amendment to such Registration Statement becomes effective; (iii) the issuance or threatened issuance by the Commission of any stop order (and the Purchaser shall take all actions required to prevent the entry of such stop order or to remove it if entered); and (iv) any request by the Commission for any amendment or supplement to such Registration Statement or any prospectus relating thereto or for additional information or of the occurrence of an event requiring the preparation of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of the securities covered by such Registration Statement, such prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and promptly make available to the holders of Registrable Securities included in such Registration Statement any such supplement or amendment; except that before filing with the Commission a Registration Statement or prospectus or any amendment or supplement thereto, including documents incorporated by reference, the Purchaser shall furnish to the holders of Registrable Securities included in such Registration Statement and to the legal counsel for any such holders, copies of all such documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity to review such documents and comment thereon, and the Purchaser shall not file any Registration Statement or prospectus or amendment or supplement thereto, including documents incorporated by reference, to which such holders or their legal counsel shall object.

 

11

 

3.1.5 State Securities Laws Compliance. The Purchaser shall use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Purchaser and do any and all other acts and things that may be necessary or advisable to enable the holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Purchaser shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph or subject itself to taxation in any such jurisdiction.

 

3.1.6 Agreements for Disposition. The Purchaser shall enter into customary agreements (including, if applicable, an underwriting agreement in customary form) and take such other actions as are reasonably required in order to expedite or facilitate the disposition of such Registrable Securities. The representations, warranties and covenants of the Purchaser in any underwriting agreement which are made to or for the benefit of any Underwriters, to the extent applicable, shall also be made to and for the benefit of the holders of Registrable Securities included in such registration statement. No holder of Registrable Securities included in such registration statement shall be required to make any representations or warranties in the underwriting agreement except, if applicable, with respect to such holder’s organization, good standing, authority, title to Registrable Securities, lack of conflict of such sale with such holder’s material agreements and organizational documents, and with respect to written information relating to such holder that such holder has furnished in writing expressly for inclusion in such Registration Statement.

 

3.1.7 Cooperation. The principal executive officer of the Purchaser, the principal financial officer of the Purchaser, the principal accounting officer of the Purchaser and all other officers and members of the management of the Purchaser shall cooperate fully in any offering of Registrable Securities hereunder, which cooperation shall include, without limitation, the preparation of the Registration Statement with respect to such offering and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys, accountants and potential Holders.

 

12

 

3.1.8 Records. The Purchaser shall make available for inspection by the holders of Registrable Securities included in such Registration Statement, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other professional retained by any holder of Registrable Securities included in such Registration Statement or any Underwriter, all financial and other records, pertinent corporate documents and properties of the Purchaser, as shall be necessary to enable them to exercise their due diligence responsibility, and cause the Purchaser’s officers, directors and employees to supply all information requested by any of them in connection with such Registration Statement.

 

3.1.9 Opinions and Comfort Letters. Upon request, the Purchaser shall furnish to each holder of Registrable Securities included in any Registration Statement a signed counterpart, addressed to such holder, of (i) any opinion of counsel to the Purchaser delivered to any Underwriter and (ii) any comfort letter from the Purchaser’s independent public accountants delivered to any Underwriter. In the event no legal opinion is delivered to any Underwriter, the Purchaser shall furnish to each holder of Registrable Securities included in such Registration Statement, at any time that such holder elects to use a prospectus, an opinion of counsel to the Purchaser to the effect that the Registration Statement containing such prospectus has been declared effective and that no stop order is in effect.

 

3.1.10 Earnings Statement. The Purchaser shall comply with all applicable rules and regulations of the Commission and the Securities Act, and make available to its shareholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder.

 

3.1.11 Listing. The Purchaser shall use its best efforts to cause all Registrable Securities included in any registration to be listed on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Purchaser are then listed or designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority of the Registrable Securities included in such registration.

 

3.1.12 Road Show. If the registration involves the registration of Registrable Securities involving gross proceeds in excess of $50,000,000, the Purchaser shall use its reasonable efforts to make available senior executives of the Purchaser to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any underwritten offering.

 

3.2 Obligation to Suspend Distribution. Upon receipt of any notice from the Purchaser of the happening of any event of the kind described in Section 3.1.4(iv), or, in the case of a resale registration on Form S-3 pursuant to Section 2.3 hereof, upon any suspension by the Purchaser, pursuant to a written insider trading compliance program adopted by the Purchaser’s Board of Directors, of the ability of all “insiders” covered by such program to transact in the Purchaser’s securities because of the existence of material non-public information, each holder of Registrable Securities included in any registration shall immediately discontinue disposition of such Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such holder receives the supplemented or amended prospectus contemplated by Section 3.1.4(iv) or the restriction on the ability of “insiders” to transact in the Purchaser’s securities is removed, as applicable, and, if so directed by the Purchaser, each such holder will deliver to the Purchaser all copies, other than permanent file copies then in such holder’s possession, of the most recent prospectus covering such Registrable Securities at the time of receipt of such notice.

 

13

 

3.3 Registration Expenses. The Purchaser shall bear all costs and expenses incurred in connection with any Demand Registration pursuant to Section 2.2, any Piggy-Back Registration pursuant to Section 2.3, and any registration on Form S-3 effected pursuant to Section 2.3.5, and all expenses incurred in performing or complying with its other obligations under this Agreement, whether or not the Registration Statement becomes effective, including, without limitation: (i) all registration and filing fees; (ii) fees and expenses of compliance with securities or “blue sky” laws (including fees and disbursements of counsel in connection with blue sky qualifications of the Registrable Securities); (iii) printing expenses; (iv) the fees and expenses incurred in connection with the listing of the Registrable Securities as required by Section 3.1.11; (v) Financial Industry Regulatory Authority fees; (vi) fees and disbursements of counsel for the Purchaser and fees and expenses for independent certified public accountants retained by the Purchaser (including the expenses or costs associated with the delivery of any opinions or comfort letters requested pursuant to Section 3.1.9); and (viii) the reasonable fees and expenses of any special experts retained by the Purchaser in connection with such registration. The Purchaser shall have no obligation to pay (i) any underwriting discounts or selling commissions attributable to the Registrable Securities being sold by the holders thereof, which underwriting discounts or selling commissions shall be borne by such holders, or (ii) the fees and expenses of any legal counsel representing any Holders. Additionally, in an underwritten offering, all selling shareholders and the Purchaser shall bear the expenses of the Underwriter pro rata in proportion to the respective amount of shares each is selling in such offering.

 

3.4 Information. The holders of Registrable Securities shall provide such information as may reasonably be requested by the Purchaser, or the managing Underwriter, if any, in connection with the preparation of any Registration Statement, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Section 2 and in connection with the Purchaser’s obligation to comply with Federal and applicable state securities laws. In addition, the holders of Registrable Securities shall comply with all prospectus delivery requirements under the Securities Act and applicable SEC regulations.

 

3.5 Legend Removal Obligations. In connection with the written request of any Holder, the Purchaser shall remove any restrictive legend included on the certificates (or, in the case of book-entry shares, any other instrument or record) representing such Holder’s and/or its affiliates’ or permitted transferee’s ownership of Registrable Securities, and promptly issue a certificate (or evidence of the issuance of securities in book-entry form) without such restrictive legend or any other restrictive legend to the holder of the applicable shares of Registrable Securities upon which it is stamped, if (i) such Registrable Securities are registered for resale under the Securities Act and such Registration Statement for such Registrable Securities has not been suspended under the Securities Act, the Exchange Act or the rules and regulations of the Commission promulgated thereunder, (ii) such Registrable Securities are sold or transferred pursuant to Rule 144, or (iii) such Registrable Securities are eligible for sale pursuant to Section 4(a)(1) of the Securities Act or Rule 144 without volume or manner-of-sale restrictions. Following the earlier of (A) the effective date of a Registration Statement registering such Registrable Securities or (B) Rule 144 becoming available for the resale of such Registrable Securities without volume or manner-of-sale restrictions, the Purchaser upon the written request of the Holder or its permitted transferee, shall instruct the Purchaser’s transfer agent to remove the legend from such Registrable Securities (in whatever form) and shall cause the Purchaser’s counsel to issue any legend removal opinion required by the transfer agent. Any reasonable and documented fees (with respect to the transfer agent, the Purchaser’s counsel, or otherwise) associated with the removal of such legend shall be borne by the Purchaser. If a legend is no longer required pursuant to the foregoing, the Purchaser will, as soon as practicable following the delivery by any Holder or its permitted transferee to the Purchaser or the transfer agent (with notice to the Purchaser) of a legended certificate (if applicable) representing such Registrable Securities and, to the extent such sale is not pursuant to an effective registration statement, such other documentation as reasonably requested by the Purchaser, deliver or cause to be delivered to the holder of such Registrable Securities a certificate representing such Registrable Securities (or evidence of the issuance of such Registrable Securities in book-entry form) that is free from all restrictive legends; provided that, notwithstanding the foregoing, the Purchaser will not be required to deliver any opinion, authorization, certificate or direction to remove the restrictive legend pursuant to this Section 3.5 if (x) removal of the legend would result in or facilitate transfer of securities in violation of applicable law or (y) following receipt of instruction from the Purchaser, the transfer agent refuses to remove the legend.

 

14

 

4. INDEMNIFICATION AND CONTRIBUTION.

 

4.1 Indemnification by the Purchaser. The Purchaser agrees to indemnify and hold harmless each Holder and each other holder of Registrable Securities, and each of their respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each person, if any, who controls an Holder and each other holder of Registrable Securities (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) (each, an “Holder Indemnified Party” ), from and against any expenses, losses, judgments, claims, damages or liabilities, whether joint or several, arising out of or based upon any untrue statement (or allegedly untrue statement) of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to such Registration Statement, or arising out of or based upon any omission (or alleged omission) to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by the Purchaser of the Securities Act or any rule or regulation promulgated thereunder applicable to the Purchaser and relating to action or inaction required of the Purchaser in connection with any such registration; and the Purchaser shall promptly reimburse the Holder Indemnified Party for any legal and any other expenses reasonably incurred by such Holder Indemnified Party in connection with investigating and defending any such expense, loss, judgment, claim, damage, liability or action; provided, however, that the Purchaser will not be liable in any such case to the extent that any such expense, loss, claim, damage or liability arises out of or is based upon any untrue statement or allegedly untrue statement or omission or alleged omission made in such Registration Statement, preliminary prospectus, final prospectus, or summary prospectus, or any such amendment or supplement, in reliance upon and in conformity with information furnished to the Purchaser, in writing, by such selling Holder expressly for use therein. The Purchaser also shall indemnify any Underwriter of the Registrable Securities, their officers, affiliates, directors, partners, members and agents and each person who controls such Underwriter on substantially the same basis as that of the indemnification provided above in this Section 4.1.

 

4.2 Indemnification by Holders of Registrable Securities. Each selling Holder will, in the event that any registration is being effected under the Securities Act pursuant to this Agreement of any Registrable Securities held by such selling Holder, indemnify and hold harmless the Purchaser, each of its directors and officers and each Underwriter (if any), and each other selling Holder and each other person, if any, who controls another selling Holder or such Underwriter within the meaning of the Securities Act, against any losses, claims, judgments, damages or liabilities, whether joint or several, insofar as such losses, claims, judgments, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or allegedly untrue statement of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to the Registration Statement, or arise out of or are based upon any omission or the alleged omission to state a material fact required to be stated therein or necessary to make the statement therein not misleading, if the statement or omission was made in reliance upon and in conformity with information furnished in writing to the Purchaser by such selling Holder expressly for use therein, and shall reimburse the Purchaser, its directors and officers, and each other selling holder or controlling person for any legal or other expenses reasonably incurred by any of them in connection with investigation or defending any such loss, claim, damage, liability or action. Each selling Holder’s indemnification obligations hereunder shall be several and not joint and shall be limited to the amount of any net proceeds actually received by such selling Holder.

 

4.3 Conduct of Indemnification Proceedings. Promptly after receipt by any person of any notice of any loss, claim, damage or liability or any action in respect of which indemnity may be sought pursuant to Section 4.1 or 4.2, such person (the “Indemnified Party”) shall, if a claim in respect thereof is to be made against any other person for indemnification hereunder, notify such other person (the “Indemnifying Party” ) in writing of the loss, claim, judgment, damage, liability or action; provided, however, that the failure by the Indemnified Party to notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability which the Indemnifying Party may have to such Indemnified Party hereunder, except and solely to the extent the Indemnifying Party is actually prejudiced by such failure. If the Indemnified Party is seeking indemnification with respect to any claim or action brought against the Indemnified Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent that it wishes, jointly with all other Indemnifying Parties, to assume control of the defense thereof with counsel satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume control of the defense of such claim or action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that in any action in which both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall have the right to employ separate counsel (but no more than one such separate counsel) to represent the Indemnified Party and its controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Indemnified Party against the Indemnifying Party, with the fees and expenses of such counsel to be paid by such Indemnifying Party if, based upon the written opinion of counsel of such Indemnified Party, representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, consent to entry of judgment or effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment or settlement includes an unconditional release of such Indemnified Party from all liability arising out of such claim or proceeding.

 

15

 

4.4 Contribution.

 

4.4.1 If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any Indemnified Party in respect of any loss, claim, damage, liability or action referred to herein, then each such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as well as any other relevant equitable considerations. The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

 

4.4.2 The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding Section 4.4.1.

 

4.4.3 The amount paid or payable by an Indemnified Party as a result of any loss, claim, damage, liability or action referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net proceeds (after payment of any underwriting fees, discounts, commissions or taxes) actually received by such holder from the sale of Registrable Securities which gave rise to such contribution obligation. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

4.5 Survival. The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Party or any officer, director or controlling person of such Indemnified Party and shall survive the transfer of securities.

 

5. RULE 144.

 

5.1 Rule 144. The Purchaser covenants that it shall file any reports required to be filed by it under the Securities Act and the Exchange Act and shall take such further action as the holders of Registrable Securities may reasonably request, all to the extent required from time to time to enable such holders to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 under the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission.

 

16

 

6. MISCELLANEOUS.

 

6.1 Other Registration Rights. The Purchaser represents and warrants that no person, other than the holders of the Registrable Securities, has any right to require the Purchaser to register any shares of the Purchaser’s capital stock for sale or to include shares of the Purchaser’s capital stock in any registration filed by the Purchaser for the sale of shares of capital stock for its own account or for the account of any other person. Further, the Purchaser represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

6.2 Assignment; No Third Party Beneficiaries. This Agreement and the rights, duties and obligations of the Purchaser hereunder may not be assigned or delegated by the Purchaser in whole or in part. This Agreement and the rights, duties and obligations of the holders of Registrable Securities hereunder may not be freely assigned or delegated by such holder of Registrable Securities in conjunction with and to the extent of any transfer of Registrable Securities by any such holder, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee (defined in the Lock-Up Agreement) but only if such Permitted Transferee agrees to become bound by the terms and conditions of this Agreement. This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties, to the permitted assigns of the Holders or holder of Registrable Securities or of any assignee of the Holders or holder of Registrable Securities. This Agreement is not intended to confer any rights or benefits on any persons that are not party hereto other than as expressly set forth in Article 4 and this Section 6.2.

 

6.3 Notices. All notices, consents, waivers, and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such other address for a party as shall be specified by like notice):

 

17

 

To the Purchaser before the Closing:

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500,

Marina Del Rey, California 90292

Tel: (917) 675-2537

Email: gerry@cgcombs.com

 

with a copy to:

 

Rimon, P.C.

1990 K Street NW, Suite 420

Washington, DC 20006

Attn: Debbie Klis

Telephone No.: (202) 935-3390

E-mail: deborrah.klis@rimonlaw.com

 

To the Company after the Closing:

New Quantum Holdings Pty Ltd

Level 21, 207 Kent St., Sydney

New South Wales, Australia, 2000

Attn: Jong Chung, Managing Director

Telephone No.: +61 430 228 328

E-mail: jong@newquantum.com

 

with a copy to:

K&L Gates

Level 31, 1 O’Connell Street

Sydney NSW 2000, Australia

Attention: Russell Lyons

Telephone: +61 2 9513 2510

E-mail: Russell.Lyons@klgates.com

 

To a Holder, to the address set forth below such Holder’s name on Exhibit A hereto.

 

6.4 Severability. In case any provision in this Agreement shall be held invalid, illegal, or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal, and enforceable, and the validity, legality, and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality, or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or incapable of being enforced, the parties will substitute for any invalid, illegal, or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal, and enforceable, the intent and purpose of such invalid, illegal, or unenforceable provision.

 

18

 

6.5 Counterparts. This Agreement may also be executed and delivered by facsimile signature or by email in portable document format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

6.6 Entire Agreement. This Agreement, the BIBCA and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies or any of the obligations of the parties hereto under any other agreement between a Subject Party and the Purchaser or any certificate or instrument delivered in connection with the Transactions, and nothing in any other agreement, certificate, or instrument shall limit any of the rights or remedies or any of the obligations under this Agreement.

 

6.7 Specific Performance. Each party acknowledges that its obligations under this Agreement are unique, recognizes and affirms that, in the event of a breach of this Agreement, money damages will be inadequate and there will be no adequate remedy at law, and agrees that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the adversely affected party or parties shall be entitled to an injunction or restraining order to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security, this being in addition to any other right or remedy available under this Agreement, at law or in equity.

 

6.8 Modifications and Amendments; Termination. No amendment, modification or termination of this Agreement shall be binding upon the Purchaser unless executed in writing by the Purchaser. No amendment, modification or termination of this Agreement shall be binding upon the holders of the Registrable Securities unless executed in writing by the holders of the majority Registrable Securities. This Agreement shall terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities. The provisions of Section 4 shall survive any termination.

 

6.9 Waivers and Extensions. Any party to this Agreement may waive any right, breach or default which such party has the right to waive, provided that such waiver will not be effective against the waiving party unless it is in writing, is signed by such party, and specifically refers to this Agreement. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred. Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance of any obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts.

 

19

 

6.10 Governing Law. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. All Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in the State of Delaware (or in any appellate courts thereof) (the “Specified Courts”). Each party hereto hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense, or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such party at the applicable address set forth in Section 6.3. Nothing in this Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

6.11 WAIVER OF TRIAL BY JURY. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.

 

6.12 Interpretation. The headings and subheadings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. In this Agreement: (i) the words “include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation”; (ii) the definitions contained herein are applicable to the singular as well as the plural forms of such terms; (iii) whenever required by the context, any pronoun shall include the corresponding masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (iv) the words “herein,” “hereto,” and “hereby” and other words of similar import shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (v) the word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and only if”; (vi) the term “or” means “and/or”; and (vii) any agreement or instrument defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified, or supplemented, including by waiver or consent and references to all attachments thereto and instruments incorporated therein.

 

6.13 Effectiveness. This Agreement shall be binding upon the Holder upon the Holder’s execution and delivery of this Agreement, but this Agreement shall only become effective upon the consummation of the Transactions. In the event that the BIBCA is validly terminated in accordance with its terms prior to the consummation of the Transactions, this Agreement shall automatically terminate and become null and void, and the parties shall have no obligations hereunder.

 

6.14 Assurances. From time to time, at another party’s request and without further consideration (but at the requesting party’s reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

 

6.15 Termination of Existing Agreements. The Existing Agreement is hereby terminated in its entirety.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

20

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  PURCHASER:
   
  CANNA-GLOBAL ACQUISITION CORP.
     
  By:  
  Name: J. Gerald Combs
  Title: Chief Executive Officer

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Durand GWA Pty Ltd ATF Durand Retirement Fund (ACN 153 215 064)
                           
  By:  
  Name: Denis John Durand
  Title: Director
     
  Address for notices:
  160 Dendy Street Brighton East VIC 3187 Australia
   
  Email: denis@fgwp.com.au

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Durand Holdings (VIC) Pty Ltd (ACN 139 540 435)
                         
  By:  
  Name: Denis John Durand
  Title: Director
     
  Address for notices:
  160 Dendy Street Brighton East VIC 3187 Australia
   
  Email: denis@fgwp.com.au

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Mr. Hyun Jong Chung ATF Chung Family Trust
                                      
  By:  
  Name: Hyun Jong Chung
  Title: Trustee
     
  Address for notices:
  8 Sunden Way NORTH EPPING NSW 2121 Australia
   
  Email: jong@newquantum.com

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  NQ Nominees Pty. Ltd. ATF NQ Nominees Unit Trust (666 485 614)
     
  By:
  Name: Hyun Jong Chung
  Title: Director
  Email: jong@newquantum.com
     
  By:
  Name: Denis John Durand
  Title: Director
  Email: denis@fgwp.com.au
     
  Address for notices:
  8 Sunden Way NORTH ROCKS NSW 2151 Australia

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Woodbridge Company Pty Ltd ATF Woodbridge Trust (609 752 801)
                               
  By:
  Name: Babar Ali
  Title: Founder & Technology Advisor
     
  Address for notices:
  79 Queen Street ASHFIELD NSW 2131 Australia
     
  Email: bali@newquantum.com

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Canna-Global LLC
     
  By:
  Name: Antony Gordon
  Title: Co-Manager
  Email:  
     
  By:
  Name: Kris Choon Kit Taw
  Title: Co-Manager
  Email:  
     
  Address for notices:

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Christine Cho
                  
  By:
     
  Address for notices:
     
  Email:  

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Dr. Wian Stander
                      
  By:
     
  Address for notices:
   
  Email:  

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Kah Yong Tham
                 
  By:
     
  Address for notices:
   
  Email:  

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Sharwin Sinnan
                  
  By:
     
  Address for notices:
   
  Email:  

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  Subramaniam Thavaraj
                  
  By:
     
  Address for notices:
   
  Email:  

 

 

 

IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives as of the date first written above.

 

  HOLDERS:
   
  J. Gerald Combs
                    
  By:
     
  Address for notices:
   
  Email:  

 

 

 

Exhibit A

 

Schedule of Holders

 

Holders   Address
     
     

 

 

 

EX-2.5 7 ex2-5.htm

 

Exhibit 2.5

 

Execution Copy

Exhibit G

 

Form Letter of Transmittal

for Securities of

New Quantum Holdings Pty Ltd.

Surrendered for Payment

Pursuant to the Bid Implementation and Business Combination Agreement

By and Among

Canna-Global Acquisition Corp,

J. Gerald Combs,

Hyun Jong Chung, and

New Quantum Holdings Pty Ltd

 

THE INSTRUCTIONS ACCOMPANYING THIS LETTER OF TRANSMITTAL SHOULD BE READ CAREFULLY, BEFORE THIS LETTER OF TRANSMITTAL IS COMPLETED. IF SECURITIES ARE REGISTERED IN MORE THAN ONE NAME, A SEPARATE LETTER OF TRANSMITTAL MUST BE SUBMITTED FOR EACH SEPARATE REGISTERED HOLDER OF SUCH SECURITIES.

 

BY SIGNING THIS LETTER OF TRANSMITTAL, YOU AGREE TO THE PROVISIONS CONTAINED HEREIN AND MAKE THE ACKNOWLEDGEMENTS AND REPRESENTATIONS PROVIDED HEREIN.

 

Ladies and Gentlemen:

 

This Letter of Transmittal is being sent to you because you are a New Quantum Holdings Pty Ltd. Shareholder in connection with that certain Bid Implementation and Business Combination Agreement (as amended from time to time in accordance with the terms thereof, the “BIBCA”), by and among (i) Canna-Global Acquisition Corp, a Delaware corporation (the “Purchaser”), (ii) J. Gerald Combs, an individual solely in his capacity as the representative from and after the Effective Time (as defined in the BIBCA) for the stockholders of Purchaser in accordance with the terms and conditions of the BIBCA (the “Purchaser Representative”), (iv) Hyun Jong Chung, an individual solely in his capacity as the representative from and after the Effective Time for the Company in accordance with the terms and conditions of the BIBCA (the “Company Representative”), and (v) New Quantum Holdings Pty Ltd, a an Australian company with Australian Company Number 628 253 743 (the “Company”, and collectively with the foregoing, referred to herein as the “Parties”). Capitalized terms used herein without definition shall have the meanings specified in the BIBCA.

 

You have received this Letter of Transmittal because the Company’s records indicate that you own ordinary shares of the Company (“Company Shares”). In order to receive payment for your Company Shares you must (a) complete and sign this Letter of Transmittal and Consent (“Letter of Transmittal”) in the space provided below and (b) mail or deliver the completed Letter of Transmittal evidencing your surrender and delivery of your Company Shares (the “Surrendered Securities”) to Continental Stock Transfer & Trust Company. We have set forth on the signature page to this Letter of Transmittal the number of Company Shares and/or the number of Options that our records indicate are held by you.

 

You must complete, sign and return this Letter of Transmittal, the Form W-8BEN to the Exchange Agent at the following address:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor | New York, NY 10004-1561

212.509.4000 | cstmail@continentalstock.com

 

PLEASE READ AND FOLLOW THE ACCOMPANYING INSTRUCTIONS CAREFULLY

 

In accordance with the BIBCA, by and among the Parties, the undersigned (the “Holder”) hereby delivers this Letter of Transmittal and surrenders to the Exchange Agent all Company Shares owned by the undersigned, in each case, in exchange for the right to receive the shares of Purchaser’s Class A Common Stock (the “Purchaser Common Stock”) payable to such Holder pursuant to and in accordance with the terms set forth in the BIBCA (the “Holder’s Payment”). Unless otherwise defined in this Letter of Transmittal, capitalized terms contained in this Letter of Transmittal will have the meanings set forth in the BIBCA.

 

Takeover Offer Consideration.

 

Pursuant to the BIBCA, Purchaser proposes to acquire all of the Company Shares by way of a Takeover Bid and to effect a business combination transaction upon the terms and subject to the conditions of the BIBCA (the “Business Combination”). See Art. II, The Takeover Offer and Art. IV, Consideration of the BIBCA.

 

 

 

At the Effective Time, by virtue of the Business Combination and without any further action on the part of the Parties, any shareholder of the Company (each, a “Company Shareholder” or “Holder”) or any other Person, subject to any applicable withholding pursuant to the BIBCA, each Company Share issued and outstanding immediately prior to the Effective Time shall be automatically converted into the right to receive, upon delivery of this properly completed and duly executed Letter of Transmittal (together with duly executed IRS Form(s) W-8BEN (and any attachments thereto) and/or W-9, as applicable) its allocable share of the Takeover Offer Consideration (the “Takeover Offer Consideration”).

 

The undersigned hereby acknowledges and agrees that all descriptions of the payment of the Takeover Offer Consideration and other matters related to the Business Combination and the other transactions contemplated by the BIBCA are set forth in summary form in this Letter of Transmittal for the undersigned’s convenience only and are qualified in their entirety by the terms of the BIBCA. For the avoidance of doubt, the undersigned hereby acknowledges and agrees that his, her or its agreements, acknowledgements and covenants herein are supplemental to and are not intended to call into doubt the existing validity or effectiveness of any of the matters set forth herein by virtue of the prior adoption of the BIBCA and approval of the Business Combination and the other transactions contemplated by the BIBCA by the requisite Company Shareholders and other actions and operation of applicable Law.

 

Without limitation to the matters set forth in this Letter of Transmittal or the BIBCA, the undersigned hereby acknowledges and agrees that (i) the undersigned has received a copy of the BIBCA and has reviewed and understands the matters set forth therein, and (ii) the undersigned has been urged to and has been given the opportunity to consult with the undersigned’s legal and tax advisors regarding the legal and tax consequences of the transactions contemplated by the BIBCA.

 

For the avoidance of doubt and without limitation of the foregoing, the undersigned hereby acknowledges and agrees that any payments made to the undersigned pursuant to the BIBCA shall be final and in no event shall Purchaser or any of its Affiliates have any liability to the undersigned for payment or disbursement by any Person (including the Exchange Agent) in accordance with the BIBCA. For the avoidance of doubt, the undersigned hereby acknowledges and agrees that the undersigned shall bear liability for any share transfer taxes applicable to the delivery of the portion of the Takeover Offer Consideration due and payable to the undersigned pursuant to the BIBCA in exchange for the Surrendered Securities.

 

The undersigned acknowledges that the Exchange Agent may not deliver the applicable portion of the Takeover Offer Consideration otherwise due and payable to the undersigned pursuant to the BIBCA unless the undersigned delivers to the Exchange Agent: (i) this Letter of Transmittal, completed in full, (ii) (a) original share certificates for the Surrendered Securities or (b) a completed Affidavit and Indemnification Concerning Lost Certificate(s) relating to the Surrendered Securities, and (iii) a completed W-8BEN (or W-9, as applicable).

 

Notice of Action by Company Shareholders; Affirmation of Consent.

 

Pursuant to the Australian Corporations Act 2001 (Cth) (the “Australian Act”), entry into the BIBCA must be approved by the board of directors of the Company (the “Board of Directors”) and at least 90% of the Company Shareholders must accept the offer for the Purchaser to acquire their Company Shares pursuant to the Business Combination (“Offer”). If the holders of at least 90% of the Company Shares accept the Offer, but not all Company Shareholders accept the Offer, then the Australian Act requires that notice of such action be given to the shareholders that did not sign the written consent. The Board of Directors approved the BIBCA and performance by the Company of the transactions contemplated in the BIBCA, including in relation to the Business Combination pursuant to a written consent. The undersigned has reviewed the written consents and hereby affirms its consent to the matters set forth therein.

 

Signing and returning to the Exchange Agent of this Letter of Transmittal constitutes notice to the undersigned of its acceptance of the Offer.

 

Acknowledgments and Agreements of the Undersigned with Respect to the Business Combination.

 

Consent to BIBCA and Other Documents. The undersigned hereby (a) acknowledges the receipt of a copy of the BIBCA and has had a chance to review the BIBCA, (b) consents to and approves the execution and performance of the BIBCA and all of the documents related thereto by the Exchange Agent and the Company and the completion of the transactions contemplated thereby, (c) forever waives, to the extent not otherwise waived, all appraisal rights or dissenter’s rights which might otherwise be available to the undersigned, and (d) agrees that other than the undersigned’s right to receive the Holder’s Payment for its Company Shares, the undersigned shall have no further rights arising out of any Company Shares that it owns and upon the completion of the Business Combination such shares shall be automatically be transferred to the Purchaser.

 

2

 

Incorporation of BIBCA. The undersigned understands and, by execution of this Letter of Transmittal agrees, that this Letter of Transmittal and all amounts payable to the undersigned as a Company Shareholder as a result of the Business Combination are subject to, and governed by, the terms and conditions of the BIBCA and the documents related thereto.

 

Significant Company Holder. If the undersigned is a Significant Company Holder, as defined in the BIBCA, then the undersigned hereby agrees to be bound by the terms of the BIBCA.

 

The Exchange

 

Agreements with Respect to Exchange of Shares and Cash Payments. The undersigned understands that the surrender of Company Shares will not be deemed to be in acceptable form until the Exchange Agent has received this Letter of Transmittal properly completed and signed, together with all required documents, in form satisfactory to the Exchange Agent. The undersigned understands that (i) unless and until the undersigned surrenders this Letter of Transmittal properly completed and signed, and all other required documents to the Exchange Agent at its address set forth on the cover of this Letter of Transmittal, no cash payments pursuant to the BIBCA shall be paid to the undersigned and (ii) no interest will accrue on any cash payment due. All questions as to the documents, validity, form, eligibility and acceptance for payment of any shares of Company Shares surrendered pursuant to any of the procedures described in this Letter of Transmittal will be determined by the Exchange Agent, and such determination will be final and binding. Delivery and surrender of Company Shares will be effected, and risk of loss and title to such shares of Company Shares will pass only upon proper delivery of this Letter of Transmittal to the Exchange Agent and, with respect to the Company Shares, surrender of the certificates evidencing ownership thereof. The undersigned has duly and validly executed and delivered this Letter of Transmittal, and it constitutes the undersigned’s legal, valid and binding obligation, enforceable against the undersigned in accordance with its terms.

 

Attorney-in-Fact. The undersigned hereby irrevocably appoints and constitutes the Exchange Agent, or its designee or appointee, as the undersigned’s true and lawful agent and attorney-in-fact with respect to the Company Shares surrendered herewith, to take all actions contemplated by the BIBCA including, without limitation, delivering this Letter of Transmittal and the undersigned’s Company Shares together with all accompanying evidences of authority, in the Exchange Agent’s sole discretion, to the Parent in connection with the completion of the Closing. This power is irrevocable and coupled with an interest, and shall not be affected by the undersigned’s death, incapacity, illness, dissolution or other inability to act. See also the section below entitled “The Exchange Agent” for additional information regarding the Exchange Agent.

 

Representations of the Undersigned. The name and address of the registered holder(s) of the Company Shares set forth on the signature page hereto are as they appear on the stock ledger with respect to Company Shares. The undersigned represents and warrants to the Company, Purchaser, the Exchange Agent and the other Company Shareholders that the undersigned (a) is the sole record and beneficial owner of each Company Share identified on the signature page to this Letter of Transmittal and the Company Shares surrendered herewith, (b) has good title to such Company Shares, (c) has full right, power, legal capacity and authority to execute this Letter of Transmittal and sell, assign, transfer and surrender such Company Shares, (d) needs no consent or approval of, and need not give notice to, any third party in order to validly sell, assign, transfer and surrender such Company Shares, (e) holds such Company Shares free and clear of all liens, claims and encumbrances and such shares are not subject to any adverse claim or any limitation or restriction on sale, transfer or delivery, and (f) is not party to any voting trusts, shareholder agreements, proxies or other agreements or understandings in effect with respect to the voting or transfer of any of the capital stock or other equity securities of the Company. The undersigned further represents and acknowledges that the undersigned (a) has read the BIBCA and this Letter of Transmittal; (b) agrees to be bound by the BIBCA and this Letter of Transmittal freely, voluntarily and without coercion, with full knowledge of its significance and the legal consequences thereof; (c) has had an adequate opportunity to review and consider the terms of the BIBCA and this Letter of Transmittal; (d) has fully informed itself of the terms, contents, conditions and effects of the BIBCA and this Letter of Transmittal; and (e) has relied solely and completely upon its own judgment in executing this Letter of Transmittal.

 

Additional Documents. The undersigned shall, upon request, execute and deliver any additional documents deemed appropriate or necessary by the Exchange Agent in connection with the surrender of the Company Share. All authority conferred in this Letter of Transmittal shall not be affected by, and shall survive, the death or incapacity of the undersigned and any obligation of the undersigned will be binding upon the successors, assigns, heirs, executors, administrators and legal representatives of the undersigned.

 

3

 

Survival of Representations, Warranties and Agreements. The representations, warranties, covenants, agreements, confirmations, appointments and releases made herein by the undersigned shall survive the execution and delivery hereof and the Closing.

 

The Exchange Agent

 

Appointment of Exchange Agent. The undersigned hereby irrevocably appoints the Exchange Agent as the undersigned’s true and lawful agent and attorney-in-fact, with full power and authority to act for and on behalf of the undersigned for all purposes of the BIBCA and the documents related thereto and agrees to be bound by the provisions of the Letter of Transmittal and such documents, pursuant to which, among other matters, the undersigned agrees to indemnify and hold the Exchange Agent harmless from any losses, claims, damages and expenses the Exchange Agent may suffer or incur in connection with any action taken by the Exchange Agent.

 

Authority of Exchange Agent. The undersigned hereby acknowledges and agrees that all decisions and actions by the Exchange Agent are binding upon all Company Shareholders, and no Company Shareholder has the right to object, dissent, protest or otherwise contest the same. The undersigned further acknowledges and agrees that the Exchange Agent, pursuant to the BIBCA and this Letter of Transmittal, has the exclusive authority to act on the undersigned’s behalf in connection with the BIBCA and the documents related thereto.

 

Waiver and Release

 

Waiver of Claims Against Trust. Reference is made to the IPO Prospectus. The Company, the Company Shareholders and the Company Representative hereby each represents and warrants that it/he has read the IPO Prospectus and understands that Purchaser has established the Trust Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser’s underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser’s public stockholders (including overallotment shares acquired by Purchaser’s underwriters) (including any successors after the Business Combination, the “Public Stockholders”) and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the Public Stockholders in the event they elect to redeem their Purchaser Common Stock in connection with the consummation of its initial business combination (as such term is used in the IPO Prospectus) or in connection with an amendment to Purchaser’s Organizational Documents to extend Purchaser’s deadline to consummate a Business Combination, (b) to the Public Stockholders if Purchaser fails to consummate a Business Combination within twelve (12) months after the End Date of the IPO (provided such date may be extended by an additional six (6) months), subject to further extension by amendment to Purchaser’s Organizational Documents, (c) with respect to any interest earned on the amounts held in the Trust Account, amounts necessary to pay for any taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company, each Company Shareholder, and the Company Representative hereby agrees on behalf of themselves and their Affiliates that, notwithstanding anything to the contrary in this Agreement, none of the Company, any Company Shareholder, or the Company Representative nor any of their respective Affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the one hand, and the Company, the Company Representative or any of their respective Representatives, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Released Claims”). The Company, each Company Shareholder, and the Company Representative on behalf of themselves and their Affiliates hereby irrevocably waives any Released Claims that any such Party or any of its Affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements hereunder and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its Affiliates). The Company, each Company Shareholder, and the Company Representative each agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter in this Agreement, and the Company, each Company Shareholder, and the Company Representative each further intends and understands such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent that any Party or any of its respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to this Agreement or Transactions, which proceeding seeks, in whole or in part, monetary relief against the Trust Account, the Parties each hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on any of their behalf or in lieu of them) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. In the event that any Party or any of its respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to this Agreement and the Transactions which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions therefrom) or the Public Stockholders, whether in the form of money damages or injunctive relief, the Party or parties defending such claim, shall be entitled to recover from the Party commencing such Action the associated legal fees and costs in connection with any such Action, in the event the Party defending such Action prevails in such Action. This section shall survive termination of the BIBCA for any reason and continue indefinitely.

 

4

 

Release and Covenant Not to Sue. Effective as of the End Date, to the fullest extent permitted by applicable Law, each Company Shareholder, on behalf of itself and its Affiliates that owns any share or other equity interest in or of such Company Shareholder (the “Releasing Persons”), hereby releases and discharges the Purchaser and the Company and its subsidiaries (collectively, the “Target Companies”) from and against any and all Actions, obligations, agreements, debts and Liabilities whatsoever, whether known or unknown, both at law and in equity, which such Releasing Person now has, has ever had or may hereafter have against the Target Companies arising on or prior to the End Date or on account of or arising out of any matter occurring on or prior to the End Date, including any rights to indemnification or reimbursement from a Target Company, whether pursuant to its Organizational Documents, Contract or otherwise, and whether or not relating to claims pending on, or asserted after, the End Date. From and after the End Date, each Releasing Person hereby irrevocably covenants to refrain from, directly or indirectly, asserting any Action, or commencing or causing to be commenced, any Action of any kind against the Target Companies or their respective Affiliates, based upon any matter purported to be released hereby. Notwithstanding anything herein to the contrary, the releases and restrictions set forth herein shall not apply to any claims a Releasing Person may have against any party pursuant to the terms and conditions of the BIBCA or any Ancillary Document.

 

Release by the Undersigned. Effective as of the Closing, the undersigned (a) hereby completely and irrevocably releases and forever discharges the Company’s directors, officers, managers, members, partners, shareholders, principals, employees, agents, representatives, predecessors, successors and assigns from any and all claims, damages, losses, demands, actions, causes of action, promises and/or liabilities whatsoever, including, but not limited to, any claims arising out of or in any way related, directly or indirectly, with the undersigned having been an equityholder and/or employee of the Company or any of its Subsidiaries, (b) completely and irrevocably releases and forever discharges the Company and its Affiliates and Subsidiaries, and their respective directors, officers, managers, members, shareholders, principals, employees, agents, representatives, predecessors, successors and assigns from any and all claims, damages, losses, demands, actions, causes of action, promises and/or liabilities arising out of or in any way related, directly or indirectly, with the undersigned having been a shareholder of the Company or any of its Subsidiaries, and (c) waives any and all claims the undersigned may have to any additional shares of the Company or any of its Subsidiaries; provided, however, that such release shall not extend to the undersigned’s rights (i) expressly set forth in the BIBCA or the exhibits thereto, and if the undersigned is an employee of the Company or any of its Subsidiaries, under any contract or agreement between the undersigned and the Company or any of its Subsidiaries, (ii) under any contract of insurance or other indemnification obligations covering or otherwise in favor of the managers, directors or officers of the Company or any of its Subsidiaries prior to the Closing, or (iii) to receive accrued but unpaid compensation (including pursuant to any employment agreement or other arrangement) or health, disability or life insurance benefits to which the undersigned is entitled, if any.

 

Confidentiality.

 

Except as may be required by Law or the rules of any stock exchange, or as otherwise permitted or expressly contemplated herein, the undersigned and his, her or its agents and representatives shall not disclose to any third party the existence of this agreement, the BIBCA or the subject matter or terms hereof and thereof; provided, however, that the undersigned shall be permitted to (a) disclose such information to his, her or its attorneys, advisors, representatives, directors, members, or investors, and (b) disclose and use such information in connection with enforcing their rights and fulfilling their obligations under this agreement or any other agreement entered into in connection with this agreement or the BIBCA. Notwithstanding the foregoing, nothing in this agreement shall restrict the ability of any of Exchange Agent from providing (i) the financial results achieved by any of the Exchange Agent entities with respect to their beneficial interest in Target Companies, (ii) a description of the Parent and its subsidiaries (including their financial performance, and the Exchange Agent’s investment and role therein), or (iii) such other information as the Exchange Agent provide to such third parties in the ordinary course of its business to the current or prospective limited partners, financing sources or other business associates of the Exchange Agent and their respective advisors in the ordinary course of business.

 

5

 

INSTRUCTIONS

 

1. Delivery of Letter of Transmittal and Certificates. Certificate(s) representing the Company shares of the undersigned, as applicable, as well as a properly completed and duly executed Letter of Transmittal and any other documents required by this Letter of Transmittal, must be delivered to the Exchange Agent at its address set forth on the cover of this Letter of Transmittal. The surrender of Company Shares will be deemed made only when this Letter of Transmittal and any other documents are received by the Exchange Agent.

 

2. Signature on Letter of Transmittal, Stock Powers and Endorsements. This Letter of Transmittal should be signed by the registered holder of Company Shares surrendered hereby without any correction or change in the name of the registered holder, the signature must correspond exactly with the name as written on the stock ledger for the Company Shares without any change whatsoever. In the event the name of the registered holder(s) needs to be corrected or has changed (by marriage or otherwise), please print such correction or change on the form itself and provide evidence of such change or correction as requested by the Exchange Agent, in its sole discretion. If (a) the surrendered Company Shares are registered in the name of a person other than the signer of this Letter of Transmittal, (b) the wire transfer of a Holder’s Payment is to be made to a person other than the signer of this Letter of Transmittal, or (c) the wire transfer of a Holder’s Payment is to be made to a person other than the registered owner(s) of the Company Shares surrendered hereby, then the surrendered Company Shares must be accompanied by duly executed stock or other power(s), signed exactly as the name(s) of the registered owner(s) appears on the Company’s stock ledger as registered or stock or other power(s), with the signatures on the stock or other power(s) guaranteed by a firm that is a bank, broker, dealer, credit union, savings association or other entity which is a member in good standing of the Securities Transfer Agents’ Medallion Program.

 

3. Payment and Delivery Instructions. The undersigned understands that delivery of a wire transfer or check representing the Holder’s Payment will be made after the Closing and after the surrender of the Certificate(s) is made, and this Letter of Transmittal and any other necessary documents are completed in acceptable form. The form of delivery (either wire or check) will be determined in the sole discretion of the Exchange Agent. The undersigned understands that the amount of any wire transfer or check representing any portion of the Holder’s Payment will be reduced by any applicable withholding taxes. No interest shall accrue on any cash payments to be delivered hereunder except as provided in the Escrow Agreement, if at all.

 

4. Lost, Stolen or Destroyed Share Certificate. In the event that the undersigned is unable to deliver any certificate(s) representing his, her or its Company Shares due to the loss or destruction of such certificate(s), such fact should be indicated on the face of this Letter of Transmittal. In such case, the holder should also contact the Exchange Agent to report the lost, stolen or destroyed certificate(s). An Affidavit of Lost Certificate must be completed in order to effectively surrender such lost, stolen or destroyed certificate(s). Surrenders hereunder regarding such lost certificate(s) will be processed only after such Affidavit of Lost Certificate has been submitted to and approved by the Exchange Agent.

 

5. IRS Form W-9 or IRS Form W-8. Under U.S. federal income tax laws, the Exchange Agent may be required to “backup withhold” a portion of the amount of any payments made to certain Company Shareholders, as applicable. To avoid such backup withholding, each Company Shareholder that is a United States person (for U.S. federal income tax purposes), must provide the Exchange Agent with such Company Shareholder’s correct taxpayer identification number (“TIN”) and certify that such Company Shareholder is not subject to such backup withholding by completing the attached IRS Form W-9. In general, if a Company Shareholder is an individual, the TIN is the Social Security number of such individual. If the Exchange Agent is not provided with the correct TIN, the Holder may be subject to a penalty imposed by the IRS. For further information concerning backup withholding and instructions for completing the IRS Form W-9 (including how to obtain a TIN if you do not have one and how to complete the IRS Form W-9 if the Stock Certificates are held in more than one name), consult the enclosed IRS Form W-9 and the instructions thereto.

 

a. Certain Company Shareholders (including, among others, certain corporations, non-resident foreign individuals and foreign entities) are not subject to these backup withholding and reporting requirements, but such Company Shareholders should certify their exemption by completing either the IRS Form W-9 or the appropriate IRS Form W-8, as applicable. A Company Shareholder who is a foreign individual or a foreign entity should complete, sign and submit to the Exchange Agent the appropriate IRS Form W-8. An IRS Form W-8BEN or W-8BEN-E or other applicable IRS Form W-8 may be obtained from the Exchange Agent or downloaded from the IRS’s website at the following address: http://www.irs.gov. Failure to complete the IRS Form W-9 or applicable IRS Form W-8 may require the Exchange Agent to withhold a portion of the amount of any payments made to a Company Shareholder.

 

6

 

b. If backup withholding applies under Applicable Law, the Exchange Agent is required to withhold a portion of any payments of the purchase price made to the Company Shareholder. Backup withholding is not an additional tax. Rather, the tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may be obtained from the IRS provided that the required information is furnished to the IRS.

 

Please consult your accountant or tax advisor for further guidance regarding the completion of the IRS Form W-9 or the appropriate IRS Form W-8, as applicable, to claim exemption from backup withholding or contact the Exchange Agent.

 

6. Miscellaneous. The Exchange Agent anticipates that it will provide notification of any defects in the deposit and surrender of any Company Shares, but neither the Parent nor the Exchange Agent shall incur any liability for failure to give such notice.

 

7. Share Transfer Taxes. If payment for Surrendered Securities is to be made by wire transfer to any person(s) other than the registered holder(s) of the Surrendered Securities, it shall be a condition of such payment that the amount of any transfer taxes (whether imposed on the registered holder(s) or such other person(s)) payable on account of the transfer (or transfers) of the Surrendered Securities shall be delivered to the Parent or deducted from such payment if satisfactory evidence of the payment of such taxes or non-applicability thereof is not submitted to the Parent or the Exchange Agent before such payment is made.

 

7

 

ALL SHAREHOLDERS MUST SIGN HERE
(Also Complete the Form W-8BEN (or W-9))

 

The undersigned acknowledges that the undersigned has thoroughly read this Letter of Transmittal and agrees to be bound by the terms and conditions set forth herein and in the accompanying materials.

 

The wire transfer or check representing the Holder’s Payment will be issued only in the name of the person submitting this Letter of Transmittal and will be mailed to the address set forth below.

 

 

 

Signature of Holder

 

Dated: ______________, 2023

 

(Must be signed by registered holder exactly as the name appears on the stock ledger. If signature is by an officer of a corporation, attorney-in-fact, executor, administrator, trustee, guardian or other person(s) acting in a fiduciary or representative capacity, then please set forth full title.)

 

Name of Holder:  

 

(Please print)

 

Tax Identification or Social Security No.:    

 

Address of Holder:    
     
     
     
Area Code and Tel. No.:    
     
Number and Class of Company Shares to be Delivered:    
     
     
     
  [Attach sheet for additional entries]  

 

[SIGNATURE PAGE TO LETTER OF TRANSMITTAL]

 

8

 

Wire instructions:

 

  Account Name:    
  Account Number:    
  Bank Name:    
  ABA Number:    

 

Lost Certificates

 

☐ I have lost my Certificate(s) that represented         Company Shares (class: _____________). I have completed the Affidavit and Indemnification Concerning Lost Certificate(s) attached hereto.

 

9

 

AFFIDAVIT AND INDEMNIFICATION CONCERNING LOST CERTIFICATE(S)

 

Re: Certificate(s) representing Company Shares

 

Class of Shares _______________________

Certificate Number(s) __________________ (the “Certificate(s)”),

Number of Shares ____________________ (the “Shares”),

Shareholder Name ____________________, being duly sworn, affirms the following:

 

1. My name is ___________. I am the legal and beneficial owner of the Certificate(s) and the Shares evidenced thereby and am entitled to the possession of the Certificate(s). This Affidavit is executed by me in such capacities. I am of lawful age and have personal knowledge of the facts and circumstances hereinafter set out.

 

2. This Affidavit is made in connection with the redemption of the Certificate(s) referenced above.

 

3. I have made, or caused to be made, a diligent search for the Certificate(s) and have been unable to locate such Certificate(s). None of the Certificate(s), the Shares or any interest in the Certificate(s) or Shares has been sold, assigned, endorsed, transferred, deposited under any agreement, hypothecated, pledged, canceled or disposed of in any manner by me. No person, entity, or governmental authority, other than me, has or has asserted any right, title, claim, equity, or interest in, to, or respecting the Certificate(s) or the Shares.

 

4. In the event that the original Certificate(s) comes into my possession, I will deliver it or cause it to be delivered to Exchange Agent, or its successor, in order that the same may be canceled.

 

5. I hereby agree to indemnify and defend the Canna-Global Acquisition Corp. and its successors and assigns, to hold each harmless from and against any and all cost, claim, liability, loss, or damage whatsoever which each may suffer or incur as a result of my inability to locate the Certificate(s), including but not limited to that which may result from any claim of ownership of the Certificate(s), the Shares, or any interest in the Certificate(s) or the Shares.

 

IN WITNESS WHEREOF, the undersigned has executed this Affidavit and Indemnification Concerning Lost Certificate(s) as of the _____ day of ______________, 2023.

 

  OWNER:  
  Printed Name:  

 

 

 

IMPORTANT TAX INFORMATION

 

Under the federal tax law, a holder who transmits Certificate(s) hereby is required by law to provide the Representative with a Form W-8BEN or such holder’s correct TIN on the Form W-9 below. If such holder is an individual, then the TIN is his or her social security number. If the Exchange Agent is not provided with the correct TIN, then the holder or other payee may be subject to a $50 penalty imposed by the Internal Revenue Service. In addition, payments that are made to such holder or other payee with respect to Certificates may be subject to backup withholding.

 

Payments subject to regular wage withholding and reporting (such as payments to employees on payroll) are not also subject to backup withholding. Certain persons (including, among others, all foreign corporations and certain foreign individuals) are not subject to these backup withholding and reporting requirements. A foreign corporation or individual may qualify as an exempt recipient or other payee by submitting to the Exchange Agent a properly completed IRS Form W-8BEN, W-8BEN-E, W-8ECI or other applicable IRS Form W-8, signed under penalty of perjury attesting to such holder’s exempt status. IRS Forms W-8 may be obtained at www.irs.gov. If backup withholding applies, then the Exchange Agent is required to withhold 24% of any payments made to the holder or other payee. Backup withholding is not an additional tax. Rather, the federal income tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, then a refund may be obtained from the Internal Revenue Service.

 

Purpose of Form W-8BEN

 

Foreign persons are subject to U.S. tax at a 30% rate on income they receive from U.S. sources that consists of: Interest (including certain original issue discount (“OID”));

 

● Dividends;

● Rents;

● Royalties;

● Premiums;

● Annuities;

● Compensation for, or in expectation of, services performed;

● Substitute payments in a securities lending transaction; or

● Other fixed or determinable annual or periodical gains, profits, or income.

 

This tax is imposed on the gross amount paid and is generally collected by withholding under section 1441 of the of the United States Internal Revenue Code. A payment is considered to have been made whether it is made directly to the beneficial owner or to another person, such as an intermediary, agent, or partnership, for the benefit of the beneficial owner. If you receive certain types of income, you must provide Form W-8BEN to:

 

● Establish that you are not a U.S. person;

● Claim that you are the beneficial owner of the income for which Form W-8BEN is being provided or a foreign partner in a partnership subject to section 1446(a); and

● If applicable, claim a reduced rate of, or exemption from, withholding as a resident of a foreign country with which the United States has an income tax treaty and who is eligible for treaty benefits.

 

Purpose of Form W-9

 

To prevent backup withholding on payments made to a holder or other payee with respect to Certificates, the holder is required to notify the Exchange Agent of the holder’s correct TIN by completing the form below, certifying that the TIN provided on the Form W-9 is correct (or that such holder is awaiting a TIN) and that (1) the holder has not been notified by the Internal Revenue Service that the holder is subject to backup withholding as a result of failure to report all interest or dividends, or (2) the Internal Revenue Service has notified the holder that the holder is no longer subject to backup withholding.

 

What Number to Give the Exchange Agent

 

The holder is required to give the Exchange Agent the TIN (e.g., social security number or employer identification number) of the record owner of Certificates.

 

NOTE: Failure to complete and return the Form W-9 may result in backup withholding of 24% of any payments made to you pursuant to the Takeover Offer. Please review the enclosed guidelines for certification of taxpayer identification number on the Form W-9 for additional details.

 

FOR ADDITIONAL INFORMATION, CONTACT YOUR TAX ADVISOR

OR THE INTERNAL REVENUE SERVICE

 

 

 

W-9

 

 

 

W-8BEN

 

 

 

EXHIBIT A

 

ACCEPTANCE FORM

 

[Insert]

 

 

 

EXHIBIT B

 

CONSENT

 

[Insert]

 

 

EX-2.6 8 ex2-6.htm

 

Exhibit 2.6

 

Execution Copy

Exhibit H

 

JOINDER AGREEMENT

TO

BID IMPLEMENTATION AND BUSINESS COMBINATION AGREEMENT

 

This JOINDER AGREEMENT (the “Joinder Agreement”) is made and entered into effective as of _____, 2023 by the undersigned (the “Joining Party”) in accordance with and pursuant to that certain Bid Implementation and Business Combination Agreement, dated as of June 10, 2023 (the “BIBCA”), by and among Canna-Global Acquisition Corp, a Delaware corporation (“Purchaser”), J. Gerald Combs, solely in his capacity as the representative from and after the Effective Time (as defined in the BIBCA) for the stockholders of Purchaser in accordance with the terms and conditions of this Agreement (the “Purchaser Representative”), New Quantum Holdings Pty Ltd, a Australian private company with Australian Company Number (ACN) 628 253 743 (the “Company”), and Hyun Jong Chung, solely in his capacity as the representative from and after the Effective Time for the Company in accordance with the terms and conditions of this Agreement (the “Company Representative”). Each of Purchaser, the Purchaser Representative, the Company, and the Company Representative may be referred to herein as a “Party” or collectively, the “Parties”. Capitalized terms used but not defined in this Joinder Agreement shall have the respective meanings ascribed to such terms in the BIBCA, a copy of which has been made available to the undersigned.

 

WHEREAS, the Parties desire and intend to effect a business combination transaction whereby upon the terms and subject to the conditions of the BIBCA, the Company Shareholders shall become shareholders of Purchaser (the “Business Combination”); and

 

WHEREAS, as a condition and inducement to Purchaser’s willingness to enter into the BIBCA, simultaneously with the execution and delivery thereof, the Joining Party is required to become a party to the BIBCA by executing and delivering this Joinder Agreement, whereupon such Joining Party will be treated as a “Party” for all purposes of the BIBCA.

 

NOW, THEREFORE, in consideration of the foregoing and the respective covenants and agreements set forth herein, and intending to be legally bound hereby, the Joining Party agrees as follows:

 

1. Representations and Warranties. The Joining Party hereby represents and warrants, solely on the Joining Party’s own behalf, to Purchaser and the Company as follows as of the date of this Joinder Agreement and as of the Closing:

 

a. By its execution of this Joinder Agreement, the Joining Party (i) has received and read the BIBCA, (ii) holds or is acquiring the Company Shares in accordance with and subject to the terms and conditions of the BIBCA, (iii) shall be treated as a “Company Shareholder” under the BIBCA, with the same rights and obligations for all purposes under the BIBCA, and (iv) hereby accepts and agrees to be bound by, and subject to all of the terms and conditions of, the BIBCA and all documents, agreements and instruments delivered thereunder and pursuant thereto (the “Ancillary Documents”).

 

b. The Joining Party’s address set forth on the signature page is accurate and complete.

 

 

 

c. The Joining Party, if it is an entity, is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is organized, and it has all requisite power and authority or, if the Joining Party is an individual, has the legal capacity, to enter into this Agreement and to perform its, his or her covenants and obligations under this Agreement. If the Joining Party is an entity, the execution and delivery of this Agreement and the performance by the Joining Party of its covenants and obligations under this Agreement have been duly authorized by all necessary action on the part of the Joining Party and no further action is required on the part of the Joining Party to authorize this Agreement or the performance by the Joining Party of its covenants and obligations. This Joinder Agreement has been duly executed and delivered by the Joining Party and constitutes the valid and binding obligations of the Joining Party, enforceable against the Joining Party in accordance with its terms, except insofar as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws of general applicability relating to or affecting creditors’ rights, or by principles governing the availability of equitable remedies, whether considered in a legal proceeding at law or in equity.

 

d. The execution and delivery of this Joinder Agreement by the undersigned shall have the same force and effect as the execution and delivery of the BIBCA by the undersigned and, upon receipt of this Joinder Agreement by the Parties, the signature of the undersigned set forth below shall constitute a counterpart signature to the BIBCA.

 

e. The Joining Party is the sole record and beneficial owner of the Company Shares. Such Company Shares owned by the Joining Party are not subject to any Liens (other than applicable community property interests (if any) and restrictions under applicable securities laws) or to any rights of first refusal of any kind, and the Joining Party has not granted any rights to purchase such Company Shares to any other person (other than rights of first refusal and repurchase rights in favor of the Company). The Joining Party has the sole right to vote such Joining Party’s Company Shares and has not deposited (or permitted the deposit of) any such Company Shares in a voting trust or granted any proxy or entered into any voting agreement with respect to any such Company Shares, and has not granted any other person any right whatsoever with respect to the voting or disposition of such Company Shares. Such Company Shares constitute all of the Company Shares owned, beneficially or of record, by the Joining Party, and, except for any Company Options held by the Joining Party as designated as being owned by the Joining Party underneath the Joining Party’s name on the signature page to this Joinder Agreement, the Joining Party has no options, warrants or other rights to acquire Company Shares.

 

f. There is no legal proceeding pending, or to the knowledge of the Joining Party, threatened, against the Joining Party, arising out of or relating to (i) the Joining Party’s beneficial ownership of Company Shares or rights to acquire Company Shares, (ii) the Joining Party’s capacity as a Shareholder or (iii) the transactions contemplated by the BIBCA.

 

g. No person has acted, directly or indirectly, as a broker, finder or financial advisor for the Joining Party in connection with the transactions contemplated by this Joinder Agreement and no Person is or will be entitled to any fee or commission or like payment, other than as set forth in the BIBCA.

 

 

 

2. Waiver and Release Regarding Prior Issuances. The Joining Party has certain notice and preemptive rights in connection with the issuance or transfer of Company Shares (including but not limited to anti-dilution rights, preemption/participation rights, rights of first refusal/offer, co-sale/tag-along rights, cash out rights, consent/approval rights, share/option vesting/conversion/exercise rights, rights with respect to non-compliances/breaches under any applicable laws, the Shareholders’ Agreement amongst the Company and the shareholders of the Company dated 31 October 2020 (the “Shareholders Agreement”), the governing documents of the Company and/or other agreement(s) we have entered into with the Company) the “Preemptive Rights”).

 

a. To the extent permissible under applicable laws, the Joining Party hereby:

 

i. represents and warrants that the Joining Party has not assigned any Preemptive Right to any Person;

 

ii. WAIVES, prospectively and retrospectively, as applicable, irrevocably and unconditionally (i) any and all of its the Preemptive Rights, as such rights relate to the issuance, transfer or sale of Company Shares prior to the date of the Business Combination (the “Prior Issuances”) or in connection with and as contemplated in the BIBCA (the “BIBCA Issuances”), and (ii) any and all breaches that may have occurred under any applicable laws, the Shareholders Agreement, the governing documents of the Company and/or other agreement(s) we have entered into with the Company as a result of or in connection with the Prior Issuance or the BIBCA Issuances; and

 

iii. on the Joining Party’s own behalf, and on behalf of the Joining Party’s affiliates and their and the Joining Party’s respective heirs, personal representatives, successors and assigns (the “Releasing Parties”), does hereby irrevocably, unconditionally, voluntarily, knowingly, fully, finally, and completely forever release, acquit and forever discharge the Company and its Subsidiaries, its past, present, and future parent companies, subsidiaries, and affiliates, and the past, present, and future, directors, managers, officers, employees, agents, representatives, successors, and assigns of each of the foregoing (collectively, the “Releasees”) from any and all claims, demands and causes of action, whether known or unknown, liquidated or contingent, relating to, arising out of or in any way connected with the Preemptive Rights attributable to the Prior Issuances or the BCA Issuances from the beginning of time through the Closing Date (the “Released Claims”).

 

b. The Joining Party acknowledges that the laws of many jurisdictions provide substantially the following: “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.” The Joining Party acknowledges that such provisions are designed to protect a party from waiving claims which such party does not know exist or may exist, and, nonetheless, the Joining Party agrees that, effective as of the date hereof, the Joining Party shall waive any such provision.

 

c. The Joining Party further agrees that none of the Releasing Parties shall: (a) institute any legal proceeding or make any claim based upon, arising out of, or relating to any of the Released Claims; (b) participate, assist or cooperate in any such legal proceeding or claim; and (c) encourage, assist and/or solicit any other person to institute any such legal proceeding or claim. Notwithstanding anything herein to the contrary, the Joining Party acknowledges and agrees that nothing in this Section 2 shall operate as a release or discharge of any claims, rights or obligations arising under the BIBCA that are not otherwise Released Claims.

 

 

 

3. Any notice, demand or other communication under the BIBCA to the Joining Party shall be given thereto at the address set forth on the signature page to this Joinder Agreement in accordance with Section 12.1 of the BIBCA.

 

4. The Joining Party agrees that the Joining Party has been represented by counsel (or been afforded the opportunity to do so) during the negotiation and execution of this Joinder Agreement and, therefore, waives the application of any law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the party drafting such agreement or document.

 

5. The Parties are intended third party beneficiaries of this Joinder Agreement and shall be entitled to enforce this Joinder Agreement against the Joining Party in accordance with its terms.

 

6. If any provision of this Joinder Agreement, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Joinder Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the Parties and the Joinder Party and such void or unenforceable provision of this Joinder Agreement shall be replaced with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.

 

7. This Joinder Agreement shall terminate and be of no force or effect upon termination of the BIBCA.

 

8. This Joinder Agreement shall be governed by, and construed in accordance with, the law of the State of Delaware without giving effect to any choice of law provisions.

 

9. This Joinder Agreement may be executed and delivered in two or more counterparts via electronic transmission, each of which shall be deemed an original and all of which shall be considered one and the same instrument.

 

[Signature page follows.]

 

 

 

IN WITNESS WHEREOF, this Joinder Agreement has been duly executed and delivered by the Joining Party effective as of the first date written above.

 

  JOINING PARTY:
   
  Durand GWA Pty Ltd ATF Durand Retirement Fund (ACN 153 215 064)
   
  By:
  Name: Denis John Durand
  Title: Director
   
  Address for notices:
   
  160 Dendy Street Brighton East VIC 3187 Australia
   
  Email: denis@fgwp.com.au

 

[Signature Page – Joinder Agreement]

 

 

 

IN WITNESS WHEREOF, this Joinder Agreement has been duly executed and delivered by the Joining Party effective as of the first date written above.

 

  JOINING PARTY:
   
  Durand Holdings (VIC) Pty Ltd (ACN 139 540 435)
   
  By:
  Name: Denis John Durand
  Title: Director
   
  Address for notices:
   
  160 Dendy Street Brighton East VIC 3187 Australia
   
  Email: denis@fgwp.com.au

 

[Signature Page – Joinder Agreement]

 

 

 

IN WITNESS WHEREOF, this Joinder Agreement has been duly executed and delivered by the Joining Party effective as of the first date written above.

 

  JOINING PARTY:
   
  Mr. Hyun Jong Chung ATF Chung Family Trust
   
  By:
  Name: Hyun Jong Chung
  Title: Director
   
  Address for notices:
   
  8 Sunden Way NORTH EPPING NSW 2121 Australia
   
  Email: jong@newquantum.com

 

[Signature Page – Joinder Agreement]

 

 

 

IN WITNESS WHEREOF, this Joinder Agreement has been duly executed and delivered by the Joining Party effective as of the first date written above.

 

  JOINING PARTY:
   
  NQ Nominees Pty. Ltd. ATF NQ Nominees Unit Trust (666 485 614)
   
  By:
  Name: Hyun Jong Chung
  Title: Director
  Email: jong@newquantum.com
     
  By:
  Name: Denis John Durand
  Title: Director
  Email: denis@fgwp.com.au
   
  Address for notices:
   
  8 Sunden Way NORTH ROCKS NSW 2151 Australia

 

[Signature Page – Joinder Agreement]

 

 

 

IN WITNESS WHEREOF, this Joinder Agreement has been duly executed and delivered by the Joining Party effective as of the first date written above.

 

  JOINING PARTY:
   
  Woodbridge Company Pty Ltd ATF Woodbridge Trust (609 752 801)
   
  By:
  Name: Babar Ali
  Title: Founder & Technology Advisor
   
  Address for notices:
   
  79 Queen Street ASHFIELD NSW 2131 Australia
   
  Email: bali@newquantum.com

 

[Signature Page – Joinder Agreement]

 

 

 

Acknowledged and agreed as of the date hereof:

 

PURCHASER:  
   
CANNA-GLOBAL ACQUISITION CORP  
   
By:  
Name: J. Gerald Combs  
Title: Chief Executive Officer  
   
PURCHASER REPRESENTATIVE:  
   
J. GERALD COMBS  
   
By:  

 

[Signature Page – Joinder Agreement]

 

 

 

Acknowledged and agreed as of the date hereof:

 

COMPANY:  
   
NEW QUANTUM HOLDINGS PTY LTD  
   
By:  
Name: Hyun Jong Chung  
Title: Managing Director  
   
COMPANY REPRESENTATIVE:  
   
HYUN JONG CHUNG  
   
By:  

 

[Signature Page – Joinder Agreement]

 

 

 

EX-99.1 9 ex99-1.htm

 

Exhibit 99.1

 

 

New Quantum Holdings Pty Ltd., a Cutting-Edge Wealth Management Platform, with Proprietary Fintech as a Service Technology, Plans to Become Public via a Business Combination with Nasdaq-listed Canna-Global Acquisition Corp.

 

~ Transaction values New Quantum Holdings at pro forma enterprise value of $800 million ~

 

~ New Quantum’s state-of-the-art platform is based on its proprietary Fintech as a Service (“FaaS”) technology ~

 

~ New Quantum’s scalable AI-based platform manages investment portfolios efficiently for the financial services industry ~

 

~ The global asset management industry hit a high-water mark of $126 trillion of assets under management (AUM), up from 23 percent a decade ago, that is expected to grow to $145 trillion by 2025 ~

 

~ New Quantum CEO, Jong Chung, will continue to lead the company ~

 

~ Business combination expected to close in the second half of 2023 ~

 

New York, June 15, 2023 - Canna-Global Acquisition Corp (“Canna-Global”) (NASDAQ:CNGL), a special purpose acquisition company, today announced the signing of a definitive Bid Implementation and Business Acquisition Agreement with Sydney-based New Quantum Holdings Pty Ltd. (“New Quantum”), a provider of cutting-edge wealth management all-in-one Fintech as a Service (FaaS), that will result in New Quantum becoming a wholly-owned subsidiary of Canna-Global, which is expected to be listed on the Nasdaq Global Market under the ticker symbol “NQH.”

 

The business combination transaction reflects an estimated proforma enterprise value of New Quantum at US$800 million and follows New Quantum’s recent acquisition of a majority interest in Morrison Securities from the ASX-listed Sequoia Financial Group for $A40.5 million. New Quantum intends to add technology solutions to the Morrison Securities marketplace to enhance the user experience. The combined entities have, in addition to a leading technology platform, AUD $20 billion of committed funds under management, and a qualified additional pipeline of AUD $80 billion.

 

FaaS technology is a business model that enables companies to outsource financial technology (fintech) services to a third-party provider. This model provides companies with a more flexible and cost-effective way to access fintech services and improve their financial operations. New Quantum’s technology manages investment portfolios efficiently for the financial services industry.

 

 

 

In connection with the proposed transaction, Canna-Global intends to file relevant materials with the United States Securities and Exchange Commission (SEC) including a registration statement on Form S-4, which will include a proxy statement/prospectus, and other documents regarding the proposed transaction, which is expected to close by the fourth quarter of 2023. The completion of the Bid Implementation also requires approval from the Australian Securities and Investments Commission (“ASIC”), which the parties hope to finalize in July 2023.

 

New Quantum CEO, Jong Chung, remarked that this transaction will unleash significant value for both companies by allowing New Quantum to offer its all-in-one FaaS in the abundant US market, as well as providing another avenue to the Middle East and Asian markets. Mr. Chung added, “When we acquired 80% of Morrison Securities, it not only confirmed our leadership position in the Australian wealth management fintech industry, but also provided us with the springboard to rapidly scale up. By merging with Canna-Global we’re realizing our ambition to be a significant global player in the fintech industry by having the foundation for measured growth that optimizes client services and support.”

 

Beaconsfield Capital Management co-founder and CIO, Shantanu Jha, who was an early investor in New Quantum, announced that “We are very pleased to see New Quantum, and its redoubtable financial technology platform, earn a place on the Nasdaq. We hope to continue guiding New Quantum in the financing of both its market leading technology and its acquisition of leading financial services firms in Australia and Asia.

 

According to a Forbes Magazine November 2022 article, the global wealth management industry is estimated to hold $103 trillion in assets under management (AUM), making it an enormous industry with AUM expected to grow to $145 trillion by 2025. North America remains at the top of geographical rankings with the highest growth in revenues and AUM, and revenues reaching a record $526 billion.

 

J. Gerald (“Gerry”) Combs, CEO of Canna-Global Acquisition Corp, remarked that “New Quantum is a pioneer with its proprietary Fintech as a service technology platform. We are proud to merge with a technology company that is already high growth, with strong gross margins, and attractive recurring revenue streams. The Nasdaq is the right home for New Quantum and is in line with its growth plans in the USA. Access to public markets will accelerate New Quantum’s ability to drive growth and innovation in an industry ripe for disruption.”

 

“New Quantum’s operating system for financial services firms, combined with the venerable and diverse financial infrastructure of the newly acquired Morrison, exemplifies our belief in vertically integrated business models that can internalize the value created by the underlying technological automation,” said New Quantum CEO, Mr. Jung.

 

Upon the closing of the transaction, New Quantum will continue to be led by its CEO, Mr Jong Chung, an experienced senior corporate executive has been operating companies for more than 25 years. He has experience across a variety of industries and a wealth of knowledge of accounting and wealth management.

 

About New Quantum Holdings Pty Ltd.

 

New Quantum Holding Pty Ltd. provides global unified fintech as a service (FaaS), delivering a fully integrated digital platform for wealth managers, family offices, governments, asset managers, fintech businesses, and financial advisors.

 

About Canna-Global Acquisition Corp

 

Canna-Global Acquisition Corp is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. In December 2021, Canna-Global consummated an initial public offering of its units, with each unit consisting of one share of Class A Common Stock and one redeemable warrant. Each warrant entitles its holder to purchase one share of Class A Common Stock at a price of $11.50 per share. Canna-Global is excited to focus on New Quantum, an emerging technology company in Australia. EF Hutton, division of Benchmark Investments LLC, served as the sole book-running manager of Canna-Global’s initial public offering.

 

 

 

Transaction Overview

 

Under the terms of the proposed transaction, New Quantum will combine with Canna-Global and become a publicly traded entity. The transaction reflects an estimated proforma enterprise value for New Quantum of $800 million.

 

Although the Boards of both New Quantum and Canna-Global have unanimously approved the transaction, the transaction remains subject to the approval of Canna-Global stockholders and other customary closing conditions.

 

Additional information about the proposed transaction, including a copy of the Bid Implementation and Business Combination Agreement will be available in a current report filed by Canna-Global on Form 8-K with the U.S. Securities and Exchange Commission (“SEC”), which may be found at www.sec.gov.

 

Advisors

 

Rimon PC is servicing as United States legal counsel to Canna-Global Acquisition Corp. K&L Gates (Australia) is serving as Australian legal counsel to New Quantum.

 

ARC Group Ltd. is serving as exclusive financial advisor to Canna-Global. EF Hutton, division of Benchmark Investments, LLC, is serving as Capital Markets Advisor.

 

Non-GAAP Financial Measures

 

This press release includes certain non-GAAP financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. Canna-Global and New Quantum believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends of New Quantum. These non-GAAP measures should not be considered in isolation from, or as an alternative to, financial measures determined in accordance with GAAP. Additionally, to the extent that forward-looking non-GAAP financial measures are provided, they are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation.

 

Important Information About the Proposed Business Combination and Where to Find It

 

For additional information on the proposed transaction, see Canna-Global’s Current Report on Form 8-K, which will be filed concurrently with this press release. In connection with the proposed transaction, Canna-Global intends to file relevant materials with the SEC, including a registration statement on Form S-4, which will include a proxy statement/prospectus, and other documents regarding the proposed transaction. Canna-Global’s shareholders and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials will contain important information about New Quantum and Canna-Global and the proposed business combination. Promptly after the Form S-4 is declared effective by the SEC, Canna-Global will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to the approval of the business combination and other proposals set forth in the proxy statement/prospectus. Before making any voting or investment decision, investors and shareholders of Canna-Global are urged to carefully read the entire registration statement and proxy statement/prospectus, when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the proposed transaction. The documents filed by Canna-Global with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov, or by directing a request to Canna-Global, 4640 Admiralty Way, Suite 500, Marina Del Rey, California 90292.

 

 

 

Participants in the Solicitation

 

Canna-Global, Canna-Global LLC (Canna-Global’s sponsor) and New Quantum and their respective directors and officers and other members of management and employees may be deemed participants in the solicitation of proxies in connection with the proposed Business Combination. Canna-Global stockholders and other interested persons may obtain, without charge, more detailed information regarding directors and officers of Canna-Global in the final prospectus of Canna-Global filed with the SEC on November 29, 2021, the Registration Statement and other relevant materials filed with the SEC in connection with the proposed Business Combination when they become available. These documents can be obtained free of charge from the sources indicated above.

 

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests is included in the proxy statement/prospectus filed with the SEC on Form S-4. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.

 

Cautionary Statement Regarding Forward-Looking Statements

 

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of federal securities laws. Forward-looking statements may include, but are not limited to, statements with respect to (i) trends in the financial advisory industry, including changes in demand and supply related to New Quantum’s products and services; (ii) New Quantum’s growth prospects and New Quantum’s market size; (iii) New Quantum’s projected financial and operational performance including relative to its competitors; (iv) new product and service offerings New Quantum may introduce in the future; (v) the potential transaction, including the implied enterprise value, the expected post-closing ownership structure and the likelihood and ability of the parties to consummate the potential transaction successfully; (vi) the risk the proposed business combination may not be completed in a timely manner or at all, which may adversely affect the price of Canna-Global securities; (vii) the failure to satisfy the conditions to the consummation of the proposed business combination, including the approval of the proposed business combination by the shareholders of Canna-Global; (viii) the effect of the announcement or pendency of the proposed business combination on Canna-Global’s or New Quantum’s business relationships, performance and business generally; (ix) the outcome of any legal proceedings that may be instituted against Canna-Global or New Quantum related to the proposed business combination or any agreement related thereto; (x) the ability to maintain the listing of Canna-Global on Nasdaq; (xi) the price of Canna-Global’s securities, including volatility resulting from changes in the competitive and regulated industry in which New Quantum operates, variations in performance across competitors, changes in laws and regulations affecting New Quantum’s business and changes in the combined capital structure; (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed business combination and identify and realize additional opportunities; and (xiii) other statements regarding Canna-Global’s or New Quantum’s expectations, hopes, beliefs, intentions and strategies regarding the future.

 

 

 

In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject, are subject to risks and uncertainties.

 

You should carefully consider the risks and uncertainties described in the “Risk Factors” section of Canna-Global’s final prospectus dated November 29, 2021, and filed with the SEC on October 12, 2021 for its initial public offering and, the proxy statement/prospectus relating to this transaction, which is expected to be filed by Canna-Global with the SEC, other documents filed by Canna-Global from time to time with SEC, and any risk factors made available to you in connection with Canna-Global, New Quantum, and the transaction. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of New Quantum and Canna-Global) and other assumptions, that may cause the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Canna-Global and New Quantum caution that the foregoing list of factors is not exclusive.

 

No Offer or Solicitation

 

This press release relates to a proposed business combination between Canna-Global and New Quantum, and does not constitute a proxy statement or solicitation of a proxy and does not constitute an offer to sell or a solicitation of an offer to buy the securities of Canna-Global or New Quantum, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

 

Canna-Global Contact

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, California 90292

Attention: J. Gerald Combs, CEO

Email: gerry@gcombs.com

Tel: 917.576.2537

 

New Quantum Media Contact:

 

Abbey Minogue, Capital Outcomes

abbey@capitaloutcomes.co

Tel: +61-488 006 979

 

And:

IR@newquantum.com

 

 

 

 

 

EX-99.2 10 ex99-2.htm

 

Exhibit 99.2

 

 

New Quantum Holdings plans to become public in the USA

 

~Via a business combination agreement with Nasdaq-listed Canna-Global Acquisition Corp

 

~ Transaction values New Quantum Holdings at pro forma enterprise value of $800 million expected to close in the second half of 2023 ~

 

New York, June 15th, 2023 - Canna-Global Acquisition Corp (“Canna-Global”) (NASDAQ:CNGL), a special purpose acquisition company, today announced the signing of a definitive Bid Implementation and Business Acquisition Agreement with Sydney-based New Quantum Holdings Pty Ltd. (“New Quantum”), a provider of a vertically integrated technology and infrastructure offering for financial services firms, that will result in New Quantum becoming a wholly-owned subsidiary of Canna Global, which is expected to be listed on the Nasdaq Global Market under the ticker symbol “NQH”

 

The business combination transaction reflects an estimated proforma enterprise value of New Quantum at USD $800M and follows New Quantum’s recent acquisition of a majority interest in Morrison Securities from the ASX-listed, Sequoia Financial Group (ASX:SEQ) in June 2023. The combined entities have, in addition to a leading technology platform, AUD $20 billion of committed funds under management, and a qualified additional pipeline of AUD $80 billion.

 

New Quantum CEO Jong Chung comments, “New Quantum’s technology and platform have the potential to revolutionize the financial services industry by providing high value services at a scale only their technology makes possible.”

 

He added: “When we acquired 80 percent of Morrison Securities, it not only confirmed our leadership position in the Australian fintech industry, but also provided us with the ballast to rapidly expand our offering in the market.”

 

Gerry Combs, CEO of Canna-Global Acquisition Corp comments, “New Quantum is a pioneer with its proprietary Fintech as a service technology platform. We are proud to merge with a technology company that is already high growth, with strong gross margins, and attractive recurring revenue streams. The Nasdaq is the right home for New Quantum and is in line with its growth plans in the USA. Access to public markets will accelerate New Quantum’s ability to drive growth and innovation in an industry ripe for disruption”.

 

New Quantum’s primary sponsor is Beaconsfield Capital Management, a Boston and London based hedge fund focused on investments in leading technology companies. Beaconsfield Capital Management Co-Founder and CIO Shantanu Jha says, “We are pleased to see New Quantum, and its redoubtable financial technology platform, earn a place on the Nasdaq. We hope to continue guiding New Quantum in developing its market leading technology and its acquisition of leading financial services firms in Australia and Asia.

 

1

 

“We continue to believe New Quantum’s operating system for financial services firms, combined with the venerable financial infrastructure of the newly acquired Morrison, exemplifies the power of vertically integrated business models that can internalise the value created by the underlying technological automation.”

 

In connection with the proposed transaction, Canna-Global intends to file relevant materials with the US Securities and Exchange Commission (SEC) including a registration statement on Form S-4, which will include a proxy statement/prospectus, and other documents regarding the proposed transaction expected to be finalised in the fourth quarter of 2023. ASIC (Australian Securities & Investments Commission) approval for the Bid Implementation is expected by mid-June, 2023.

 

About New Quantum Holdings Pty Ltd.

 

New Quantum Holding Pty Ltd provides global unified fintech as a service (FaaS), delivering a fully integrated digital platform for wealth managers, family offices, governments, asset managers, fintech businesses, and financial advisors.

 

About Canna-Global Acquisition Corp

 

Canna-Global Acquisition Corp is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. In December 2021, Canna-Global consummated an initial public offering of its units, with each unit consisting of one share of Class A Common Stock and one redeemable warrant. Each warrant entitles its holder to purchase one share of Class A Common Stock at a price of $11.50 per share. Canna-Global is excited to focus on New Quantum, an emerging technology company in Australia. EF Hutton, division of Benchmark Investments LLC, served as the sole book-running manager of Canna Global’s initial public offering.

 

Transaction Overview

 

Under the terms of the proposed transaction, New Quantum will combine with Canna-Global and become a publicly traded entity. The transaction reflects an estimated pro forma enterprise value for New Quantum of $800 million.

 

Although the Boards of both New Quantum and Canna-Global have unanimously approved the transaction, the transaction remains subject to the approval of Canna-Global stockholders and other customary closing conditions.

 

Additional information about the proposed transaction, including a copy of the Bid Implementation and Business Combination Agreement will be available in a current report filed by Canna-Global on Form 8-K with the U.S. Securities and Exchange Commission (“SEC”), which may be found at www.sec.gov.

 

Advisors

 

Rimon PC is servicing as United States legal counsel to Canna-Global. K&L Gates is serving as Australian legal counsel to New Quantum.

 

ARC Group Ltd. is serving as exclusive financial advisor to Canna-Global. EF Hutton, division of Benchmark Investments, LLC, is serving as Capital Markets Advisor.

 

2

 

Non-GAAP Financial Measures

 

This press release includes certain non-GAAP financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. Canna-Global and New Quantum believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends of New Quantum. These non-GAAP measures should not be considered in isolation from, or as an alternative to, financial measures determined in accordance with GAAP. Additionally, to the extent that forward-looking non-GAAP financial measures are provided, they are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation.

 

Important Information About the Proposed Business Combination and Where to Find It

 

For additional information on the proposed transaction, see Canna-Global’s Current Report on Form 8-K, which will be filed concurrently with this press release. In connection with the proposed transaction, Canna-Global intends to file relevant materials with the SEC, including a registration statement on Form S-4, which will include a proxy statement/prospectus, and other documents regarding the proposed transaction. Canna-Global’s shareholders and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials will contain important information about New Quantum and Canna-Global and the proposed business combination. Promptly after the Form S-4 is declared effective by the SEC, Canna-Global will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to the approval of the business combination and other proposals set forth in the proxy statement/prospectus. Before making any voting or investment decision, investors and shareholders of Canna-Global are urged to carefully read the entire registration statement and proxy statement/prospectus, when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the proposed transaction. The documents filed by Canna-Global with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov, or by directing a request to Canna-Global, 4640 Admiralty Way, Suite 500, Marina Del Rey, California 90292.

 

Participants in the Solicitation

 

Canna-Global and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from Canna-Global’s shareholders in connection with the proposed transaction. A list of the names of those directors and executive officers and a description of their interests in Canna-Global will be included in the proxy statement/prospectus for the proposed business combination when available at www.sec.gov.

 

Information about Canna-Global’s directors and executive officers and their ownership of Canna-Global shares of common stock is set forth in Canna-Global’s final prospectus for its for its initial public offering dated November 29, 2021, and filed with the SEC on October 12, 2021, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement/prospectus pertaining to the proposed business combination when it becomes available. These documents can be obtained free of charge from the source indicated above.

 

3

 

New Quantum and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Canna-Global in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the proxy statement/prospectus for the proposed business combination.

 

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests is included in the proxy statement/prospectus filed with the SEC on Form S-4. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.

 

Cautionary Statement Regarding Forward-Looking Statements

 

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of federal securities laws. Forward-looking statements may include, but are not limited to, statements with respect to (i) trends in the financial advisory industry, including changes in demand and supply related to New Quantum’s products and services; (ii) New Quantum’s growth prospects and New Quantum’s market size; (iii) New Quantum’s projected financial and operational performance including relative to its competitors; (iv) new product and service offerings New Quantum may introduce in the future; (v) the potential transaction, including the implied enterprise value, the expected post-closing ownership structure and the likelihood and ability of the parties to consummate the potential transaction successfully; (vi) the risk the proposed business combination may not be completed in a timely manner or at all, which may adversely affect the price of Canna-Global securities; (vii) the failure to satisfy the conditions to the consummation of the proposed business combination, including the approval of the proposed business combination by the shareholders of Canna-Global; (viii) the effect of the announcement or pendency of the proposed business combination on Canna-Global’s or New Quantum’s business relationships, performance and business generally; (ix) the outcome of any legal proceedings that may be instituted against Canna-Global or New Quantum related to the proposed business combination or any agreement related thereto; (x) the ability to maintain the listing of Canna-Global on Nasdaq; (xi) the price of Canna-Global’s securities, including volatility resulting from changes in the competitive and regulated industry in which New Quantum operates, variations in performance across competitors, changes in laws and regulations affecting New Quantum’s business and changes in the combined capital structure; (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed business combination and identify and realize additional opportunities; and (xiii) other statements regarding Canna-Global’s or New Quantum’s expectations, hopes, beliefs, intentions and strategies regarding the future.

 

In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject, are subject to risks and uncertainties.

 

4

 

You should carefully consider the risks and uncertainties described in the “Risk Factors” section of Canna-Global’s final prospectus dated November 29, 2021, and filed with the SEC on October 12, 2021 for its initial public offering and, the proxy statement/prospectus relating to this transaction, which is expected to be filed by Canna-Global with the SEC, other documents filed by Canna-Global from time to time with SEC, and any risk factors made available to you in connection with Canna-Global, New Quantum, and the transaction. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of New Quantum and Canna-Global) and other assumptions, that may cause the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Canna-Global and New Quantum caution that the foregoing list of factors is not exclusive.

 

No Offer or Solicitation

 

This press release relates to a proposed business combination between Canna-Global and New Quantum, and does not constitute a proxy statement or solicitation of a proxy and does not constitute an offer to sell or a solicitation of an offer to buy the securities of Canna-Global or New Quantum, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

 

Contact

 

Canna-Global Acquisition Corp.

4640 Admiralty Way, Suite 500

Marina Del Rey, California 90292

Attention: J. Gerald Combs, CEO

Email: gerry@gcombs.com

 

Media Contact:

 

Abbey Minogue, Capital Outcomes

abbey@capitaloutcomes.co

+61-488 006 979

 

And:

IR@newquantum.com

 

5